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Abstract
A unique transgenic mouse line displayed the phenotype of sex-linked cleft 
palate. As no other mouse line expressing this transgene demonstrated a similar phenotype, it 
is argued that the disorder is due to the disruption of the cellular locus. At the very least this 
mutation results in redirecting expression of the transgene in a unique fashion, alternatively, a 
gene(s) at the locus is critical to normal secondary palate development. Therefore 32.8Kb of 
cellular DNA of the cellular locus disrupted in this mutant has been cloned and characterised.
This 32.8Kb of wild type DNA has been characterised at the level of conservation of 
sequence between species and expression. No potential gene encoding sequences were 
initially found. Subsequently, using the technique of exon-trapping several exons have been 
isolated from the wild type locus. When these exons were hybridised to Northern blots of 
embryonic and post-natal RNAs they revealed a 4.5Kb, a 0.8Kb and a 0.5Kb transcript, each 
expressed in the head and body during embryonic development. The 0.8Kb message was 
shown to be expressed post-natally in a tissue specific manner.
Five individual exons have been isolated and sequenced. They range in size 
from 81bp to 446bp. One exon (exon p50, 446bp in size) was found to be composed of 
repetitive sequence but it did not contain an open reading frame (ORF) that spanned the exon.
The other four exons (exon p51, p52, p56 and p57) were found to contain an ORF that
V:
spanned the exon. Database analysis with the sequence of the exons revealed that two of the 
exons (exon p56 and exon p57) showed no homology to nucleotide sequences in databases.
and another (exon p52) exhibited a high level of similarity to CaM kinase II at both the
nucleotide and amino acid level.
Using RT-PCR, two of the exons (exon p52 and exon p57) were shown to be 
expressed at the RNA level during development in the wild type mouse. Exon p52 and exon 
p57 were also found to be spliced together. Cloning and sequencing of this exon p52-exon 
p57 RT-PCR product revealed that this RT-PCR product contained a single ORF that spanned 
the sequence of both exons spliced together. The amino acid sequence of the putative peptide
I!
_
encoded by this ORF revealed 47% identity to the calmodulin-binding domain of CaM kinase
II. Analysis of this RT-PCR product in RNA derived from transgenically positive spleen 
revealed that several products are present which are absent in the wild type. These novel 
products hybridise with exon p52 and exon p57 sequences as well as the transgene sequences, 
indicating that the splicing of the RT-PCR product is aberrant in the transgenic mutant.
A human form of heritable sex-linked cleft palate has been well documented. 
The phenotypes observed in the transgenic mutant and the cloning of the gene from the wild 
type locus may lead to the identification of the human gene involved in heritable sex-linked 
cleft palate, as well as provide a model for the analysis of the disorder.
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81 INTRODUCTION
1.1 Mouse developmental mutants
This thesis describes the isolation and characterisation of a locus whose 
disruption by transgene insertion resulted in a mouse developmental mutant that 
exhibited sex-linked cleft palate. Much of the progress in mammalian developmental 
biology throughout this century is based on studies of the developmental genetics of 
mutations in the laboratory mouse. Many of the 1300 or so genetic loci currently 
mapped in the mouse were identified originally on the basis of a mutant 
developmental phenotype in inbred mouse strains (Lyon and Searle, 1989). These 
classic mutants have been augmented by the use of highly efficient chemical 
mutagens and X-ray irradiation to generate new mutants (for review, see Rinchik 
1991). For the major part of this century the descriptions of the temporal and spatial 
aspects of these mutant gene phenotypes helped reveal information about the 
respective wild type gene action, while the underlying molecular mechanisms of 
gene action were inaccessible. With the advances in recombinant DNA technology 
and improvements in genetic and physical mapping methodologies, the large 
collection of mutants generated is now being defined at the molecular level (Reith 
and Bernstein, 1991).
The advances in recombinant DNA technology and embryonic stem cell 
culture allow the generation of new mouse mutants for known loci (Capecchi, 1989; 
Rudnicki and Jaenisch, 1991). When this capability is coupled with the new 
methodologies for analysing the genes of organisms, the genomes of organisms can 
now be modified to address specific developmental problems. Over the past 10 years 
transgenic technology has succeeded in generating a range of exciting developmental 
mutants. The analysis of these mutants has given a great insight into the mechanisms 
of mammalian embryogenesis and its genetic control. With the increased capabilities 
of technology the goal of the present day developmental biologist remains
unchanged from that of the pioneers', namely to identify the role of the genes 
responsible for controlling the developmental mechanisms active during 
embryogenesis.
Some genes that play critical roles in murine development have been 
identified because there was pre-existing knowledge about the basic biochemical 
defect, or they were the homologues of genes essential for normal development in 
other organisms, a process known as 'functional cloning'. Unfortunately, 'functional 
cloning' is of no use for the vast majority of genes active during development as no 
functional information exists. An alternative approach to identifying gene loci is the 
method of 'positional cloning' (Collins, 1992). It requires the physical location of the 
gene in the genome to be known and usually little information is required regarding 
the gene's function. Positional cloning is based on the methods of chromosome 
walking and the identification of expressed sequences. This can be extremely 
laborious and time consuming especially if the region of the chromosome to be 
walked is large. Sometimes other features of the genome can aid in the cloning of the 
gene, e.g. cytogenetic markers such as translocations and rearrangements. In some 
cases the nature of the mutant gene's sequence can aid in its isolation, e.g. the 
expanded trinucleotide repeat of fragile X locus (Verkerk et al., 1991) can be 
detected by Southern analysis.
However for the majority of genes present in the mouse genome the 
position of the locus is unknown. In these cases the size of the region to which the 
gene is assigned (the critical region) is usually more than two megabases, (2 x 10^  
base pairs), requiring the isolation and examination of all the genes contained in that 
region. Positional cloning is very labour intensive and expensive and it will benefit 
greatly from the ability to assign gene loci accurately on the genome. This 
assignment requires the generation of a high resolution molecular genetic linkage 
map of the mouse genome (Copeland and Jenkins, 1991), Positional cloning will also 
benefit from the construction of overlapping yeast artifical chromosome contigs that 
cover the entire genome.
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With the increased information available from a physical map of the 
genome and the new methodologies for analysing DNA, in time, functional and 
positional cloning will be superseded by the candidate gene approach (Ballabio, 
1993). The candidate gene approach does not require the isolation of new genes, but 
relies on the availability of information from previously isolated genes. With the 
steady increase in transcript density for each mouse chromosome the candidate gene 
approach will gradually improve with time. A striking example of the success of the 
candidate gene approach is the cloning of the human glycerol kinase gene (GK). Two 
groups spent several years mapping and cloning the GK critical region before finally 
isolating the gene by positional cloning, whereas another group mapped a randomly 
isolated expressed sequence tag (EST), homologous to bacterial glycerol kinase, to 
the human Xp21 region (Ballabio, 1993). The second group found that the gene they 
had isolated directly using EST screening was the candidate gene for human 
glycerol kinase deficiency. It was the combined information on function and position 
which led to the gene's identification, bypassing the time consuming approach of 
positional cloning.
When a locus has no known function and no candidate gene is available the 
rate limiting step in gene identification is the need to sift through hundreds of 
thousands of base pairs to identify a transcript. A method to avoid the time 
consuming and costly sift of genetic sands is to tag the gene in some way. The tag 
acts as a genetic landmark that simplifies identification of the gene. The tag 
sometimes generates a phenotype by its presence and this phenotype may reveal 
information about the gene's normal function. Since the advent of transgenic 
technology there have been several interesting reports of mutants generated by 
transgene insertion. There has also been a drive to produce a more systematic method 
of generating insertional mutations using enhancer trap and reporter constructs 
(Rijkers et a l , 1994). These new systems, coupled with advances in embryonic stem 
cell culture allow a prescreening for patterns of expression before the analysis of 
phenotype requires extensive breeding. Here, however only insertional mutations as
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a result of retroviral infection or microinjection of transgenic DNA and some 
spontaneous mutants are discussed further.
1.2 Insertional mutagenesis
The process of generating transgenic mice requires the introduction of 
foreign DNA into a host's genome. There are two major strategies for achieving this, 
the first is retroviral infection and the second is microinjection of linear constructs. It 
is logical to assume that if the pattern of integration of the transgene is purely 
random then the transgene should integrate in host genes at a certain frequency. The 
presence of the transgene may disrupt or insertionally mutate a host gene resulting in 
a mutant phenotype. This method of generating mutants aids the molecular analysis 
of the disrupted gene as the problems associated with positional cloning are not 
encountered. The presence of transgene sequences in or near the host gene acts as a 
readily identifiable marker for the host gene enabling the cloning of the interrupted 
locus. This allows the structure and function of the mutated gene to be analysed 
using molecular genetic techniques. However, problems do occur depending on the 
method chosen to introduce the transgenic sequences into the host.
There are now well documented examples of the generation of insertional 
mutants in the mouse by either, microinjection of cloned DNA into the pronucleus of 
fertilised oocytes or by retroviral infection of pre-implantation embryos.
Retroviral insertional mutagenesis
Retroviruses are RNA viruses that replicate via a DNA intermediate called 
the provirus. Transgenic mice can be generated at high frequency by retroviral 
infection of pre-implantation embryos. A commonly used retrovirus in the generation 
of transgenic mice is the Moloney-Murine leukaemia virus (Mo-MLV), This 
retrovirus can cause viremia, as a result of its replication in the host cells which has 
been shown to induce leukaemia in mice. To prevent this, replication incompetent 
recombinant retroviruses are used to generate the transgenic mice. Concentrated 
recombinant retrovirus is introduced to 8- or 16-cell embryos by infection prior to
12
introducing the embryos into the uteri of pseudopregnant mice. Approximately 80% 
of the preimplantation embryos exposed to the retrovirus give rise to transgenically 
positive mice. During replication a single provirus integrates into the hosts genome.
In contrast to pronuclei microinjection, retroviral integration results in a 
short duplication of cellular sequence on either side of the provirus. Therefore, any 
mutant phenotype associated with proviral integration is more likely to be a result of 
the integration of the provirus rather than larger rearrangements in genomic DNA. 
The presence of a single copy of the provirus and the lack of any major alterations in 
the cellular sequence of the transgenic mouse greatly aids in the interpretation of any 
phenotype that may result from proviral integration. This is a great aid when it comes 
to the isolation of genes affected by retroviral integration. However, a draw back of 
retroviral insertional mutagenesis is the preference shown by retroviruses to integrate 
near DNase-1-hypersensitive regions, suggesting a preference for transcriptionally 
active chromatin or chromatin in an open configuration. This may result in proviral 
integration in or near the subset of genes active during the earliest stages of 
embryogenesis. Although the majority of insertional mutants have been generated by 
microinjection, because of the frequent complexity of integration most of the best 
characterised mutants are those that have been generated by retroviral insertion 
(Rudnicki and Jaenisch, 1991). These transgenic mutants exhibit a wide range of 
interesting phenotypes that allow a study of many different molecular processes and 
the subsequent identification of genes involved.
The first described insertional mutation was the Movl3 mouse (Jaenisch et 
al., 1983). It had been generated by the infection of day 8 mouse embryos by Mo- 
MLV. Embryos homozygous for the insertion at the Movl3 locus die at day 12 of 
development, this results from necrosis of erythropoietic and mesenchymal cells in 
the liver. Integration of the Mo-MLV was found to be in the first intron of the al(I) 
collagen gene, reducing its level of expression in most tissues (Kratochwil et a l, 
1989). Evidence suggested that the reduction in expression observed in the Movl3 
line results from disruption of cis -acting regulatory elements within the first intron.
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However, the introduction of of the human proal (I) collagen gene into the Movl3 
line resulted in only partial rescue of the homozygous phenotype. This indicated that 
either there is a subtle functional defect in the hybrid protein or that a second 
functional gene was disrupted by the Mo-MLV integration (Wu et a l, 1990).
Another interesting insertional mutant mouse is the M pvl?  mouse line 
resulting from the infection of preimplantation embryos with an MPSVneo retrovirus 
(Weiher et aL, 1990). The vast majority of mutants characterised show embryonic 
failures, however, the M pvl7 mutant develops normally and only exhibits a 
phenotype in the adult mouse. Adult mice homozygous for the Mpvl? integration 
develop nephrotic syndrome and chronic renal failure, occurring between 2 and 9 
months post-natally. Fragments of DNA detected flanking the provirus revealed a 
1.7kb RNA transcript that was ubiquitously expressed during embryonic 
development and expressed at high levels in the kidney, brain and heart of the adult. 
This transcript was not detected in Mpvl 7 homozygous for the insertion mice. The 
1.7kb transcript encodes a 176 amino acid residue protein that contains two 
hydrophobic domains suggesting membrane association. This Mpvl? mouse line has 
not only been used to identify a gene important in kidney function, but it may also 
prove to be a mouse model for human nephrotic syndrome (Weiher et a l , 1990), To 
isolate a gene of this nature from human patients with renal failure would have been 
very expensive and very labour intensive. Insertional mutagenesis offers the 
opportunity to generate mouse models of human diseases either by design or good 
fortune.
Spontaneous insertional mutations
Since the first description of a retroviral insertional mutation there have 
been several reports of mutations generated by spontaneous retroviral and 
retrotransposon insertion. Bowes et a l, (1993), have shown that the mutated gene 
responsible for the disease of retinal disintegration in the rd mouse encodes the p 
subunit of cGMP phosphodiesterase (p-PDE). It was observed that an endogenous 
xenotropic murine leukaemia virus {Xmv ) was closely linked to the rd  locus by
genetic linkage analysis. Closer analysis revealed that the Xmv-28 provirus had 
integrated within the first intron of the rd p-PDE gene in the opposite orientation 
with respect to the sense strand of the p-PDE gene. This integration event was 
associated exclusively with the rd phenotype. In rd mice the level of p PDE 
transcripts was markedly decreased and the transcripts are of abnormal size. It 
appears that proviral integration results in the rd phenotype by disrupting 
transcription of the p-PDE gene.
There have been several reports of proposed retrotransposable element 
integrations resulting in mutant phenotypes m humans (Holmes et a l, 1994). The LI 
elements are found in all mammalian genomes and belong to a class of 
retrotransposable elements that lack long terminal repeats. When the LI element 
replicates it usually exhibits a variable length target site duplication flanking the 
element. Other features include a 3' poly A tail, along with 5' truncation of the 
majority of elements (only about 3% of the 50,000-100,000 elements present in the 
human genome are the full length of 6.1kb). Holmes et aL, (1994), reported the 
identification of an LI insertion into the dystrophin gene resulting in Duchenne 
muscular dystrophy and the isolation of its precursor. They were able to identify the 
LI element that was the precursor of the LI element that inserted in the dystrophin 
gene based on the presence of a single-copy unique sequence component (USC) 
flanking the insertion and the precursor.
Insertional mutagenesis by microinjection of zygotes
Microinjection of cloned DNA into the pronucleus of fertilised mouse 
oocytes results in integration of the transgenic DNA in about 25% of animals bom 
(Rudnicki and Jaenisch, 1991). Insertional mutants are generated at a frequency of 
about 8% and many of these are recessive lethal. This frequency may be a low 
estimate as many of the phenotypes may be very subtle and difficult to detect. The 
majority of transgenic mice generated by microinjection contain multiple copies of 
the transgene construct, often as tandem repeats at a single locus. At the site of 
integration, the host chromosome often has undergone deletions, inversions, 
duplications, translocations, and other major modifications. Most of the insertional 
mutants that have been characterised were generated by microinjection. This reflects 
the popularity of microinjection over other methods of introducing transgenic DNA, 
rather than any inherent advantage of microinjection for generating insertional 
mutants. Also, possibly the rearrangements generated a more dramatic phenotype 
(more mutational).
Although microinjection of pronuclei has generated several exciting 
insertional mutants, there are a number of serious limitations, the major limitation 
being the integrity of the integration site in the host DNA. As mentioned above when 
microinjected transgenes integrate they do so in a complex fashion, usually inducing 
profound changes in the chromosomal structure and organisation of cellular sequence 
at the integration site. These changes in cellular sequence, e.g., large inversions and 
translocations may affect more than one gene, making it difficult to identify the 
cause of the observed phenotype, e.g., the legless mouse insertional mutant has at 
least two integrated transgenes separated by 30kb of cellular sequence integrated on 
chromosome 12 (Singh a/., 1991).
The legless mutant mentioned earlier is a transgenic insertional mutation 
found in the pHTl-1 line of transgenic mice (McNeish et aL, 1988). All the mice 
homozygous for this mutation have deficient hindlimbs, with structures distal to
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femur absent. The forelimbs of legless mice are also malformed, but this 
malformation is highly variable.The mutant mice have aberrant brains, with the most 
anterior structures usually absent. Craniofacial clefts are observed in about 50% of 
the mutants and half of the mutant mice exhibited situs inversus, a mirror image 
arrangement of internal organs. Molecular analysis of the disrupted region indicated 
two tightly linked insertion sites separated by 30kb of cellular sequence. Evidence 
suggests that transgene insertion has disrupted more than one gene, and several 
cDNAs have been isolated from libraries (Singh et ai, 1991).
Several of the insertional events described in the literature resulted in the 
mutation of genes important in development. It should be stressed that the insertional 
mutations were serendipitous events, the transgenic mice were created to investigate 
the effect of a transgene's expression, not to create an insertional mutant. Also, many 
insertional events generating mutant phenotypes are not identified as they result in
:embryonic lethality and are not detected in the screen for the expected phenotypes.
While some of the insertional mutations result in the identification of novel loci 
involved in developmental pathways, other insertional events produce phenotypes 
similar to well characterised mouse mutants. An example of this is the insertional 
mutation anterior digit-pattem deformity, add. Generated during the construction of 
transgenic mice harbouring the human al-acid glycoprotein genes (Dente et al.,
1988), add mice exhibit a forelimb defect where the thumb becomes elongated and 
the second digit often contains an extra phalanx (Pohl et al., 1990). Using mouse
,DNA from the site of insertion flanking the transgene, add has been mapped close to 
the centromere on chromosome 13. Evidence suggests that the add locus is tightly 
linked to a genetically mapped locus extra-toes (Xt). The phenotype of the double 
mutant add /Xt suggests that they are allelic.
Another insertional mutant that exhibits limb deformities is the novel 
mouse mutant fused toes (Ft), discovered in the course of generating transgenic mice 
with the activated human Ha-ras gene under the control of the human (3-interferon 
promoter (Van der Hoeven et a l, 1994). A founder female exhibited the novel
-■[
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phenotype characterised by fused toes on the fore limbs and hemizygous animals 
displayed a thymic hyperplasia. Homozygosity of the transgene insertion leads to 
malformation of the developing brain, loss of the genetic control of left-right 
asymmetry and to death around day 10 of embryonic development. Analysis of limb 
development and immature thymocytes in vitro indicated that apoptosis 
(programmed cell death) is affected in the mutant line. As the phenotype may be a 
result of transgene insertion, it was possible to use the transgene sequences to map 
the site of insertion to chromosome 8. As with the fused toes mutant no gene has so 
far been identified at this locus. To date no gene has been isolated from around the 
site of insertion, but this insertional mutation may allow the identification of a novel 
gene involved in apoptosis during murine development. In case of both the add and 
Ft mutants it has not been formally proven that transgene expression is not involved 
in the phenotypes observed.
The rearrangements accompanying transgene insertion that occurs with 
microinjection of zygotes makes the identification of loci responsible for the mutant 
phenotype very difficult. Wilson et at,, (1993), have reported a transgenic mouse line 
that exhibits a mutant phenotype of sex-linked cleft palate, the transgene contains the 
Latent Membrane Protein-1 (LMP-1) from Epstein-Barr Virus (EBV). Analysis of 
this transgenic line revealed that the transgene was present on the X chromosome as 
a tandem repeat of two copies in a head to tail configuration. Unexpectedly the site 
of transgene integration appeared not to have undergone any major rearrangements, 
the transgene flanking fragments were isolated and found to be contiguous in wild 
type DNA (McFarlane and Wilson, in press). Therefore the affected locus is only 
disrupted by the presence of the transgene and not affected by major rearrangements. 
This thesis describes the work aimed at characterising the disrupted locus in this sex- 
linked cleft palate insertional mutant.
This sex-linked cleft palate transgenic mutant offered the chance to isolate a 
gene involved in secondary palate formation during embryogenesis. The advantages 
of this mouse model are:
IE
(1) The clean insertion of the transgene will aid the genetic interpretation of the 
mutation.
(2) The phenotype presented in the mutant is "relatively simple".
(3) The palate is a well studied structure through development but little is known 
about the genetic controls.
(4) This insertional mutant is a possible mouse model for the documented and 
mapped human heritable disorder of sex-linked cleft palate. The non sex-linked form 
of cleft palate is a very common disorder in humans.
1.3 Morphogenesis of the secondary palate
The developing palate is often used as a model system for investigating 
fundamental questions common to the embryogenesis of many structures as it 
appears relatively late in embryogenesis and can be excised and cultured under 
chemically defined conditions (Ferguson, 1988). It also exhibits many important 
features such as morphogenetic movements, extracellular matrix synthesis, 
neurotransmitter synthesis, cell adhesion, epithelial-mesenchymal interactions and 
regional patterning (reviewed in Ferguson, 1987).
Mesenchymal cells from the neural crest migrate to the primitive oral cavity 
where in association with craniopharyngeal ectoderm they form the bilateral 
maxillary processes. The palatal shelves arise from the maxillary processes and 
initially grow vertically down the sides of the tongue. At a precise moment during 
development they elevate to a horizontal position above the tongue where by a 
combination of processes they fuse at about day 15 of embryonic development 
(Figure 1). The palatal shelves associate with each other through the medial edge 
epithelia, this rapidly degenerates by a combination of cell death and cell migration. 
This establishes mesenchymal continuity across the unified palate, the mesenchymal 
cells then consolidate and differentiate. Cleft palate may result from the perturbation 
of any number of critical processes during palate formation: defective palatal shelf 
growth, delayed or failed shelf elevation, defective shelf fusion, failure of cell death
Figure 1: Histological section through the anterior region of the 
palate in a (a) day 13.5 embryonic mouse head and traverse 
histological sections through the mid-palate region of (b) early 
day 14 and (c) late day 14 embryonic mouse head. Note the 
vertical palatal shelves (p) firmly wedged against the tongue (t) 
in preparation for shelf elevation in figure 1(a). The palatal 
shelves first approximate each other, figure 1(b), their medial 
edge epithelia (arrowed) then contact with each other and fuse 
to form the midline epithelial seam, figure 1(c). x21 (Ferguson, 
1988).
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or cell migration along the medial epithelial edge or failure of subsequent 
mesenchymal differentiation resulting in postfusion rupture (Ferguson, 1988).
Trying to unravel the molecular processes that govern palate development 
is therefore very difficult, considering the number and complexity of the mechanisms 
involved. Each of these molecular mechanisms will be regulated by any number of 
genes and so cleft palate may result from several genetic dysfunctions. The 
susceptibility of the palate to clefting is also reflected in the ability to induce cleft 
palate with the use of chemicals such as retinoic acid and alcohol. The high 
incidence of cleft palate observed with craniofacial malformations suggests that the 
development of the palate is very dependent on the orofacial environment. These 
failures can result from defects in the palate itself, e.g. failed shelf elevation or steric 
interference from craniofacial morphology. It was observed that during the period of 
shelf elevation, there is almost no growth in head width, but constant growth in head 
height. This means that the base of the growing palatal shelves are moving away 
from the tongue, resulting in the path of least resistance for shelf elevation being 
above the tongue (Diewart, 1978). Therefore, changes in craniofacial morphology 
may well impair shelf elevation preventing subsequent palatal shelf fusion.
Shelf elevation is a rapid event occurring in minutes or hours in vivo. It is 
governed by an intrinsic force generated within the palatal shelves, the major 
component of which is a regionally specific build up of glycosaminoglycans, 
especially hyaluronic acid. Hyaluronic acid is highly electrostatically charged 
capable of binding up to 10 times its weight in water. In the early stages of 
shelf growth the accumulation of hyaluronic acid is responsible for the majority of 
the increase in shelf size by extracellular matrix swelling rather than mesenchymal 
cell division. The shelf elevating force is partly delivered by stout bundles of type I 
collagen which run down the centre of the shelf from the base. The epithelial 
covering of the shelves exhibits differential traction that helps direct the swelling 
force. The mesenchymal cells at the centre of the shelves are themselves contractile 
and able to secrete neurotransmitters that regulate the degradation of
glycosaminoglycans and influence the contractility of the mesenchymal cells 
themselves (Ferguson, 1988). When the palatal shelves make contact they adhere to 
each other by means of a sticky cell surface glycoprotein coat, to form an epithelial 
seam. This epithelial interaction is specific, the epithelium of the palatal shelves will 
not fuse with any other epithelium.
Mouse medial edge epithelial cells rapidly form desmosomes and 
accumulate desmoplakin on their cell membranes just prior to contact (Ferguson, 
1988). Antibodies generated to the medial edge epithelium have identified several 
new cell surface molecules, none of the antibodies to known cell adhesion molecules 
produce a similar pattern of staining of medial edge epithelia. These new antibodies 
may identify novel proteins active during palatal shelf fusion. Certain lectins have 
been identified at the medial edge epithelium suggesting the presence of surface 
molecules rich in carbohydrate. In the chicken, which displays physiological cleft 
palate, the medial edge epithelia exhibit none of the sticky surface coat 
specialisations, do not form desmosomes and do not adhere to each other.
No sooner has the epithelial seam formed than it begins to thin. This is 
achieved by an increase in palatal height and a migration of epithelial cells onto the 
oral and nasal surfaces of the palate. Some of the epithelial seam cells undergo 
apoptosis while others are observed to migrate into the mesenchyme. Single palatal 
shelves have been shown to undergo differentiation, so this process of medial 
epithelium disruption is not dependent on shelf contact.
A series of experiments carried out by Ferguson and Honig, 
revealed that the signal for medial edge epithelium is specified by the underlying 
mesenchyme. Epithelial-mesenchymal recombination experiments using 
combinations of mandibular, limb and palatal tissues within and between mouse, 
chicken and alligator embryos were attempted. It was found that for the chicken and 
alligator the mesenchyme signals nasal, medial and oral epithelial differentiation in a 
species-specific fashion. The mouse exhibited similar results except that the mouse 
epithelium receives its signal to differentiate at the onset of palatogenesis and will
continue to do so even if placed on a ’neutral' mesenchyme. The mouse mesenchyme 
can signal differentiation to epithelium of other species.
There are four possible ways in which the mesenchyme could signal 
epithelial differentiation; (a) extracellular matrix molecules, (b) soluble factors, (c) 
direct cell-cell contact and (d) a combination of a-c. Direct cell-cell contact does not 
occur between mesenchymal cells and epithelial cells as shown by electron 
microscopy, it therefore seems unlikely that direct cell-cell contact is involved in the 
signalling. An immunocytochemical survey of the developing palate revealed the 
presence of collagen types I-X, laminin, fibronectin, tenascin, heparan sulphate 
proteoglycan, chrondroitin 0, 4, 6, sulphates in patterns of expression that suggested 
these molecules were not involved in the signalling pathway. Collagen IX exhibited 
an interesting pattern of expression. It is absent from the mesenchymal cells of the 
developing palatal shelves at day 12 to day 13 of development, but just prior to 
palatal shelf elevation type IX collagen appears on the surface of the epithelial cells 
at the medial edge. This is the precise time of mesenchymal signalling. However it is 
not clear whether the appearance of type IX collagen is the mesenchymal-epithelial 
signal or whether it is actually a response to the signal.
The mesenchymal-epithelial signal may be a soluble growth factor, such as 
epidermal growth factor, transforming growth factor alpha (TGFa), transforming 
growth factor beta (TGF(3), acidic and basic fibroblast growth factors (FGF) and 
platelet-derived growth factor (PDGF), all of which are expressed during palate 
development. These growth factors have a plethora of conflicting effects on cell 
behaviour and on the extracellular matrix e.g. the synthesis of extracellular matrix 
molecules such as type IX collagen is stimulated by TGFa and TGF|3, while it is 
inhibited by FGF, all of which are known to be present in the developing palate. 
TGFa and PDGF stimulate cell division in mesenchymal cells, whereas TGF|3 
inhibits palatal mesenchymal cell growth and kills some cells. It should be noted that 
the same growth factor can stimulate cell division at one concentration and inhibit it 
at another; populations of cells respond differently to the same concentration of a
growth factor depending upon their density and the nature of their substratum 
(Massague, 1987). No account has been taken of the presence of the receptors for the 
growth factors. These may exist in any pattern of distribution across the palatal 
shelves. So we have another layer of complexity with gradients of growth factors 
interacting with gradients of their respective receptors. The expression of soluble 
growth factors during palate development results in a complex pattern of interactions 
between the effects of the various growth factors, some of which will be synergistic 
and others antagonistic.
The different developmental mechanisms that may result in cleft palate are 
understood at the morphological level. The genes controlling these events are less 
easily defined mainly due to the numerous processes and pathways involved or 
implicated. The following molecules alone are all implicated: extracellular matrix 
molecules particularly hyaluronic acid, collagen molecules e.g. type IX, tenascin, 
soluble factors e.g. EGF, PDGF, TGFa, TGF(3, FGF, cytokeratins and cell surface 
molecules.
1.4 Genes whose disruption result in cleft palate
Recently it has been reported that TGFp 3 plays a vital role in 
palatogenesis. A transgenic knockout mouse for TGFp 3 has been created and the 
only phenotype observed was that of cleft palate (Mark Ferguson, personal 
communication). TGFp 3 is expressed in many tissues during embryonic 
development, however it was expressed at very high levels at the tips of the palatal 
shelves prior to palatal shelf fusion. This TGFp 3 knockout mouse has revealed a 
single gene whose disruption specifically results in cleft palate. How this gene's 
diruption impinges on palate development is not understood as yet, but provides a 
key signal from which relevant molecular interactions may be investigated.
Many of the cases of cleft palate observed in both mouse and human do not 
involve mutations of genes specifically involved in palatogenesis. Rather the cleft 
palate observed is a secondary effect of other mutated developmental pathways.
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Recently several genes responsible for patterning of the head have been identified. 
Chisaka and Capecchi, (1991), produced direct evidence that Hox genes play an 
important role in the patterning of the head. They generated a germline mutation in 
the mouse Hox-1.5 gene using homologous recombination to disrupt the endogenous 
gene in embryonic stem cells, Lufkin et a l, (1991), also generated germline 
mutations in a Hox gene, the Hox-1.6 gene. Both mutations resulted in neonatal 
lethality of mice homozygous for the disrupted allele. Both of these mutations 
resulted in cleft secondary palate though they are not directly involved in 
palatogenesis. Mice homozygous for the Hox-1.5 mutation exhibit a wide range of 
throat abnormalities, defects of the heart and arteries as well as craniofacial 
abnormalities.
The Hox-1.6 mutant links Hox genes and the branchial region of the head. 
The abnormalities observed are localised to cells derived from rhombomeres 4-7 and 
their associated second and third branchial arches. The abnormal neural crest 
derivatives are confined to the neurogenic structures (Lufkin et a l, 1991). Many of 
the affected structures derive from interactive tissues and so it is not possible to 
differentiate between primary and secondary effects of gene disruption. However 
what is clear is the altered regional specification of the neural epithelium, leading to 
altered patterning in the rhombomeres and the subsequent alteration of patterning of 
the branchial arches. This results in the absence of certain cranial nerves and ganglia 
and multiple malformations of the inner ear and bones of the skull (Lufkin et a i , 
1991).
The Hox-1.5 homozygous mutant phenotypes are observed in a complex set 
of tissues largely confined to the head and thorax, and not all tissues that express 
Hox-1.5 gene are affected (Chisaka and Cappechi, 1991). The abnormalities in 
case appear confined to a subset of the mesenchymal components, while the 
neurogenic derivatives appear completely normal. Cranial neural crest generates 
most of the mesenchyme for bone and connective tissue of the branchial arch. It is 
believed that crest migration takes place in two waves: the first phase comprising the
mesenchymal components, and the second phase representing the neurogenic crest. 
Comparison of the results from the two mutant mice indicates that patterning of the 
subpopulations of the neural crest occurs before migration from the neural 
epithelium. In both cases the rhombomeres themselves appear morphologically 
normal suggesting that Hox genes have a role in specifying segmental identity rather 
than generating the individual segments. The disruption of Hox-1.5 and Hox-1.6 
reveal how the developing palate is not only very susceptible to perturbations in 
genes required for palatal development but also to the disruption of genes not 
normally associated with the developing palate. Disruption of a particular gene may 
alter the patterning or a regulatory cascade during development so that phenotypes 
are observed in tissues not normally associated with that gene's expression domain. 
An alternative explanation is that cleft palate is a secondary event resulting from the 
abnormalities in craniofacial development in these animals.
These Hox genes have been shown to be fundamental to pattern formation 
in the developing cranial structures. They are by no means sufficient to explain the 
molecular mechanisms responsible for head development. A recent report has 
exposed the phenotypic effects of mutations in a structural protein on the developing 
palate. Mouse cartilage matrix deficiency {cmd ) is an autosomal recessive mutation 
characterised by cleft palate, short limbs, tail and snout (Watanabe et a l, 1994), 
Biochemical and immunological studies have demonstrated a major reduction in the 
amount of aggrecan in the cartilage matrix of cmd mice, although normal levels of 
link protein and type II collagen were detected. Aggrecan, a proteoglycan, is one of 
the major structural components of cartilage whose function is to absorb shock and 
resist compression in the joints. It is extensively modified by substitution with 
chondroitin sulphate and keratin sulphate chains, and by other oligosaccharides. 
Watanabe et a l, (1994) reported the mapping of the aggrecan gene to the cmd locus 
and the identification of a mutation within the coding region of aggrecan.
The aggrecan gene contains 18 exons and was mapped to chromosome 7. A 
7 base pair deletion was found in exon 5 of a genomic clone for the N-terminal
portion of the cmd associated aggrecan gene. The deletion results in a truncated 
polypeptide which may affect the binding of hyaluronic acid, this coupled with 
possible interference in oligosaccharide binding may result in an unstable protein 
(Watanabe et a l,  1994). The cause of cleft palate in this mutant remains to be 
elucidated, though it is quite possible that the aggrecan mutation does not affect 
palate development directly. The presence of a shortened snout and a normal sized 
tongue would suggest a greatly reduced oronasal cavity during development. This 
smaller oronasal cavity may effect palatal shelf elevation resulting in cleft palate. 
Another possibility is that the binding of hyaluronic acid, which has been shown to 
be important in shelf elevation, is affected and this impinges on palatal shelf 
elevation, prevents shelf fusion and results in cleft palate.
An important feature of palate development is the epithelium-mesenchymal 
signal that induces palatal differentiation. It is believed that mutation of the genes 
that encode these epithelial-mesenchymal signals is involved in disruption of palate 
development. Recently, homeobox genes of the Msx class have been shown to be 
expressed in the epithelial or mesenchymal components of disparate tissues 
undergoing morphogenesis. In vertebrates, the expression of Msx-1 and Msx-2 is 
observed in many embryonic tissues in which epithelial-mesenchymal interactions 
occur during morphogenesis including the limb, the developing mandible and teeth 
(Hill etal., 1989, MacKenzie e ta l, 1991 and MacKenzie et a l, 1992).
In the vertebrate limb, the apical ectodermal ridge (AER) regulates the 
mesenchymal expression of Msx-1 and Msx-2, as demonstrated by transplantation 
experiments (Robert et a l , 1991) and heterospecific grafting experiments (Brown et 
a l , 1993). Msx-2 gene expression and skeletal differentiation of the first pharyngeal 
arch ectomesenchyme exhibit a strict requirement for an epithelial signal, suggesting 
that Msx expression is required for the formation of craniofacial bone. In the 
developing tooth bud, the dental epithelium is required to induce the underlying 
mesenchyme to differentiate into the dental follicle and dental papilla and also to 
activate Msx-1 expression in the mesenchyme (Jowett et a l, 1993), It appears
Msx-1 and Msx-2 are primary mediators of inductive signals transmitted between 
epithelial and mesenchymal layers in these tissues.
Satokata and Maas (1994), have generated homozygous Msx-1~ mice. They 
report that these mice die in the immediate postnatal period and exhibit marked 
abnormalities in craniofacial development, including cleft secondary palate, a failure 
of tooth and aveolar bone development in the mandible and maxilla, and 
abnormalities of the skull, malleus, nasal bones and conchae (Satokata and Maas, 
1994). The abnormal dental development could be predicted from the pattern of gene 
expression (MacKenzie et a l , 1991, and MacKenzie et a l, 1992). But the disruption 
of palate development could not be predicted as Msx-1 is normally absent from the 
developing palate. Also Msx-1 has a widespread pattern of expression throughout the 
developing embryo yet it is predominantly the craniofacial structures that are 
affected. This suggests that Msx-1 has a unique function in the developing head. The 
phenotypes observed in the Msx-1' mouse suggests that during limb development 
Msx-1 expression is either not required or its absence can be compensated by the 
expression of other genes e.g. Msx-2. The abnormal phenotypes observed offer the 
possibility that Msx-1 is a candidate gene for mutation in craniofacial abnormalities 
observed in humans especially cleft palate.
The palatal shelves do elevate in the Msx-l~!Msx-l' micQ but are 
developmentally delayed. This resembles the phenotype seen in many cases of 
human cleft palate. Although Msx-1 is expressed at day 12 of embryonic 
development anteriorly in the developing palatal shelves, it is not expressed at the 
time of shelf elevation (day 13.5). The palatal shelves are adjacent to the alveolar 
maxillae and also adjacent to the dental follicle mesenchyme. In the Msx-l'IMsx-1' 
mice these alveolar maxillae are deficient. Satokata and Maas (1994), propose that 
the absence of Msx-1 expression in the dental follicle mesenchyme is related to 
impaired palatal development. This would suggest a link between the occurrence of 
cleft palate and abnormal tooth development. In fact 35% of individuals with isolated 
cleft palate exhibit abnormalities of their incisors and molars. Alternatively, the cleft
palate in the Msx-1 mice may arise because of a deficiency of the neural crest 
derived mesenchymal cells, as a result of problems with either neural crest cell 
proliferation or migration.
The abnormalities associated with mandibular growth and development 
could result in the pathological trapping of the palatal shelves between an 
abnormally large highly situated tongue on a small mandible. The Msx-1 ~ mice have 
a small mandible and so it is possible that the cleft palate observed is secondary to 
this abnormality. However, the palatal shelves observed in the Msx-1' mice are 
raised but do not fuse. This suggests that palatal shelf elevation occurs but that the 
palatal shelves are deficient in some respect that prevents palatal fusion, this may be 
a result of delayed shelf elevation. But it is still possible that many human cases of 
cleft palate result from the disruption of a gene involved in mandibular growth and 
development.
As the developing palate is a very complicated developmental system, the 
genes described to date whose mutation results in cleft palate may impinge on palate 
development in many ways. TGF(33 is the only candidate gene whose pattern of 
expression suggested that it may have a direct critical role in palate development. 
The TGF|33 knockout mouse supports this, in that mice homozygous for the 
knockout mutation only exhibit cleft palate (Ferguson, personal communication). 
This mouse mutant may be a model for the human condition of cleft palate, though 
most cases of human isolated cleft palate probably occur as a result of multifactorial 
inheritance. However, several families have been documented that inherit cleft palate 
in a X-linked Mendelian fashion. Wilson et a l , (1993), have reported the generation 
of a transgenic mouse mutant that exhibits sex-linked cleft palate and may be a 
mouse model for the human heritable condition.
1.5 A transgenic mouse line displays sex-linked cleft palate
A series of transgenic mice were generated by microinjection of transgenic 
constructs designed to express the Latent Membrane Protein (LMP) from Epstein-
Barr Virus (EBV) (Wilson et al. , 1990). One of the transgenic mouse lines generated 
exhibited the unique phenotype of sex-linked cleft palate, none of the other LMP 
expressing mouse lines exhibited this phenotype. The transgenic line was designated 
PyLMP.5. All transgenically positive male offspring from PyLMP.5, died within 24 
hours of birth. The survival of transgenically positive females was strain dependent. 
When positive females were bred into the mouse strain C57B1/6, transgenically 
positive females died within the first two weeks post-natally. When the positive 
females were bred into the outbred strain GDI, a few females survived to maturity. 
The ill health of the adult females resulted in small, infrequent litters. In the fourth 
generation from the founder female the PyLMP.5 line became extinct. The founder 
female (F2 of C57B1/6 x DBA2) may have been sufficiently mosaic or strain hybrid 
to avoid the severe mutant phenotype. 2/3 of the founders' offspring were 
transgenically negative but the transgene was transmitted to subsequent generations 
at the expected Mendelian ratio of 50% supporting the idea of a mosaic founder.
Of the transgenically positive progeny, new bom males were found to have 
cleft secondary palates, while females surviving to maturity did not. Both 
transgenically positive male and female mice were 50% smaller than transgenically 
negative counterparts and had altered cranial morphology, with a shortened 
(retognathic) lower jaw, indicative of abnormal development of the mandible and 
maxillae (Wilson et al. , 1993).
Histological examination of the head of a neonatal male presenting cleft 
palate revealed that the only major difference between affected and unaffected 
animals was the presence of the cleft palate. In affected animals the palatal shelves 
had elevated and were horizontal, but much smaller than normal. They extended only 
a third of the width of the palate. The oral and medial edge epithelia of the affected 
palatal shelves were heavily keratinised, while in the anterior palatal region the 
mesenchyme contained condensations of pre-osseous tissue and blood vessels. The 
presence of these features is associated with the differentiation normally observed in 
the palatal mesenchyme of the mid-palatal suture and indicates that the palatal
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shelves have undergone a normal pattern of differentiation in the mutant There were 
no abnormalities appparent in the snout, premaxillary region, or teeth (both incisors 
and molars).
Additional phenotypes were observed in this transgenic line. As females 
matured they began to display kinks in their tails and finally they assumed a hunched 
posture, due to spinal kinks. Sectioning of these kinks revealed that the bone was 
surrounded by an inflammatory cell infiltrate. The diagnosis was of cellulitis. None 
of the other LMP expressing transgenic lines displayed this bone deformation. The 
PyLMP.5 mouse did share other phenotypes with other LMP expressing lines such as 
retarded growth, delayed eye opening and sparse fur growth, but these were noted as 
being more severe in this transgenic line (Wilson et a l, 1990 and Wilson et a l, 
1993).
1.6 Cloning of the DXRiB 1 locus
The cellular sequences flanking the transgene were isolated and cloned, 
Wilson et a l, (1993), showed that the integrant existed as two copies of the 
transgene in a head to tail tandem array on the X chromosome. The cellular 
sequences flanking the transgene were cloned from a recombinant phage X library 
constructed using the mutant genomic DNA. The cloned isolates consisted of 1.8kb 
and 1.2kb of cellular sequence bounded by EcoR /  sites (used in the cloning), 
flanking the 5' and 3' ends of the transgene. When these cloned fragments were used 
as probes on Southern blots of genomic DNA from transgenically positive and 
transgenically negative mice, both were found to be unique sequence. The 
preintegration site was present as a single copy in transgenically negative males (a 
3.0kb EcoR I fragment) and two copies in transgenically negative female. In 
transgenically positive males this single copy was disrupted (10.6kb EcoR I 
fragment), while one copy was disrupted in transgenically positive females and the 
other copy remained intact, thus demonstrating that the transgene had integrated into 
the X chromosome as predicted by the phenotype.
Both the isolated cellular fragments of DNA from the transgenic line 
hybridised to the 3.0kb EcoR I fragment, indicating that they are contiguous in the 
preintegration site. This also suggested that the transgene insertion was not 
accompanied by any gross rearrangements of cellular DNA. In this instance the 
absence of any gross rearrangements should aid the identification of the mutated 
gene(s). The phenotypes observed may result from the transgene influencing a 
cellular gene in a number of ways. Transgene integration may have physically 
disrupted a cellular locus. It may have altered the pattern of expression of the cellular 
locus by either perturbing the cellular locus' regulatory sequences or by the 
introduction of transgenic regulatory sequences. There is also the possibility that the 
splicing of the cellular locus is perturbed resulting in hybrid transcripts and possibly 
transient hybrid proteins.
The cloned flanking sequences were highly conserved across all mouse sub 
species tested and specific in rat, hamster and marmoset indicating high homology 
to these sequences. The cloned cellular flanking sequences were used as probes on 
Northern blots of post-natally derived RNAs. This analysis would identify if the 
cellular sequences were part of a transcription unit post-natally. No transcripts were 
identified in this analysis, so it would appear that none of the sequences is part of a 
transcript expressed after birth (Wilson et a l, 1993). This Northern analysis was 
repeated on a Northern blot of embryonic RNAs, again no messages were detected 
(unpublished). This suggests that the cellular sequences are not part of a transcript at 
any of the time points analysed and this was further substantiated by the complete 
sequencing of the sequences, no open reading frames (ORF) were found.
However, when a Northern blot of RNAs from transgenically positive 
tissues was probed with LMP sequences two hybrid LMP/cellular transcripts were 
detected. The 2.5kb and 0.8kb LMP specific transcripts were detected on a Northern 
blot of total RNAs from a day 10 post-natal transgenically positive female mouse, 
when probed with LMP sequences. These messages were expressed in the skin and
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tongue (they were also detected in a different PyLMP transgenic mouse line that had 
an autosomal site of transgene insertion).
In addition to these two LMP specific transcripts two larger transcripts were 
detected, unique to line PyLMP.5. Approximately 4.5kb and lOkb in size these 
transcripts were detected in all tissues analysed except the liver, therefore these 
transcripts have a pattern of expression completely different to that of the transgene 
sequences. Considering that the transgene is present at the site of insertion as a 
double copy totalling 7.6kb, the larger of the two transcripts must contain cellular 
sequence. This suggests that there are cellular sequences present at or near the site of 
transgene insertion capable of being expressed at the RNA level. No hybrid proteins 
were detected in skin samples (using anti-LMP antisera) in which the hybrid
Vtranscripts were detected (Wilson et a l, 1990). The presence of these hybrid 
transcripts that must contain cellular sequence and the lack of similar phenotypes in 
other LMP-1 expressing transgenic lines suggested that transgene integration had 
disrupted a cellular locus and thereby resulted in the sex-linked cleft palate 
phenotype.
However an understanding of the phenotypes that result from transgene 
integration at the DXRiB 1 locus is complicated by transgene expression. Firstly, the 
transgene itself encodes a protein, LMP-1, that has been shown to have pleiotropic 
effects. LMP-1 has been shown to inhibit differentiation of human epithelium 
(Dawson et a l, 1990) and to cause morphological transformation of immortalised 
human kératinocytes (Fahraeus et a l, 1990). In addition to these phenotypic effects 
LMP-1 has been shown to induce the expression of Bcl-2 (Henderson et a l, 1991).
Bcl-2 is a proto-oncogene and its expression has been shown to promote the survival 
of B cell precursors and to block programmed cell death in B cells. The oncogenic 
activity of Bcl-2 is thought to result from its ability to promote cell survival rather 
than cell proliferation (Martin et a l, 1993). LMP-1 has been shown to induce 
changes in the profile of keratins expressed in the skin of mice and induce 
hyperplasia (Wilson et a l, 1990). The evidence to date is that LMP-1 induces a
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range of changes in the cell that affects its state of differentiation and proliferation, 
one of the cell types affected is epithelial cells.
In palate development the epithelium plays a crucial role in inducing and 
responding to changes in the mesenchymal cells it is in contact with. Due to the 
speed of palatal development the epithelium responds rapidly to the inducing signals. 
If anything changes the differentiation state of the cells in the developing palate then 
it may be expected that palate development itself may be effected. In the transgenic 
line the insertion of a LMP-1 expressing transgene resulted in the phenotype of sex- 
linked cleft palate. The fact that LMP-1 has been shown to induce changes in the 
differentiation state of several cell types raises the possibility that it is the LMP-1 
expression and not a disrupted gene that results in cleft palate. Several other 
transgenic lines were created that expressed the LMP-1 transgene and none of these 
exhibited the mutant phenotype (Wilson et a l, 1990). However the transgenic line 
that exhibited cleft palate expressed LMP-1 at the highest level of all the transgenic 
lines but only in the skin. So the phenotype observed in the mutant line may be a 
result of redirected transgene expression due to the cellular locus.
What is not clear is if it is the LMP protein or disruption of a cellular 
protein that results in the observed phenotype. The minimalist interpretation is that 
the cellular locus causes the expression of LMP-1 in the developing palate or skull 
with the result that the phenotype is unique to this line. While the maximal 
interpretation is that LMP-1 expression is not involved and the presence of the 
transgene at this locus disrupts a cellular protein and this disruption alone results in 
the phenotype. There is also the possibility that the cleft palate phenotype results 
from a position between the minimalist and maximal interpretations, i.e. a 
combination of cellular disruption and transgene expression.
If the sex-linked phenotype does result from transgene expression it is still 
valuable to clone this locus. The transgene specific and hybrid transcripts exhibited 
different patterns of expression and the hybrid transcripts were not detected in any 
of the other LMP-1 expressing lines. This indicates that there are sequences present
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at the cellular locus directing the expression of these hybrid transcripts and possibly 
the LMP transcripts in development. Also the larger of the two hybrid transcripts 
was too large to be transgene sequence alone, it therefore must contain some cellular 
sequences. It is also quite possible that the phenotype of sex-linked cleft palate 
results from a combination of effects from the transgene site of insertion and 
transgene expression. However, all the observations from the mutant mouse indicate 
that there are important cellular sequences present at this locus. Both minimal and 
maximal interpretations indicate that there is a developmentally expressed gene at 
this locus, therefore it is relevant to clone this locus as all interpretations point to the 
presence of a gene. The cloning of this locus will allow some understanding of the 
sequences present, their functions and their involvement in the sex-linked cleft palate 
phenotype.
Unfortunately the transgenic line that exhibited sex-linked cleft palate 
became extinct and so it was not possible to investigate the role of LMP-1 expression 
in the sex-linked cleft palate phenotype. This problem can only be addressed by the 
regeneration of the transgenic mouse for the site of insertion with a different 
transgene. If these transgenic mice exhibit sex-linked cleft palate then it is the 
disrupted product of the cellular locus that resulted in the mutant phenotype and not 
LMP-1 expression. The generation of these transgenic mice is considered in the 
discussion.
As the 3kb of transgene flanking sequence consisted of unique sequence it 
could be used to map the site of insertion to known markers on the X chromosome. 
The cloned cellular DNA was given the locus map nomenclature DXRibl (DNA 
segment, X chromosome, Robertson Institute of Biotechnology, 1) and mapped by 
interspecific backcross analysis using progeny from the matings of [(C57B1/6J x 
Mus spretus)¥l X C57B1/6J] (Copeland and Jenkins, 1991). The mapping results 
indicated that DXRibl mapped to the proximal region of the X chromosome, closely 
Hnked to but separate from Ara/and DXPasS,
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As mentioned earlier cleft palate is a common developmental abnormality 
(both heritable and spontaneous) in the human population. The incidence of cleft 
palate is approximately 1/1500 live births, with little variation between races (Stanier 
et a l, 1993). Three families have been studied which display heritable sex-linked, 
non-syndromic cleft palate and it is quite possible that this disrupted DXRibl locus is 
the homologue of the locus affected in the human form of sex-linked cleft palate. 
However, the closest marker to DXRibl is Araf and Arafvsmçs to X pll on the human 
X chromosome. The locus thought responsible for sex-linked cleft palate (CP+A) has 
recently been mapped to the other arm Xq21.1-Xq21.31 of the human X 
chromosome. The gene order of the mouse and human X chromosome are well 
conserved with breaks in blocks of synteny. Therefore, DXRiB 1 may yet be the 
homologue of CP+A at a break in synteny, or alternatively be an entirely different 
locus. Ankyloglossia (tongue-tied) is often associated with the human X-linked cleft 
palate and is found in the three kindreds studied (Moore et a l, 1987; Rollnick and 
Kaye, 1986; Gorski et a l, 1992). The similarity in phenotypes between these 
families suggests that the same gene might be involved in each case with the 
possibility that failure of programmed cell death in the tongue is the primaiy site of 
the gene defect, with cleft palate as a secondary effect. The tongue-tied phenotype 
was not observed in the mouse mutant nor has it been observed in any mice which 
may be a due to of species difference. It is interesting to note that Stanier et a l , 
(1993), propose that the X-linked cleft palate is a secondary effect of gene 
dysfunction. The presence of the craniofacial abnormalities and spinal kinks in the 
transgenic line suggests that the cleft palate observed with this line, is possibly a 
secondary effect. Even if the gene disrupted in the transgenic line is not involved 
directly in palate development, it may still be a developmentally important gene with 
a vital role in craniofacial morphogenesis.
Given the observations suggesting the presence of important gene 
sequences at this locus and the strong possibility that transgene insertion had 
disrupted a cellular locus, the 3kb of unique DNA that flanked the transgene was
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used to screen a wild type mouse genomic DNA to isolate a larger region of genomic 
DNA from around the site of transgene insertion. This wild type genomic DNA was 
then characterised.
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2 RESULTS:
2.1 Isolation of wild type mouse genomic DNA from around the site of
transgene insertion
The first step in isolating the disrupted gene was to isolate a large fragment 
from the wild type locus. A recombinant Lambda phage library containing C57 
Black/6, female mouse spleen DNA (Stratagene) was screened using the 3kb of 
cloned cellular sequences that flanked the transgene. Seven positive phage were 
identified hybridising to the flanking sequence probe. After difficulties in the first 
rounds of screening to obtain pure isolates of authentic recombinants, the mouse 
genomic library was rescreened using the transgene flanking sequence as the probe. 
The plaque purification of identified phage was continued. After twenty rounds of 
plaque purification two phage isolates from the first library screen were found to 
exhibit an expected restriction pattern upon digestion with EcoR L Further 
recombinants were identified in a second screen that contained the transgene flanking 
regions of cellular DNA. Three of the identified phage from the two rounds of 
screening were further studied in detail to yield the restriction map of the wild type 
locus (Figure 3).
These were designated Phage 1, Phage 4 and Phage 7. Digestion of Phage 
DNA with Not I liberated the genomic DNA present in each recombinant phage DNA 
clone. When restriction digested with Not /, Phage 1 was found to contain 18.2kb of 
cellular DNA, Phage 4 contained 20.8kb of cellular DNA and Phage 7 contained 
17.9kb of DNA, These cellular DNA fragments overlap to give 32.8kb of contiguous 
DNA from the wild type mouse X chromosome that surrounds the site of transgene 
insertion (Figure 3).
Each of the individual DNA fragments from the isolated phage was 
restriction mapped using enzymes with sites present in the multiple cloning site of the 
phage DNA (Figure 2). This information was used to produce a restriction map
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Phage 1 Phage 7 Phage 4
U El  NI XI El  El  U E I N I X I E I E I U Q N I X I E I E I  
NI XI  NI XI NI XI
Size Kb
Figure 2:Restriction Digest analysis of isolated recombinant Phage 
DNA. Phage DNA from the three isolated Phage was restriction 
digested with the enzymes indicated; U, undigested; El, EcoR I; NI, 
Not /; XI, Xha 7; El NI, EcoR I + Not 7; El XL, EcoR I  + Not I. The 
individual phage isolates are indicated above the enzymes used.Note; the EcoR I digests of each phage isolate are 
represented in the Physical map of the locus Figure 3.In the phage EcoR I, Not I, Xba I and double digests the 
20kb and 9kb Phage arms are apparent In the Phage 1 EcoR I  +A/bt 7 double digest a 6kb, 3.2kb, 3kb, 1.9kb, 1.5kb and 0.7kb fragments are observed.In the Phage 7 EcoR I  + Not I double digest a 6kb, 3kb, 
2.7kb, 1.9kb, 1.5kb, 1.3kb and 1.2kb fragments are observed. In the 
Phage 4 EcoR I  + Not I double digest 4.1kb, 3.9kb, 3.5kb, 3,0kb, 
1.9kb, 1.4kb, 1.3kb and 1.25kb fragments are observed.
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spanning the entire 32.8kb of mouse genomic DNA isolated. The fragments 
generated by digestion with EcoR I, ranging in size from 0.7-6kb, were subcloned 
into the plasmid pBluescript (Materials and Methods).
Based on previous studies where genes have been isolated from large 
stretches of genomic DNA, the approach of using the subclones as probes on blots 
was taken. Noted in Goodfellow et a l, (1991), species conserved regions are 
generally associated with a gene or important motif. For these subclones, it was 
important to separate unique and repetitive sequences and evaluate whether they are 
expressed or not. Southern blots of restriction digested mouse genomic DNA were 
probed with the individual EcoR I fragments in order to identify regions that 
contained unique or repetitive sequences. These fragments were also used as probes 
on Northern blots of embryonic mouse total RNAs to evaluate whether a fragment of 
DNA contained transcribed sequence or not. The conservation of sequence across 
species was investigated by probing Southern blots of DNAs derived from a number 
of species. Zoo blots, with selected individual subcloned EcoR I fragments. Those 
DNA fragments that were conserved across species and expressed were sequenced.
2,2.1 Identiticatioii of unique sequence at the wild type locus
Unique sequence was identified at this locus as it is not possible to interpret 
the expression pattern from a DNA fragment containing repetitive sequence. 
Individual EcoR I fragments derived from the isolated phage were used as probes on 
Southern blots of mouse genomic DNA restriction digested with EcoR I. This 
analysis would reveal whether the DNA present was unique sequence or composed of 
repetitive sequence. Examples of the results analysis are shown in Figure 4 and 
summarised diagramatically in Figure 7. A large proportion of the subfragments from 
the 32.8kb of isolated DNA contained repetitive sequence. Several fragments of the 
isolated DNA consisted solely of unique sequence, includmg the original 3kb EcoR I 
fragment found in all phage isolates and used to screen the phage X library. Some of 
the fragments containing repeated sequences are relatively large (e.g. the 6kb EcoR /
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(a) 
Size kb
>20 > -
M F (b) 
Size kb
M F
# 1 2 > m
7 ^ ■
V)
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(c) 
Size kb
12 > -
M F
3.5kb EcoR I 
Phage 4
1 .6 \C d E c o R I  Phage 7
6kb EcoR I Phage 7
Figure 4: Southern blot analysis of mouse genomic DNA probed 
with EcoR I fragments from the isolated genomic clones.
3.3pg of mouse genomic DNA from male (M) and female 
(F) was digested withJSco/? V, electrophoresed on an 0.7% agarose 
gel, Southern blotted and probed with radio-labelled EcoR I 
fragments from the isolated genomic clones spanning the DXRiB 1 
locus. The EcoR I  fragments used to probe the Southern blots are shown with each blot shown. A summary of the Southern analysis 
for the entire 32.8kb of cloned DNA is presented in Figure 7.
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fragment from Phage 1 and Phage 7) and probably include unique sequences within 
them. Therefore these fragments were further digested with other enzymes to 
generate smaller fragments and these were then used for the analysis.
In the case of the 6kb EcoR I fragment, it was digested with BamH I  and 
Hind III yielding fragments of 2.2kb, l.Skb, 1.2kb and l.Okb in size which were 
subcloned into pBluescript (Materials and Methods). Southern analysis revealed that 
all of these smaller fragments still contained repetitive sequence, however the 1.2kb 
fragment appeared to hybridise to a unique band at about 6kb in size (data not 
shown).
Another fragment that contained highly repetitive sequence was a S.Okb 
EcoR I fragment from Phage 1 and Phage 7. (It was possible to separate this S.Okb 
fragment from the S.Okb £’co/î /  fragment flanking the transgene in Phage 7, since the 
latter was incomplete in the phage being present at one end of the clone as a 2.7kb 
EcoR I  + Not I  fragment ). The S.Okb EcoR I fragment from Phage 7 was digested 
with BamH I and Hind IIL This produced three fragments a l.Skb BamH I + Hind III 
fragment, a l.Okb BamH I + Hind III fragment and a 0.7kb Hind III fragment. Each 
of these fragments were also shown to contain highly repetitive sequences, however a 
predominant band was observable on the Southern blot probed with the l.Skb 
fragment (data not shown).
Phage 4 EcoR I fragments 4.1kb and 3.9kb were composed of highly 
repetitive sequences. The subfragments generated by digestion with I and Sst I of 
these fragments were used as probes on Southern blots. All of these were also found 
to be highly repetitive. As such, none of the subfragments that were derived from the 
large repetitive EcoR I fragments was found to contain unique sequence and these 
were not further restricted in an attempt to isolate unique sequences.
2.2.2 Reverse Southern analysis
An alternative approach to identify fragments harbouring repetitive 
sequences, Reverse Southern analysis, was used. In this method cloned DNA, (phage
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or plasmid), is probed with total, labelled, genomic DNA (Materials and Methods). 
Mouse genomic DNA is composed of repetitive sequences that are present at very
of aU three phage digested with EcoR I was probed with total genomic DNA that had
high copy numbers, hence, when total genomic DNA is hybridised to a Southern blot 
it reveals those fragments that contain the most repetitive sequence. A Southern blot i;
been radiolabelled by random priming. Figure 5 shows that the 6kb and the repetitive
.3kb EcoR I fragments of Phage 1 and Phage 7 are highly repetitive. The 4.1kb EcoR I 
fragment of Phage 4 was shown to be highly repetitive too, confirming the earlier
results (above). This technique also revealed that at least two fragments must be 
S.Okb in size, the original unique fragment found flanking the transgene and a
repetitive fragment, migrating together. The Reverse Southern analysis did not reveal 
the S.9kb EcoR I fragment as being repetitive. This means that the S.9kb EcoR I .i;
fragment, although containing highly repetitive sequences, contains sequences that 
are not widely dispersed throughout the mouse genome.
The Reverse Southern analysis was repeated on restriction digests of Phage 
4, 4.1kb EcoR I  fragment, the 6kb EcoR I (data not shown) and the Skb EcoR I 
fragments shared between Phage 1 and Phage 7. All restriction fragments on these 
blots were found to be repetitive by Reverse Southern analysis. Figure 6 shows the 
results of Reverse Southern analysis of the Phage 1 and Phage 7, repetitive Skb EcoR 
I fragment digests. Several different digests are shown ui Figure 6. Three fragments 
were produced upon digestion with BamH I and Hind HI, a 1.4kb, Ikb and a 0.7kb 
fragment. Reverse Southern analysis identified the 0.7kb fragment as the most highly 
repetitive. Reverse Southern analysis also identified the other two BamH I + Hind III 
subfragments, though the intensity of signal indicated that they were not as repetitive 
as the 0.7kb fragment.
2.3 Expressional analysis of isolated DNA
In order to identify transcribed sequences the EcoR I fragments isolated 
from the 32,8kb of DNA were used as probes on Northern blots of wild type and the
4 4
Phage clone 
1 7 4
Size kb
4.1 > -
Figure 5: Reverse Southern analysis of EcoR I digested genomic 
clones.
l\ig  of genomic clones were digested with EcoR /, 
electrophoresed on an 0.7% agarose gel, Southern blotted and 
hybridised with radio-labelled total genomic DNA. The blot was washed at high stringency. Each lane represents EcoR I  digests of 
the phage indicated.The 3kb and 6kb EcoR I  fragments from Phage 1 and Phage 7, along with the 4. Ikb EcoR I fragment of Phage 4 hybridise to 
total genomic sequences.
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Size kb
I
Figure 6: Reverse Southern analysis of the repetitive 3kb EcoR I fragment from Phage 1 and Phage 7.
Ipg of the repetitive 3kb EcoR I fragment was digested 
with each of the enzymes indicated, lane 1, Accl\ lane 2, BamH /; lane 3, EcoR V\ lane 4, Hind IJ1\ lane 5, Sst /; lane 7, Acc I + Sst /; lane 9, BamH I  + EcoR V; lane 11, BamH I  + Hind III. Samples were electrophoresed on an 0.7% agarose gel. Southern blotted and hybridised with radio-labelled total genomic DNA. The blot shown 
was washed at high stringency.
All fragments hybridi% to genomic sequences, the O.Tkb 
BamH I-Hind III fragment hybridises most intensely in lane 11.
46
I
I.
II
pa
I
V / o
Iz
I
§Is
s
Cu
S'I
I
i l l
s? II
O
I I  S’i l -
I >
O'
1
i
.m
i
47
transgenic mutant RNA. A transcript that is involved in the phenotype at this locus 
should be disrupted in its pattern of expression between transgenically positive RNA 
and transgenically negative RNA, The hybrid transcripts detected by transgene 
probing were most highly expressed in the brain. It was therefore decided to 
investigate the expression of these sequences in RNA prepared from transgenically 
positive and transgenically negative mouse brains.
All of the EcoR /  subclones were used as probes on Northern blots of RNA 
from transgenically positive and transgenically negative day 10 post-natal brains. 
Figure 8 shows the result of one of these hybridisations. The blot shown is that 
probed with the repetitive 3kb EcoR I fragment from Phage 1 and Phage 7. A very 
large message is observed, significantly larger than lOkb, in both transgenically 
positive and transgenically negative samples. At this resolution it is not possible to 
tell if there is a change in size of the transcripts between transgenically positive and 
negative samples. However, the hybrid transcripts previously identified in the 
transgenically positive RNA were not seen in this analysis.
Several other fragments hybridised to large transcript(s). The 6kb and 1.4kb 
EcoR I fragments from Phage 1 and Phage 7, along with the EcoR I + Not 1 0.7kb 
fragment from Phage 1 and the EcoR I + Not I l.Skb fragment from Phage 7, all 
exhibited this pattern of expression. This was also true of the 4.Ikb and the 3.9kb 
fragments from Phage 4. However all of these were shown to harbour repetitive 
sequences. No expression could be detected from any of the unique DNA fragments.
The phenotype caused by the insertional mutation of cellular sequences 
results from a perturbation in craniofacial development, thus the cellular sequences 
should be expressed during embryonic development. The transgenic mutant mouse 
line that exhibited sex linked cleft-palate unfortunately became extinct. As a result no 
transgenically positive embryonic RNA was available for analysis. However, wild 
type RNA was prepared from whole mouse embryos at different stages of 
development and used to analyse the patterns of expression exhibited from the locus.
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Size kb
4.4
2.4
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Figure 8: Expression analysis of isolated genomic DNA from the 
DXRiB 1 locus.
10|-Lg samples of total RNA isolated from the brains of line 
PyLMP.5 transgenically positive (+) and transgenically negative (-) 
day 13 post-natal mice, were electrophoresed on a 1% agarose 
formaldehyde gel. This gel was Nortiiem blotted and probed with 
radio-labelled EcoR I fragments from the isolated genomic cloned 
DNA. The blot shown was probed with the repetitive 3kb EcoR I 
fragment from Phage 7. It was found to hybridise to RNA transcripts greater than lOkb in size in both transgenically positive 
and transgenically negative brain RNAs.
The results of the analysis are summarised in Figure 11.
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All the EcoR I fragments derived from the isolated 32.8kb of RNA were 
used as probes on Northern blots of mouse embryonic total RNA. RNAs were 
derived from the body and head of day 11.5 to day 16.5 embryonic mice (the total 
gestation period for the mouse is 20 days). A representative result of this expression 
analysis is presented in Figure 9. The repetitive 3kb EcoR I fragment from Phage 1 
and Phage 7 was found to hybridise at high levels to non-discrete messages, that 
appear to increase in the level of expression during development. It was found that 
from Phage 1 and Phage 7 the 6kb EcoR I fragment was also expressed at very high 
levels. A fragment from Phage 7, a 1.3kb EcoR I fragment, which was shown to 
contain some repetitve sequence but was not completely repetitive, was also found to 
exhibit a similar pattern observed with the repetitive fragments. The transcripts 
observed were not discrete for all three fragments. Rather they were very large >10kb 
and probably as a result of RNA degradation, are very smeared. The fact that the 6kb 
fragment and the Skb EcoR I fragments contain highly repetitive sequences the 
messages detected may be derived from numerous different unrelated genes which 
also harbour the repeats. The Northern blots were reprobed with the smaller 
subcloned fragments from the 6kb and the 3kb EcoR I fragments. The patterns of 
expression were identical to those observed with the original entire fragments (data 
not shown).
The 4. Ikb EcoR I and the 3.9kb EcoR I fragments of Phage 4 were found to 
hybridise to embryonic RNAs. The transcripts observed were very large, >10kb, and 
apparently developmentally regulated. These Phage 4 fragments reproduced the 
patterns of expression observed with the Phage 7 fragments. Again, the DNA 
fragments from Phage 4 that exhibit expression during development are those 
identified as being the most highly repetitive. Expression was only detected with 
fragments that were shown to contain repetitive sequences, none of the fragments 
found to contain solely unique sequences demonstrated expression. The presence of 
repetitive sequences makes the interpretation of the analysis of expression very
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DAY 16.5 15.5 
B H B H
Size kb
9.5 -►
7.5 -►
4.4
2.4 -►
1.4 - ►
13.5 12.5 
B H B H
0.6
Figure 9; Expressional analysis during embryonic development of 
cloned genomic DNA.lOpg samples of total RNA isolated from the whole body 
and heads of embryonic mice at different stages of development were electrophcwesed on a formaldehyde agarose gel. The day of embryonic development is indicated above the samples, 'B' indicates 
whole body RNA and ’H’ indicates whole head RNA. This gel was Northern blotted and probed with the radio-labelled repetitive 3kb 
EcoR I fragment from the isolated Phage 1 and Phage 7 cloned 
genomic DNA.
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difficult. Those fragments hybridising to the post-natal RNAs were also found to 
hybridise to the embryonic RNAs
2.3.1 Reverse Northern analysis
Since the patterns of expression observed by Northern analysis of 
embryonic RNAs were difficult to interpret Reverse Northern analysis was 
attempted. Consonant with the technique of Reverse Southern analysis. Reverse 
Northerns involve the probing of Southern blots, though instead of genomic DNA as 
the probe, labelled RNA is used (Materials and Methods). Only highly transcribed 
sequences would be detected using this method. The labelling of the RNA is actually 
first strand cDNA synthesis, incorporating radiolabelled nucleotides, primed by either 
oligo [dT] or random primers. Here, first strand cDNA synthesis of day 15.5 
embryonic RNA was primed using oligo [dT]. This produced a cDNA probe from the 
Poly [A]+ fraction which was used against a Southern blot of Phage DNAs digested 
with EcoR L
The results of the Reverse Northern analysis are presented in Figure 10. The 
cDNA probe hybridises to the 6kb EcoR I  fragment and the repetitive 3kb EcoR I 
fragment from Phage 1 and Phage 7. It also hybridised to the 4. Ikb EcoR I  fragment 
from Phage 4. On longer exposures of the blot the 1.4kb EcoR I  fragment that was 
shown to contain some repetitive sequences from Phage 4 is found to hybridise to 
transcripts present in the labelled cDNA. The 1.9kb EcoR I fragment from Phage 1 
and 7 is also seen to hybridise with labelled cDNA, but the 1.9kb EcoR I  fragment 
from Phage 4 does not appear to hybridise to the cDNA. From restriction mapping it 
is believed that each Phage isolate shared the 1.9kb EcoR I  fragment and 
hybridisation of EcoR I fragments from one phage to another confirmed this 
observation. This suggests that the lack of signal is an artifact due to unequal loading 
between samples. The Reverse Northern analysis was repeated using RNA 
radiolabelled by random priming. The results obtained using this
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F%ure 10: Reverse Northern analysis oîEcoR I digested genomic 
clones. l\xg of isolated Phage genomic clones were digested with 
EcoR I, electrophoresed on an 0.7% agarose gel, Southern blotted 
and hybridised with reverse transcribed radio-labelled embryonic 
day 15.5 total RNA primed with oligo [dT]. Wash stringency of the blot shown was high; the phage clone is indicated for each track.The 3kb and 6kb EcoR I  fragments from Phage 1 and 
Phage 7, along with the 4. Ikb EcoR I fragment of Phage 4 are 
detected A 1.9kb EcoR 2 fragment from Phage 1 and 7 and a 1.4kb 
EcoR I fragment from Phage 4 are detectable on longer exposures of this blot.
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RNA probe were similar to those using the oligo [dT] primed RNA probe (data not 
shown).
There are differences between the results of the Northern analysis and the 
Reverse Northern analysis. Several of the fragments identified by Northern analysis 
as being expressed, e.g. the O.Vkb EcoR I + Not I fragment of Phage 1, are not 
identified by the Reverse Northern analysis. This is a reflection of the difference in 
sensitivity of the two methods. No hybridisation was observed to the unique 
fragments. The results of the Reverse Southern analysis and the results of the Reverse 
Northern analysis confirm that the most highly repetitive sequences are those that 
hybridise to expressed sequences. These expressed sequences may not be derived 
from this locus and are hybridising to expressed repetitive sequences from other 
genes. As only the repetitive sequences hybridise to transcripts, these analyses do not
reveal whether a transcript is expressed from this locus or not. All of the information 
obtained from the previous Southern and Northern analyses are presented in the 
summary Figures 7 (for Southerns) and Figure 11 (for Northerns),
2,3.2 Analysis of differences in expression between transgenically positive
and transgenically negative tissues
It was impossible to analyse the patterns of expression of the locus during 
mutant embryonic development due to lack of transgenically positive embryonic 
RNA. However post-natal tissues were available from transgenically positive mice.
The large transcript(s) hybridising to the repetitive 3kb EcoR I fragment from Phage 
7 was examined in post-natal RNAs from transgenically positive and transgenically 
negative tissues (Figure 12). There are no bands observable in most of these samples.
A band is observed in the lung samples and there is a clear difference between the 
transgenically (+) and transgenically (-) lung samples. In transgenically negative lung 
RNA a band is observable at 4kb, this signal is not present in the transgenically 
positive RNA sample. A difference observed between both the lung samples and the 
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Transgenically - 
V B LR H LG S
Transgenically +
V B LR H LG T
Size kb
Figure 12: Analysis of expression between post-natal transgenically 
positive and transgenically negative tissues.lOpig samples of total RNA isolated from the tissues of age 
matched transgenically positive (+) and transgenically negative (-) 
tissues. Samples are V, viscera; B, brain; LR, liver; H, heart; LG, 
lung; S, spleen and T, thymus. Samples were electrophoresed on a 
1% formaldehyde agarose gel. This gel was Northern blotted and 
probed with the radio-labelled repetitive 3kb EcoR I fragment from the isolated Phage 1 and Phage 7 cloned genomic DNA.Note: a band is present in the transgenically negative lung 
sample running at about 4kb that is not observed in the transgenically positive lung sample.
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a lack of background smears. This may be due to the lung samples being more intact 
than the other samples, although visualisation of the samples by Ethidium Bromide 
staining revealed that all samples appeared intact. The Ethidium Bromide staining of 
the gel indicated loading was even, apart from the brain RNA samples. The presence 
of repetitive sequence makes interpretation of the blot very difficult.
2.4 Analysis of sequence conservation across species
A feature of DNA encoding important sequence, ie. sequence that forms 
part of a functional gene product, is that it usually exhibits a degree of conservation 
between DNA from different species. The more necessary the function of a protein 
domain for protein activity then a higher degree of conservation of the sequence that 
encodes it is usually observed. The degree of sequence conservation of the isolated 
unique and expressed DNA fragments was investigated by hybridising these to 
Southern blots of DNAs derived from different species, referred to as Zoo blots. The 
Zoo blots used in this analysis consisted of DNAs derived from mouse, rat, hamster 
and human restriction usually digested with EcoR I but also EcoR V. The 
hybridisation conditions were made less stringent (by lowering the temperature and 
increasing the salt concentration) to allow sequences with some divergence from each 
other to hybridise. The washing conditions used, subsequent to the hybridisation,
:were very much less stringent than normal. The blots were then exposed and washed 
again, either decreasing the salt concentration of the wash or increasing the 
temperature of the wash and on occasion both. These rounds of washes with 
increasing stringency, resulted in blots that first displayed a pattern of non specific 
hybridisation. This pattern was replaced gradually by a more specific pattern of 
hybridisation. Hence the more conserved the sequence the better the ability to remain 
hybridised with the increasing stringency of the washes.
Some of the results of the Zoo blot analysis can be seen in Figures 13 to 18.
The fragments of isolated DNA studied in depth were those that exhibited patterns of 
expression as detected by Northern blot analysis. Figures 13(a) and 13(b) show the
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Figure 13 (a): Evolutionary conservation of the Apa I -\-Sst I 
DNA subfragments of the 4. Ikb EcoR I DNA fragment from Phage 4.
4pg of genomic DNAs (listed below) were digested with EcoR 
I, electrophoresed, Southern blotted and hybridised with (i) the O.Tkb 
Apa /+  Sst I subfragment, (ii) the 0.8kb J^a I+Sst I subfragment, (iii) 
the l.Skb Apa I+Sst I and (iv) the 1.4kb Apa I+Sst I subffagment. 
Wash stringency of the blots shown are IxSSC, 0.1% SDS, 55°C.
DNAs were derived from the tissues of; lane 1, mouse female; 
lane 2, mouse, male; lane 3, rat; lane 4, hamster and lane 5, human.
Note that the fragments are highly repetitive in the mouse but 
bands are apparent in some of the other species DNA samples 
indicating the presence of unique sequence.
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Figure 13(a): Evolutionary conservation of Apa /+ Sst I subfragments of the 4. Ikb 
EcoR I fragment from Phage 4 washed at low stringency.
Figure 13 (b): Evolutionary conservation of the Apa I+Sst I 
DNA subfragments of the 4. Ikb EcoR I DNA fragment from Phage 4.
4\xg of genomic DNAs (listed below) were digested with EcoR 
/, electrophoresed. Southern blotted and hybridised with (i) the O.Tkb 
Apa /+  Sst /  subfragment, (ii) the 0.8kb Apa I+Sst I subfragment, (iii) 
the l.Skb Apa I+Sst I and (iv) the 1.4kb ^ a  I-k-Sst I subfragment. 
Wash stringency of the blots shown are IxSSC, 0.1% SDS, 65°C.
DNAs were derived from the tissues of; lane 1, mouse female; 
lane 2, mouse, male; lane 3, rat; lane 4, hamster and lane 5, human.
Note that compared to the previous low stringency wash 
(figure 13(a)) unique sequence is apparent in the human DNA 
samples, indicating the conservation of sequence across species at 
medium stringency.
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Figure 13(b): Evolutionary conservation of Apa 7+ Sst I subfragments of the 4.Ikb EcoR I fra ien t isolated from Phage 4. Blots were washed at medium 
stringency.
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Zooblot analysis for the Phage 4 ,4.1kb EcoR I fragment: Apa I+Sst I subfragments.
At low stringency (55°C, IxSSC) the highly repetitive nature of the Apa I+Sst I 
fragments derived from Phage 4, 4.Ikb EcoR I fragment is obvious (Figure 13(a)).
For each subfragment the sequence is highly repetitive in mouse, rat and hamster 
DNA. The human DNA does not appear to hybridise the mouse sequences as weU as 
DNA from other species and does not give as repetitive a signal. The Phage 4, 4. Ikb 
EcoR I  fragment, l,3kb Apa 1+ Sst I  subfragment hybridises to a discrete 3kb band in 
human DNA at low stringency (55°C and IxSSC).
When increasing the stringency by decreasing the salt concentration to 
0. IxSSC but maintaining the temperature of the wash at 55°C more information can 
be obtained from the blots. With the O.Vkb, the 0.6kb and the 1.4kb Apa I + Sst I 
subfragments the pattern of hybridisation observed with mouse DNA is highly 
repetitive, (Figure 13(b)). Discrete bands are however observable in the tracks of 
other species DNA. A band is observed in human DNA with all three subfragments 
and a hamster signal observed with the O.Vkb and the 0.6kb Apa I  + Sst I 
subfragments. The strong repetitive signal of the female mouse track obscures the rat 
DNA track and it is difficult to determine whether a signal is present or not.
The 1.4kb Apa I + Sst I subfragment from the Phage 4, 4.1kbEcoR 1 
fragment remains repetitive across all species except human where a faint band is 
observable at about 3kb (as with the l.Skb subfragment). The signal observed with 
the l.Skb Apa I + Sst I subfragment is much less repetitive at this stringency of 
0. IxSSC. A band is clearly apparent in male mouse DNA, this band is not obvious in 
the female mouse DNA sample. This is due to the female DNA being slightly 
degraded. Rat DNA does not contain any bands at all and there may be a band 
present in hamster DNA. However there clearly is a band present in the human DNA 
sample.
When the temperature was increased to 68®C and the salt concentration 
increased to IxSSC the pattern of hybridisation for all the subfragments of the Phage 
4, 4.1kb EcoR I fragment remained the same (data not shown). The stringency was
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increased to high (68°C and 0.IxSSC), and the blots exposed for three days. The 
1.4kb Apa I + Sst I subfragment was found to be still repetitive across mouse, rat and 
hamster, with no bands detected. The band in human DNA was still observable. 
These results indicate that the 1.4kb Apa I ■¥ Sst I subfragment is highly repetitive hi 
mouse and this repetitive sequence is conserved in the genomes of rat and hamster. 
This repetitive sequence is not present in human DNA, but some unique sequence 
clothed in repetitive sequence in the mouse genome is conserved into human DNA 
(data not shown).
The 0.6kb and the O.Vkb Apa I + Sst I subfragments exhibited a similar 
pattern of hybridisation when the blots were washed at high stringency. The 
sequences are highly repetitive in the mouse where no bands are observed at all, just 
two black smears are present in the mouse DNA lanes. With both subfragments a 
band is observed in the human DNA lane, it migrates at 6kb in size. A faint band of 
about 8kb was observed in the hamster DNA sample with the 0,6Kb subfragment. 
These results reveal that the O.Vkb and 0.6kb Apa I Sst I subfragments are highly 
repetitive in mouse and these repetitive sequences are not conserved m other species. 
As was observed with the 1.4kb Apa I Sst I subfragment, there are sequences 
present in 0.6kb and O.Vkb J^a I ■¥ Sst I subfragments which are conserved in human.
The hybridisation pattern of the Zoo blot probed with the l.Skb Apa I + Sst 
I subfragment from 4. Ikb EcoR I fragment of Phage 4, after washing at high 
stringency, reveals that this fragment does not contain as repetitive a sequence as the 
other subfragments from the Phage 4, 4. Ikb EcoR I fragment. A well defined band is 
present at 4. Ikb in the male mouse DNA lane. This result confirms that the 
subfragment is derived from a 4. Ikb EcoR I fragment. Although the repetitive nature 
of this subfragment is somewhat less than that of other subfragments, no obvious 
bands are present in the DNA samples of the other species, except the human sample 
where a band just larger than the 4. Ikb fragment is evident. The ability of sequences 
present in the Phage 4, 4. Ikb EcoR I fragment to hybridise to a discrete fragment 
present in human DNA, but not to clearly defined sequences in other species may
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suggest that the conserved sequence may be of importance in the human but not in rat 
or hamster. This is unlikely due to the higher conservation between rodents, than 
conservation between rodents and humans. Alternatively the size of the band in rat 
and hamster was either too large or too small to give good signal. The possibility of
contamination of the human DNA sample has not been rigorously eliminated.
Using human DNA from different sources and digesting with EcoR V no 
homologous bands were evident. Figure 14 shows that when the Phage 4,4. Ikb EcoR 
/, l.Skb Apa /+  Sst I subfragment was used to probe this Zoo blot a 20kb fragment 
was identified in all mouse samples. The signal is quite faint as the fragment 
identified is large and may not have transfered fuUy during blotting. When the blot 
was washed at intermediate stringency (68°C and O.SxSSC) a band was observed in 
the rat DNA lane, a band was also observed in the hamster lane indicating a degree of 
conservation. This supported the idea that the lack of hybridisation with the previous 
Zoo analysis was a result of poor signal rather than a lack of conservation. When the 
blot was washed at 68°C and 0.IxSSC these bands were no longer seen. It is difficult 
to decide whether there are any bands observed in the human samples, at any of the 
washing conditions. There is a smear at the top of the blot suggesting that a large 
homologous fragment may be present but it is difficult to tell whether it is a real 
signal or not. These results taken together with the previous Zoo analysis suggest that 
the l.Skb fragment is moderately conserved across species. Further digests with 
different enzymes would clarify this situation.
The Zoo blot analysis was repeated for other fragments derived from the 
isolated 32.8kb of mouse genomic DNA. The other fragments that produced signals 
on Northern and Reverse Northern Blots were from Phage 1, Phage 4 and Phage 7. 
The results of the Zoo analysis of the 6kb EcoRl fragment, the repetitive 3kb EcoR I 
fragment from Phage 7 and the 3.9kb EcoR I fragment of Phage 4 at low stringency 
are shown in Figure 15(a). These fragments were further restriction
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Figure 14: Evolutionary conservation of the l.Skb Apa /+  Sst I  
subfragment of the 4. Ikb EcoR I  fragment from Phage 4.
4|ig of genomic DNAs (listed below) were digested with 
EcoR y, electrophoresed, Southern blotted and hybridised with the l.Skb I  + Sst I  subfragment from the 4.Ikb EcoR I  fragment from Phage 4. Wash stringency of the blot shown was O.SxSSC, 
0.1% SDS, 650C.
DNAs were derived from the tissues of; lane 1, mus 
domesticus, female; lane 2, mus domesticus, male; lane S, mus 
spretus, female; lane 4, mus spretus, male; lane 5, mus 
macedonicus, female; lane 6, mus macedonicus, male; lane 7, mus 
hortulanus, female; lane 8, mus cookii, male, lane 9, rat; lane 10 & 
11 hamster; lane 12, dog; lane IS, rabbit; lane 14, cow; lane 15 & 
16, primate; lane 17,18,19 & 20, human; lane 21, chicken; lane 22, axolotl; lane 2S, salmon; lane 24, drosophila; lane 25, C. elegans', lane 26, S. cerevisiae.
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digested and used in the Zooblot analysis, but all the fragments and subfragments 
were found to be repetitive in the Zoo analysis.
The 6kb EcoR I fragment was restriction digested with BamH I and Hind III 
producing several fragments, 2.2kb, l.Skb, 1.2kb and l.Okb. These fragments were 
used to probe Zoo blots containing mouse, rat, hamster, marmoset and human DNAs. 
(The probes were subject to ’quashing' prior to addition to hybridisation buffer, see 
below). Figure lS(b) shows examples of the results. At low stringency (SS^C and 
IxSSC) the 2.2kb and the l.Okb BamH I + Hind III fragments were found to be 
highly repetitive but only in the mouse. The other DNAs exhibited a very low 
background of hybridisation but no clearly defined bands are observable as it 
contains a mouse specific repeat and the rest of the sequence may not be conserved. 
The l.Skb subfragment is highly repetitive across all species as shown by the Zooblot 
in Figure 15(b), There are no bands discernible at all in any of the DNA samples. The 
l,2kb BamH I + Hind HI subfragment from the 6kb EcoR I fragment produced a 
clearly discernible band in mouse DNA when hybridised to the Zoo blot see Figure 
15(b). As expected this band is 6kb in size. There is a slightly smaller band present in 
the rat DNA sample just less than 6kb in size. There appear to be no bands in either 
marmoset or human DNA samples and the sequences are moderately conserved in 
rodents. When the temperature of the washes was increased to 68°C and the 
stringency increased to IxSSC, the pattern of hybridisation for all the blots remained 
unchanged (data not shown). These results suggest that the 2.2kb and the l.Okb 
BamH I + Hind III subfragments of Phage 7 6kb EcoR I fragment are composed of 
repetitive sequence that is present at high levels in the mouse genome. These 
repetitive sequences are not well conserved between different species. The pattern of 
hybridisation observed with the l.Skb BamH I + Hind III subfragment on a Zoo blot 
suggests that it consists of repetitive sequence also. This repetitive sequence though 
is conserved across species. The 1.2kb BamH I + Hind III subfragment of the Phage 
7 6kb EcoR I fragment contains a sm all amount of
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Figure 15 (a) : Evolutionary conservation of several EcoR I DNA 
fragments isolated from cloned genomic DNA.A\x% of genomic DNAs (listed below) were digested with 
EcoR I, electrophoresed, Southern blotted and hybridised with (a) the repetitive 3kb EcoR I fragment from Phage 7, (b) the 6kb EcoR 
1 fragment from Phage 7 and (c) the 3.9kb EcoR I fragment from Phage 4. Wash stringency of the blots shown is IxSSC, 0.1% SDS, 
65°C. DNAs were derived from the tissues of; lane 1, mouse female; lane 2, mouse, male; lane 3, rat; lane 4, cow; lane 5,
marmoset and lane 6, Human.
Note that all three fragments appear to be repetitive at this 
wash stringency.
Figure 15 (b): Evolutionary conservation of the Apa I+Acc I 
DNA subfragments of the 6kb EcoR /DNA fragment from Phage 7 .
4|xg of genomic DNAs (listed below) were digested with EcoR 
/, electrophoresed. Southern blotted and hybridised with (i) the l.Okb 
Apa /+  Acc I  subfragment, (ii) the 1.2kb Apa I+Acc I subfragment, 
(iii) the 1.5kb Apa I+Acc I and (iv) the 2.2kb Apa I+Acc I 
subfragment. Wash stringency of the blots shown are IxSSC, 0.1% 
SDS, 65°C. All of these probes were "quashed" with 100p,g of 
sonicated unlabelled mouse DNA (for details of quashing see section 
2.4.1).
DNAs were derived from the tissues of; lane 1, mouse female; 
lane 2, mouse, male; lane 3, rat; lane 4, hamster and lane 5, human.
Note that the 1.2kb fragment appears to to hybridise to a faint 
band at about 6kb in mouse DNA and a slightly smaller band in rat 
DNA.
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Figure 15(b): Evolutionary conservation of the Apa I + Acc I subfragments 
of the 6kb EcoR I DNA fragment from Phage 7.
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repetitive sequence as shown by Zoo blot analysis. This sequence is conserved into 
rat and hamster at high stringency of washing.
All of the other EcoR I fragments identified from the isolated DNA were 
characterised by Zoo blot analysis. These data are summarised in Figure 16. The 
summary figure details the degree of conservation of DNA across species for the 
entire 32.8kb of isolated DNA.
The Phage 7, 3kb EcoR I fragment, 1.6kb EcoR I fragment and 1.4kb EcoR I 
fragment were found to be repetitive across all species at all stringencies of washing. 
The 2.7kb EcoR I+Not I fragment (that represents the 3kb EcoR I fragment disrupted 
by transgene insertion in the mutant mouse line) was found to be conserved across 
rat, hamster and marmoset at intermediate stringency (see Introduction). The 1.9kb 
EcoR I  fragment, contained unique sequences m the mouse that were not conserved 
across species. These fragments are shared with the Phage 1 isolate. In Phage 7 the 
1.3kb EcoR I+Not I fragment (not found on Phage 1) appeared repetitive at low 
stringencies of washing. With increasing temperature and stringency the repetitive 
nature of the signal decreased but is still present and a band was clearly visible in the 
mouse DNA lane. This band is present as two copies in the female genome and only 
one in the male genome, due to the fragment being present on the X chromosome. 
This can be clearly seen in Figure 17. At intermediate washing stringency of (55°C 
and O.lxSSC) a band was clearly observable in rat, cow, primate and yeast. Several 
bands are observable in the human DNA samples, but it exhibits a repetitive nature, 
as do the primate DNA samples (Figure 17). From this blot the sequence of the 1.3kb 
EcoR I + Not /, from Phage 7, contains sequence that is repetitive in human but not 
repetitive in mouse. It is possible that a repetitive DNA element is present in this 
DNA fragment that has a low copy number in the mouse but that copy number is 
greatly expanded in the human genome or is functionally homologous to a human 
repeat.
When the temperature of the wash was increased to 68®C and the stringency 
maintained at O.lxSSC the pattern of hybridisation changed only slightly. The mouse
s 3 Iîüî
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Figure 17: Evolutionary conservation of the 1.3kb EcoR I  + Not I DNA fragment from Phage 7.
4pig of genomic DNAs (listed below) were digested with 
EcoR V, electrophoresed, Southern blotted and hybridised with the 
1.3kb EcoR I + Not I  fragment from Phage 7. Wash stringency of 
the blot shown was O.lxSSC, 0.1% SDS, 55°C.DNAs were derived from the tissues of; lane 1, mus 
domesticus, female; lane 2, mus domesticus, male; lane 3, mus 
spretus, female; lane 4, mus spretus, male; lane 5, mus 
macedonicus, female; lane 6, mus macedonicus, male; lane 7, mus 
hortulanus, female; lane 8, mus cookii, male, lane 9, rat; lane 10 & 11 hamster; lane 12, dog; lane 13, rabbit; lane 14, cow; lane 15 & 
16, primate; lane 17,18,19 & 20, human; lane 21, chicken; lane 22, 
axolotl; lane 23, salmon; lane 24, drosophila; lane 25, C. elegans; 
lane 26, S. cerevisiae .
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signal was unchanged and the signals observed with other species DNA decreased in 
intensity. The pattern of hybridisation observed in the primate and human DNA 
sample was unchanged. It is not possible to tell whether any unique sequences are 
conserved from the mouse DNA fragment into human DNA due to the highly 
repetitive nature of the signal observed.
All of the other EcoR I fragments from Phage 4 were characterised by Zoo 
blot analysis. Their pattern of hybridisation to, and conservation across DNA from 
different species are depicted in Figure 16. The highly repetitive 3.9kb EcoR I 
fragment from Phage 4 exhibits strong conservation of its repetitive sequence 
between DNAs from different species, demonstrated by high stringency 
hybridisations. While the 1.25kb EcoR l+Not I fragment demonstrated that it 
contained highly repetitive sequences also, this repetitive sequence was not 
conserved between species. The 1.2kb EcoR I  fragment and the 1.4kb EcoR I + Not I 
fragment from Phage 4 harbour some repetitive sequence, observable at low 
stringency, suggesting that the sequence is not repetitve but has homology to a repeat. 
This repetitive sequence hybridised to the DNA of other species under these 
conditions. At high stringency, the patterns of hybridisation observed with these 
fragments revealed that they contained sequences that were homologous to repetitive 
sequences. These sequences were not conserved across species at any of the high 
stringency washing conditions used. The 3.5kb EcoR I fragment from Phage 4 was 
unique in mouse and did not display any conservation of sequence across species 
even at low stringencies of washing used.
2.4.1 Analysis of unique sequence conservation by "quashing" repetitive
elements
A considerable problem with the analysis of this locus has been that it is 
composed extensively of repeated sequence. There was the possibility that short 
stretches of unique sequence were hidden within these repetitive sequences. In order 
to address the conservation of small stretches of unique sequence within repetitive
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Figure 18: Evolutionary conservation of the 4.1kb EcoR I  DNA 
fragment from Phage 4.4|og of genomic DNAs (listed below) were digested with 
EcoR I, electrophoresed, Southern blotted and hybridised with a 
'quashW' 4.1kb EcoR I  fragment from Phage 4. Wash stringency of 
the blot shown was O.lxSSC, 0.1% SDS, 60®C.DNAs were derived from the tissues of; Mm, mus 
domesticus, male; Mf, mus domesticus, female; R, rat; H, hamster. 
Ma, marmoset and Hu, human.
A band at about 4.1kb is visible in the marmoset and human 
samples. Comparison of the pattern observed in this blot, with a 
quashed 4.1kb EcoR I  probe, to those of subfragments of the 4.1kb 
fragment in Figurel2 (washed at a similar stringency) reveals the 
absence of repetitive signal from all the DNA samples except the 
mouse.
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stretches, highly repetitive stretches were quashed. Labelled probe fragments were 
prehybridised with a 2,000-fold excess of cold unlabelled sonicated genomic DNA 
thereby competing out (quashing) highly repeated sequences from the probe and 
preventing their hybridisation to a blot. Any unique sequence present in the probe 
fragment has an extremely low probability of binding to the sonicated DNA and 
remains competent (single stranded) to hybridise to the blot.
The Zoo blot analysis was repeated using the 'quashing' technique, for those 
fragments identified as being highly repetitive and highly expressed. For the 6kb and 
repetitive 3kb EcoR /  fragments from Phage 1 and Phage 7 'quashing' of the repetitive 
sequences removed all signal from the Zooblots upon washing, except for the 1.2kb 
BamHI+Hind III subfragment from the 6kb EcoR/fragment see Figure 14(b). This 
result indicates that most of these fragments are composed solely of repetitive 
sequences, or that if unique sequences were present (as indicated by the results of the 
1.2kb BamH I + Hind III from the 6kb fragment exhibiting unique sequence in 
Figure 15(b)) they were so small and interspersed with repeats as to evade detection 
by this technique (data not shown).
Using a quashed Phage 4, 4.1kb EcoR I probe fragment unique sequences 
were detected in marmoset and human DNA. Although the pattern of hybridisation is 
still very repetitive in mouse the repetitive signal that was observed in the rat and 
hamster lanes is greatly reduced, though no single band is observed in these lanes. No 
repetitive signal is observed at all in the marmoset and human lanes. These two DNA 
samples both exhibit a single band sized at about 4.1kb. The results of this 'quashed'
Zoo blot indicate that the 4.1kb EcoR I fragment of Phage 4 contains unique 
sequence shrouded in repetitive sequences. It also reveals that this unique sequence is 
conserved into marmosets and humans (Figure 18).
2.5 Sequence analysis of selected isolated DNA fragments
The analyses of the isolated locus have shown that the DNA at this locus is 
highly complex. It was clear that in order to identify any DNA sequences contained
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in a transcript an alternative approach of investigation was required. From the 
information obtained about patterns of expressed sequence and the highly repetitive 
nature of these sequences, it was felt that dideoxy sequencing of some of the isolated 
fragments might yield more information regarding a potential gene. The fragments 
selected for sequencing were some of those that were shown to be expressed at high 
levels and/or shown to exhibit conservation of sequence across species. Some of the 
fragments were only partially sequenced and not aU of the sequence data is presented 
here.
Figure 19 shows the sequence data obtained for the Phage 7, 3kb EcoR I, 
O.Tkb BamH I  + Hind III subfragment, which was highly repetitive and expressed. A 
search for Open Reading Frames (ORF) using the MacVector'i’M program identified 
several ORFs. These ORFs were either incomplete, as they resided at the ends of the 
sequence or composed of only about 100 nucleotides. When the sequence was 
scanned for putative splice acceptor and donor sequences, using MacVector^ M  ^none 
was found to be located at the ends of the small ORFs. A database search was carried 
out using the 0.7kb subfragment sequence against those sequences present in the 
BLASTN database. Due to the repetitive nature of the sequence many matches were 
found in the search e.g., 100 nucleotide long stretches of the complete 700 
nucleotides of sequence were found to be 80% identical to sequences spread across 
the mouse beta globin locus (Shehee et aU 1989). The mouse beta globin locus is 
over 55,000 base pairs long. Another match was to the mus musculus long 
interspersed sequence LINE-1 (LlMd-6) (Burton et al., 1991), this match exhibited 
78% across 400 nucleotides. A large number of other matches were obtained from the 
database using the 0.7kb subfragment sequence, they all shared the repeats of the two 
matches detailed here. The database information confirmed that the sequences 
present in the 0.7kb subfragment are repetitive and are wide spread in the mouse 
genome.
Sequence information was obtained for the Phage 7, 1.3kb EcoR I + Not I 
fragment which had been found to be expressed and contain repetitive sequences.
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F%ure 19:Sequence of the O.Tkb BamH I + Hind III subfragment from the repetitive 3kb EcoR 1 fragment from Phage 7.
10 20 30 40 50GCTCCACCGC GGTGCGGCCG CTCTAGAACT AGTGGATCCA TCCCATATCACGAGGTGGCG CCACGCCGGC GAGCTCTTGA TCACCTAGGT AGGGTATAGT60 70 80 90 100GCCTCCAAAC GCCTGACACC ATTGCATACC CCAGCAAGAT TTTGCTGAAACGGAGGTTTG CGGACTGTGG TAACGTATGG GGTCGTTCTA AAACGACTTT110 120 130 140 150GGACCCTGAT ATAGCTGTCT CTTGTGAGGC TATGCTGGTG CCTGGCAAACCCTGGGACTA TATCGACAGA GAACACTCCG ATACGACCAC GGACCGTTTG160 170 180 190 200ACAGAAGTGG ATGCTCACAG TCATCTATAG ATGGAACACA GGGCCCCCAGTGTCTTCACC TACGAGTGTC AGTAGATATC TACCTTGTGT CCCGGGGGTC210 220 230 240 250TGGAGGAGCT AGAGAAAGTA CCAAAGGAGC TAAAGGGATC TGCAACCCTAACCTCCTCGA TCTCTTTCAT GGTTTCCTCG ATTTCCCTAG ACGTTGGGAT260 270 280 290 300TAGATGGAAC AACAATATGA ACTAATCAGT ACCCCCAGGA GCTCGTGTCTATCTACCTTG TTGTTATACT TGATTAGTCA TGGGGGTCCT CGAGCACAGA310 320 330 340 350TAGCTGCATA TGTATCAGAA GA*TGGCCTA GTCTGCCATC ACTGGGAAGAATCGACGTAT ACATAGTCTT CT*ACCGGAT CAGACGGTAG TGACCCTTCT360 370 380 390 400GAGGCCCTTT GGTCTTGCAA ACTTTATATG CCTCAGTACA GGGGGAATGCCTCCGGGAAA CCAGAACGTT TGAAATATAC GGAGTCATGT CCCCCTTACG410 420 430 440 450AGGGCCAAGA AGGTAGGTGG GTATGGGAGT GGGGGGGGGG TTAGGGTATGTCCCGGTTCT TCCATCCACC CATACCCTCA CCCCCCCCCC AATCCCATAC460 470 480 490 500GGGGACTTTT GGAATATCAT TTGAAATATA AATGAGGAAA ACAGGTTGTACCCCTGAAAA CCTTATAGTA AACTTTATAT TTACTCCTTT TGTCCAACTA510 520 530 540 550GTGGCAATCA CACACACAGA CACACACAGA CACACAGACA CACAGACACACACCGTTAGT GTGTGTGTCT GTGTGTGTCT GTGTGTCTGT GTGTCTGTGT560 570 580 590 600CAGACACACA GACACACACG TTAAGCAGTT AGTATTCACT GTAGATCAATGTCTGTGTGT CTGTGTGTGC AATTCGTCAA TCATAAGTGA CATCTAGTTA610 620 630 640 650ATTGTCATAT AGGAACCAGG CATTCTTTTC CAAGATTGAA GATGATGTTTTAACAGTATA TCCTTGGTCG GTAAGAAAAG GTTCTAACTT CTACTACAAA610 620 630 640 650TCCCTATAAA ACCCTAGAGT AAATTCTAAC TGCCTTACAA AAATCAGCCAAGGGATATTT TGGGATCTCA TTTAAGATTG ACGGAATGTT TTTAGTCGGT660 670 680 690 700TTAAGTAGTT CACATTCAGA TTTTÀAAAAC AGGTTGTAAATTCATCAA GTGTAAGTCT AAAATTTTTG TCCAACAT
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The complete sequence of this fragment could not be obtained due to an internal 
region through which sequencing could not pass, possibly due to a conformation 
block. However, over Ikb of sequence information was obtained from the ends of 
this fragment. Several small putative ORFs were identified using M a c V e c to r T M  
program but no splice sites were identified at either end of the ORFs. The internal 
block to sequencing was a (GA)20 repeat, this was possibly larger but the repeat 
sequence prevented the polymerase from progressing properly across it. The database 
search with this sequence revealed that this (GA)n sequence motif is common in 
sequences present in the database. It is found in the sequences of the Rattus norvegius 
renin gene, exons 1-9 (Fukamizu et aL, 1988), the mouse beta globin complex 
(Shehee et aL, 1989), the 5' flanking sequence of the homo sapiens activin beta-A 
subunit (Tanimoto et aL, 1992) and the mouse microsatellite marker DNA for IL-2 
gene encoding Interleukin 2 (Hearn et aL, unpublished 1992) to mention but a few.
When this (GA)n repeat is removed from the database analysis only two 
matches were found. The first of these was to sequence from a Homo sapiens DNA 
repeat region (Weber, unpublished 1994), this match consisted of 62% identity over 
only 86 nucleic acid residues. The second match was with sequence from the 
Drosophila retrotransposon 412 genome. Again it exhibited a moderate level of 
identity, 63%, over a small region of 72 nucleic acids. This sequence analysis is very 
interesting m the light of the Zoo blot analysis of the Phage 7, 1.3kb EcoR I  + Not I 
fragment. It was found to consist mainly of unique sequence in mouse but to be 
highly repetitive in primates and humans. The identification of these repetitive 
elements coupled with the Zoo blot data supports the idea that these elements are 
present in the mouse genome at a very low level, but at high levels in the genomes of 
primates and humans.
The partially conserved 4. Ikb EcoR I fragment from Phage 4 was also 
sequenced. It had previously being subcloned and undergone further restriction 
digests. Digestion with BamH I + Hind III yielded four fragments, accounting for the 
complete 4. Ikb fragment which were subcloned into pBluescript. These four
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subfragments were partially sequenced. The sequences obtained for the Phage 4, 
4. Ikb EcoR /, 1.3kb BamH I + Hind III subfragment were found to contain several 
putative ORFs. Sequence analysis failed to reveal splice sites present at the 
boundaries of these putative ORFs. The search of the BLASTN database revealed 
that the sequence was similar to known repetitive sequences. The most obvious 
similarity was with. Homo sapiens (haplotype 1, allele MS32) minisatellite (Jeffrey, 
unpublished, 1990), with which it shared 80% identity at the nucleotide level. 
Another interesting match from the database search was to a sequence from 
Dictyostelium discoideum that encoded a nucleoside diphosphate kinase (ndkm) gene 
(Troll et aL, 1993). Over a region of 114 nucleic acids it exhibited 56% identity to the 
sequence from the 1.3kb BamH I + Hind III subfragment. The sequence of the 1.3kb 
Bam H I + Hind III subfragment was shown to contain short stretches of sequence 
similar to that of repetitive elements from other organisms. No matches were found at 
high identity or to span the entire sequence of the 1.3kb BamH I + Hind III 
subfragment.
The partial sequence obtained from the ends of the 1.4kb BamH I + Hind III 
subfragment of Phage 4 was found to contain putative ORFs using the MacVector™ 
program but no splice sites were shown to flank these putative ORFs. Database 
searches using this sequence indicated that the sequence was composed of B2 like 
repetitive sequences. This B2 family of repeats is widely dispersed in the genome of 
many organisms. The partial sequence of the 1.4kb BamH I + Hind III subfragment 
exhibited 82% identity to the consensus sequence of the Rattus norvegicus Bl- and 
B2 repeats across 150bp of sequence (Den Dunnen and Schoenmakers, 1987). This 
B2 repeat is present in the mouse genome also. The database search revealed 
homology to the sequence of a small poly adenylated B2 RNA gene present in the 
mouse genome (Tillib et aL, 1985). The region of homology between the partial 
sequence of 1.4kb subfragment and the sequence of the B2 RNA was 150bp long 
and exhibited 77% identity. This repetitive sequence is often closely associated with 
gene sequences. The 150bp of sequence found in the 1.4kb subfragment that was
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shown to be similar to sequence from the B2 repeat sequence was also found to be 
similar to a sequence from another mouse gene. The similar sequence was found in 
sequence from exon 4 and 5 of the gene encoding myotonic dystrophy protein kinase 
(DM-PK) from Mus musculus (Mahadevan et aL, 1993).
The sequence data gained for some of the fragments confirmed and 
explained the results obtained with the blotting analyses of expression and 
conservation of the sequences at this locus. The presence of so many repetitive 
elements and their distribution between different species supported the Zoo blot data. 
The presence of the defined repetitive sequences in. the transcripts of many different 
genes explains why such high levels of expression are observed as well as the lack of 
discrete bands when the isolated fragment is used as a probe on a Northern blot of 
total RNAs.
The sequence data, while aiding our understanding of the genomic analysis 
did not reveal a putative ORF with splice sites flanking it. So it was still not possible 
to identify any sequences that may be part of a relevant transcript. Even though much 
of the sequence characterised showed some relation to expressed sequences we were 
unable to determine whether we were observing the expression from the locus, or the 
hybridisation of the isolated DNA to other expressed sequences. The problem 
remained as to whether a gene was present within the 30Kb of isolated DNA or not. 
To unravel the highly complex nature of this locus required an alternative method of 
analysis.
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2.5.1. Critique I
The data presented in Section 2 indicated that there were extensive 
repetitive sequences present in the DNA cloned from the locus (exemplified in 
Figure 4 (c) and summarised in Figure 7). Several probes when hybridised to 
genomic DNA Southern blots resulted in a heavy smear of hybridisation 
(exemplified by Figure 4(c)). Which was interpreted as the probe fragment 
containing repetitive sequence. Alternative interpretations could be that the probe 
DNA had degraded or that there was degraded genomic DNA on the blots (both of 
which would result in a smear of hybridisation). The latter was clearly not the case. 
Restriction digested genomic DNA samples were visualised by Ethidium Bromide 
staining and UV illumination before blotting and showed no evidence of degradation 
as satellite bands were present and the DNA was digested to a large range of 
fragment sizes. With regard to the probe fragments, although these were not verified 
as being intact (by gel analysis) subsequent to this use as probes, several pieces of 
data suggest that these were intact; (i). certain probes hybridised selectively to DNAs 
of different species suggesting the presence of repeat sequences in one species not 
present in another. A degraded probe would not demonstrate this selectivity (a more 
detailed explanation of this is given below); (ii), the probes hybridised to the 
predicted bands on plasmid blots (data not shown), and again degraded probes might 
hybridise to more fragments; (iii), in certain instances the repetitive signal could be 
quashed by the addition of excess cold genomic DNA to reveal specific bands 
(Figure 18), which would not happen with a degraded probe. The probe fragments 
were routinely isolated by electrophoresing restriction digested plasmid DNA on low 
melting point agarose gels and were observed to be intact. Probes that had been 
isolated from low melting point agarose on different occasions produced the same 
results. Taken together these observations demonstrate that the probes were intact 
and that the interpretation of repetitive sequence content must be correct.
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There is still a possibility that the interpretation of these results is flawed.
This difficulty would have been overcome by the inclusion of positive controls on all 
of the blots probed and presented. If a probe was found to hybridise to the control in 
the expected manner then this would have answered some of the questions posed by 
the presence of such extensive repeats. It would also have helped ascertain whether 
there were any problems with the hybridisation conditions and the quality of the 
blots. The presence of positive controls on all Southern, Zoo and Northern blots 
would have aided our interpretation of results greatly.
The results of the Southern analysis are corroborated by the results of the 
Zoo blot analysis of the cloned DNA which revealed species specific repeats. This 
can be clearly seen in Figure 13 (b) i, which shows the presence of repeat sequence 
in the mouse genomic DNA samples but none in the human or hamster genomic 
DNA samples. This situation is reversed in Figure 17, which represents a Zoo blot 
probed with a 1.3kb EcoR I + Not I fragment. In this instance the probe fragment 
hybridises to a 9kb EcoR V fragment in mouse genomic DNA samples indicating that 
the fragment is unique in mouse DNA. Interestingly, however, the murine fragment 
contains sequences which hybridise to extensive repeat sequences in primate and 
human DNA samples. These results indicate that there are repeat containing 
sequences present in the cloned DNA and that these repeat sequences are different 
from each other and are species specific.
The findings from the Southern analysis distinguishing repetitive and 
unique fragments are completely supported by those of the Reverse Southern 
analysis and sequencing analysis of cloned DNA. Those fragments that had been 
shown to contain repeats by conventional Southern analysis (as in Figure 4) also 
hybridised in Reverse Southern analysis (Figure 5) suggesting high degree of 
representation in the genome. Moreover, in an attempt to identify small regions of 
coding sequence several candidate fragments of cloned mouse genomic DNA were 
sequenced. Database analysis revealed multiple repeat elements as was expected 
from the previous results, (described in detail in section 2.5). The results of the
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Southern, Reverse Southern and sequence analysis when viewed together support the 
conclusion that the locus studied in this thesis is replete with repeat containing 
sequence.
These conclusions also hold for the Northern analyses, section 2.3. Again 
the probe fragments must have been intact and the smear of hybridisation signal can 
only be due to RNA containing repeats. The RNAs used for these Northern blots 
were total RNAs and these were electrophoresed on denaturing gels, stained with 
ethidium bromide and illuminated with UV light. In so doing it was possible to 
identify the 28S ribosomal band which indicated that the RNA was intact as any 
degradation would have resulted in smearing or absence of the 28S ribosomal band.
With many of the fragments used as probes in the Zoo blot analysis repetitive 
signals were observed as discussed above. It is usually more informative to use probe 
fragments in the size range of O.Skb to Ikb in Zoo blot analysis to reveal conserved 
motifs. However, most of the probes used in the analysis presented in this thesis 
were slightly larger than this, in the range Ikb to 2kb. However, in the absence of 
useful restriction sites to obtain smaller probe fragments, an attempt was made to 
prevent the repetitive sequences of the larger probe fragment from hybridising by 
using the technique of quashing (Figure 18).
At this point this approach (Zoo blotting to detect conserved motifs) was 
not pursued further as the exon-trapping approach was considered as providing a 
more effective means of isolating the exon sequences. In retrospect, in consideration 
of the small size of the exons and the extensive repeat sequences within the region it 
was a fortuitous decision as other methods available may well have failed to yield 
gene sequences.
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2.6 EXON-TRAPPING OF ISOLATED DNA
2.6.1 Prologue
Exon amplification or 'trapping' is a method for detecting genes, 
independent of their transcriptional status. In exon-trapping experiments a genomic 
fragment is cloned into the intron of a reporter vector, which provides splice donor 
and acceptor sites flanking the inserted sequence. After processing of the primary 
transcript in tissue culture, any exon contained within the insert will be included 
(trapped) between the vector exons. Genomic fragments not containing exons will be 
simply spliced out during processing of the vector transcript. RNA-based PCR 
amplification using oligodeoxynucleotide primers specific for the reporter gene 
sequences is then used to detect the presence of any genomic derived exons. The 
method can only trap exons that possess both splice donor and acceptor sites. As the 
first and last exons of a gene do not contain both splice sites these will not be trapped 
and therefore genes must contain at least two introns to be isolated by exon-trapping.
Exon-trapping is ideally suited to screening large, complex sources of DNA 
for functional exons (Church et a l, 1994). Church et a l, have reported that when 
pools of 9-12 cosmids from human chromosome 9 were screened, an average of 1.4 
exons was obtained per 20-25Kb of genomic DNA screened. This Figure increases 
when cosmids were screened individually. Exon-trapping was used recently to 
identify a copper transporter gene defective in individuals with Menkes disease 
(Vulpe et a l, 1993) ,the neurofibromatosis type 2 tumour suppressor gene (Trofatter 
et a l , 1993) and the candidate gene for Huntington's disease (The Huntington's 
Disease Collaborative Research Group, 1993), Having been unable to identify any 
gene encoding regions using a strategy based on the conservation of DNA sequence 
across species or by expression analyses, exon trapping was employed for the DXRib 
1 locus.
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2.6.2 Preparation of phage DNA for exon-trapping
The cloned 32.8kb of DNA from the DXRib 1 locus was used for exon- 
trapping as detailed in the Materials and Methods. The exon-trapping vector, pSPL3, 
was digested with EcoR I  and treated with Calf Intestinal Phosphatase (CEP). The 
three isolated recombinant phage containing the 32.8kb of mouse genomic DNA 
were also digested with EcoR /. No EcoR I sites are present in the phage arms 
ensuring that only mouse genomic DNA fragments were subcloned. The genomic 
fragments from the three phage were then shotgun cloned into the vector, pSPL3, 
(Materials and Methods) and the three ligation mixes transformed into XLl-Blue 
seperately. The non-recombinant frequency of each transformation was estimated by 
plating 10% of each transformation on medium containing lOOpg/ml of carbenicillin. 
The remaining 90% of each transformation was used to inoculate 50ml of selective 
liquid medium. In the case of each transfomiation, the non-recombinant frequency 
was found to be less than 10% and all colonies analysed by mini-prep analysis and 
subsequent restriction digest analysis were found to contain inserts. Plasmid DNAs 
from the three pooled clones were used for COS-7 cell transfections. By this method, 
only exons spanning an EcoR I  site would be missed.
2.6.3 Expression of subcloned DNA in COS-7 cells
10^  X COS-7 cells were transfected with Ipg of the vector pSPL3 containing 
the mouse genomic DNA fragments. Three separate transfections were performed, 
one for each pool of clones derived from the three individual recombinant phage 
isolates. The cells were incubated at 37^C for 24hrs after which total RNA was 
prepared yielding 40-50pg of RNA (Materials and Methods). 3\xg of this total RNA 
was then used for cDNA synthesis.The cDNA synthesis reaction was primed using 
an oligomer (SA2) from the 3' end of the reporter construct, ensuring that cDNA 
synthesis only occurred from vector derived RNA transcripts. Primary PCR was 
performed on this cDNA using primers homologous to the reporter exons. This PCR
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produced a double stranded product, composed of the control exons flanking any 
exons that had been trapped by splicing events. To eliminate any products resulting 
from cryptic splice sites or single splice donors/acceptors, or vector alone splicing 
events the primary PCR product was treated with Bst XI, as described in Materials 
and Methods. This restricted all products that did not contain a functionally spliced 
exon product and exons that contained a Bst XI site. A secondary PCR reaction was 
performed on the Bst Xi treated primary PCR product. The primers used for this 
reaction are nested in relation to the initial primers. This helped ensure the specificity 
of the amplified exons. The primers used in the second round of PCR also contained 
dUMP residues that allow efficient uracil DNA glycosylase (UDG) cloning into the 
pAMPlO cloning vector (Gibco BRL)(Materials and Methods). The secondary PCR 
reaction was also carried out in parallel on samples that had not undergone Bst XI 
treatment as a control.
After the secondary PCR reaction, 5pi of each 50pl reaction was 
electrophoresed in a 2% agarose gel (Figure 20). As predicted a major product of 
177bp is present in the vector control lane. This vector derived product is also 
present in the Bst XI untreated lanes of mouse genomic derived exons. This vector 
product is removed by treatment with Bst XI, Several other bands are also present in 
those samples that did not undergo Bst XI treatment, these may be vector derived or 
the result of cryptic splicing events in the samples. There appears to be a band at 
220bp and another at 480bp common to all untreated samples, removed by treatment 
with Bst XI. Phage 1 derived exon-trapped products consist mainly of a single band 
270bps in size, with several fainter products running at 600-700bp. Exon-trapped 
products from Phage 4 appear more numerous and discrete. Again there is a 270bp 
product, as observed with Phage 1, but bands are also present at 300bp, 340bp, 390bp 
and 450bp. Fainter bands are also present at 600-700bp. The products observable in 
the Phage 7 sample again consist of the 270bp shared with the other phage, in 
addition to a band at 350bp. This PCR product is apparently slightly larger than the 
340bp band seen with Phage 4. As with the exon-trapped products derived from the
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Figure 20: Agarose gel analysis of secondary PCR products from 
exon-trapping.Exon-trapping products from Phage 1,4 , 7, the control exon 
(C) and the vector only control (V) were either treated with (+) or without (-) Bst XI. A fifth of the secondary PCR reaction produced by exon-trapping from each sample was electrophoresed on a 2.0% 
agarose gel and visualised with UV light by ethidium bromide staining.
The lOObp and 200bp bands x^esent in all untreated samples 
that correspond to vector derived products are removed by Bst XI 
treatment A band smaller than SOObp product is present in the Bst 
XI treated samples from the cloned genomic DNA. Several other products are present in the cloned DNA samples, Phage 7 exhibits 
several (xoducts at 700bp, Phage 4 exhibits discrete products 
ranging in size from SOObp to 450bp. There are clear differences between Bst XI treated and imtreatôl samples as well as between 
controls and genomic samples.
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other phage, bands are observable at 600-700bp. In the case of Phage 7, these 
products are discrete and three can readily be identified. All these PCR products are 
resistant to Bst XI treatment.
When comparing the exon-trapped products from the three phage with 
products derived from the vector control or control exon, a clear difference was 
observable (Figure 20). This result suggested that the exon-trapping had been 
successful. The total Bst XI treated, secondary PCR products were then used to 
confirm their derivation from the 3 phage isolates and further characterised. This was 
achieved by probing Southern blots of recombinant phage DNA digests, mouse 
genomic DNA digests and Northern blots of mouse embryonic total RNA with the 
secondary PCR products as the probe.
2.6.4 Analysis of the products of exon-trapping to confirm authenticity
To confirm if any of the trapped product is derived from mouse genomic 
DNA, total exon-trapped PCR product from the individual phage was radio-labelled 
by random priming (Materials and Methods) and then hybridised to Southern blots of 
Phage DNA, Each phage blot consisted of DNA from the original three phage 
isolates digested with a restriction enzyme, in this case EcoR /. This probing of phage 
DNA was repeated for each of the three samples of exon-trapped products. Figure 21 
demonstrates that several sequences from the original phage, have been trapped. 
Hybridisation with PCR product from Phage 1 and Phage 7 is consistent with the 
high level of shared sequence between these phage. It is also interesting to note that 
the fragments of DNA that exhibited the highest level of expression by Northern 
analysis and Reverse Northern analysis, i.e., the 6kb and 3kb EcoR I fragments (see 
Figure 11), appear to contain functional exons. The 1.9kb EcoR I  fragment that is 
shared between all three phage also appears to contain a functional exon. The 
consistency between the three individual experiments is suggestive of valid product, 
not cryptic or artifact products.
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Figure 21: Location of trapped exons in cloned genomic DNA.
Southern blots of cloned genomic DNA probed with total secondary PCR products from exon-trapping. Each Southern blot 
represents Ipg of each genomic clone digested with EcoR I and Not 
/; lane 1, Phage 1; lane 2, Phage 4; lane 3, Phage 7, electrophoresed 
through 0.8% agarose gel. Southern blotted and probed witii total secondary PCR products derived from Phage 1, Phage 4 and Phage 
7 as indicated above.Note: that the 4. Ikb fragment is unique to Phage 4 and only 
detected by Phage 4 PCR products. The 3.2kb EcoR I + Not I of Phage 1 which overlaps the 4.1kb fragment of Phage 4, is detected by Phage 4 PCR products but not by either Phage 1 or 7 PCR 
products. Phage 1 and Phage 7 PCR products detect similar fragments as the sequence of both overlap. They also detect the 
1.25kb EcoR I +Not I fragment from Ph%e 4.
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The pattern of hybridisation with Phage 4 is quite dissimilar to that of Phage 
1 and Phage 7. Although it shares the signals seen with the 1.9kb and the 1.2kb 
EcoR I fragments, it also hybridises to several unique bands. The 4.Ikb , 3.9kb and 
the 3.5kb EcoR I fragments are identified from Phage 4. Northern and Reverse 
Northern analysis indicated high expression of the 4.1kb fragment (see section 2.3). 
The 3.2kb EcoR I /  junctional fragment of Phage 1 (equivalent to the 4.Ikb 
EcoR I fragment of Phage 4) also hybridised to the total Phage 4 exon-trapped 
product. As would be predicted, this Phage 1 fragment did not hybridise to the PCR 
products of exon-trapping derived from Phage 1 or Phage 7. This is a result of the 
fragment not being present in Phage 7 and as only EcoR I fragments have been 
ligated into the exon-trapping vector the EcoR I /  jxmctional fragment of Phage 
1 was not cloned into the exon-trapping vector. Therefore any functional exon within 
this Phage 1 junctional fragment would only be isolated from the Phage 4 4.Ikb 
EcoR I fragment. In all, the probing of the phage blots with the PCR products of 
exon-trapping suggests that there are functional exons spread across the entire 32.8kb 
of isolated DNA.
2.6.5 Analysis of expression of total exon products
In order to gain information on the expression patterns of these isolated 
exons. Northern blots of embryonic RNA were probed first. Northern blots of total 
RNA from the head and body of embryonic day 15,5 mice, were probed with 
randomly labelled total secondary PCR product. The Northern blots presented in 
Figure 22 represent one week long exposures. Phage 7 derived exon-trapping 
products hybridise to several transcripts. A signal can be clearly seen at 500 
nucleotides and another clearly defined at 800 nucleotides. Both of these transcripts 
are found in both head and body RNA. There are also several other signals on the 
blot. One appears to shadow the 28S Ribosomal RNA band in both head and body, 
the probe also hybridises to a large transcript.
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Figure 22: Expressional analysis of exons trapped from the cloned 
genomic DNA in development.Northern blots of day 15.5 embyonic RNA probed with the 
total secondary PCR products from exon-trapping. Each lane represents lOpig of total RNA prepared from either embryonic day
15.5 head or body electrophoresed through a formaldehyde 
denaturing gel. Northern blotted and hybridised with; (a) Total 
secondary PCR products derived from Phage 1, (b) Total secondary 
PCR products derived from Phage 4, (c) total secondary PCR 
products derived from Phage 7. Lane 1 is embryonic day 15.5 head 
RNA and lane 2 is embryonic day 15.5 body RNA.Note: Phage 1 and Phage 7 exons hybridise to a O.Skb and 
0.5kb transcript, while exons from phage 4 hybridise to the O.Skb transcript Exons from all Phage appear to hybridise to transcripts at 
about the 28S ribosomal RNA band.
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The pattern of hybridisation seen with Phage 1 is similar to that of Phage 7.
The bands seen at 500 nucleotides and 800 nucleotides are clearly visible as are the 
signals shadowing the 28S Ribosomal band and those found higher up on the blot.
However, here there appears to be a doublet at 800 nucleotides. This may be an 
artifact of the Northern blot or it could represent two RNA transcripts, which 
hybridise with exons with sequence derived from Phage 1 EcoR /  fragments. Phage 4 
exon-trapped products hybridise to the 800 nucleotide transcript much more intensely 
than either Phage 1 or Phage 7. The 800 nucleotide message may be a doublet, but 
the resolution of the gel makes this difficult to determine. Like Phage 1 and Phage 7;
Phage 4 derived exons also hybridise to the 500 nucleotide message but less 
intensely than observed with Phage 1 and Phage 7 (this is not apparent from the
■ :...photograph in Figure 22). Also like Phage 1 and Phage 7 products there is a strong
r.i.
signal that corresponds to the 28S Ribosomal RNA, but no signal is seen at lOkb.
In order to rule out the possibility that the vector sequences within the PCR 
products are fortuitously hybridising to the blots, the secondary PCR product 
produced by the vector control was used to probe a Northern blot. This Northern blot 
contained total RNA from embryonic mice at different stages of development and 
from several post-natal tissues. The signal which appears to run with the 28S 
Ribosomal RNA, can be readily discerned (data not shown). Therefore this signal 
appears to be of vector origin as the probing 'conditions’ are specific. However, none 
of the other signals is detected. This demonstrates that the transcripts at 500 
nucleotides and 800 nucleotides observed with the mouse genomic derived secondary 
PCR products are real and not artifacts of the exon-trapping vector. Thus the 
products from all three phage contain functionally expressed exon(s) and are 
expressed during development.
The pattern of expression during development and in post-natal tissues was 
analysed for the exons from Phage 7. Figure 23(a) shows a blot of embryonic RNAs 
and post-natal RNAs probed with total exons from Phage 7, The 800 nucleotide 
message can be seen in the body sample from day 12.5, it is also present in the RNA
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samples from the bodies of day 13,5, day 14.5 and day 15,5 mouse embryos. The 800 
nucleotide message also appears to be present in the head sample of day 14,5, but the 
signal is quite faint. The 800 nucleotide message is present in post-natal heart and 
lung, the signal does not appear to be present in the skin, kidney and brain sample. 
From this blot it is difficult to say whether the 500 nucleotide message is present in 
any of the samples but there appears to be a diffuse signal at about 500 nucleotides in 
size in some of the samples. Whether this is a bona fide message or not will require 
further analysis.
There is a band observable at 5kb in the body RNA sample from day 13,5 
embryos with the Phage 7 exons, this message is not observed in any of the post­
natal tissue samples. This indicates that sequences within the Phage 7 exons 
hybridise to a 5kb message that is expressed only at day 13.5 in the body of 
embryonic mice (in this analysis). This 5kb message may be expressed at other 
stages of development or at levels not detected in this analysis which would require a 
more rigorous analysis than that attempted here to detect it.
The pattern of expression in development and post-natally of the Phage 4 
exons was also analysed as shown in Figure 23(b). As can be seen in Figure 23(b) the 
800 nucleotide message is detected in the body of day 12.5 RNA sample and appears 
to increase in the level of its expression in day 13.5, day 14.5 and 15,5 body RNA 
samples. The 800 nucleotide message is also present in the day 16.5 and 20.5 body 
RNA samples but due to loading differences it is difficult to state whether there is a 
change in the level of expression. The 800 nucleotide message is also detected in the 
head RNA samples from day 13.5 onwards, it also appears to show an increase in the 
level of expression with an increase in age to day 15,5 of embryonic development.
In the post-natal tissues the 800 nucleotide message was detected in the 
bone, spleen and stomach RNA samples. Due to great variations in the amount of 
RNA in these post-natal samples the 800 nucleotide message may also be expressed 
in other tissues but it will not be detected in this analysis. None of the other two
90
Embryonic Day
12.5 13.5 14.5 15.5 Adult
H B H B H B B S H K L B r
Size kb
9.5
7.5
4.4
1.4
0.6
Figure 23 (a): Analysis of expression of the secondary PCR 
products from Phage 7 during mouse embryonic development and post-natally.Total RNA was prepared from the heads (H) and bodies (B) of mouse embryos at different stages of emlxyonic development 
indicated above, and tissue samples of adult mice. Tissues 
represented are S, adult skin; H, adult heart; K, adult kidney; L, adult lung; and Br, adult brain.lOpg samples of total RNA were electrophoresed through a 
denaturing fcxmaldehyde gel, blotted and probed with radio-labeUed 
total secondary PCR products of exon-trapping from Phage 7.Note: the O.Skb transcript seen in FigurelS is present, however due to the poor quality of the blot,it is difficult to state whether the 0.5kb transcript is present or not
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Figure 23 (b): Northern blot analysis of total exons trapped from 
Phage 4 during embryonic development and post natally.
Total RNA was prepared from the heads and bodies of 
mouse embryos at different stages of embryonic development and tissue samples of adult mice. lOpg samples of total RNA were 
electrophoresed through a 1.0% denaturing formaldehyde agarose 
gel, blotted and probed with radio-labelled total secondary PCR 
products of exon-trapping from Phage 4. Lanes 1,3,5.7, 9,11 and 13 represent total RNA from the heads of day 11.5, day 12.5, day 13.5, day 14.5, day 15.5, day 16.5 and day 205 embryonic mice respectively. Lanes 2,4, 6, 8,10,12 and 14 represent total RNA 
from the bodies of day 11.5, day 12.5, day 13.5, day 14.5, day 15.5, day 165 and day 20.5 embryonic mice respectively. Lane 15, adult bcttie; lane 16, adult kidney; lane 17, adult liver, lane 18, adult lung; lanelP, adult skin and lane 20, adult spleen; lane 21, adult stomach; lane 22, adult testes; lane 23, adult thymus and lane 24, adult spleeiL Lower panel shows Nathem blot jHobed with Gapdh as a
loading control.
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messages (5kb and 500 nucleotides) were detected in this analysis, indicating that 
exons trapped from Phage 4 only hybridise to the 800 nucleotide message.
2.6.6 Differences in expression of exons between transgenically positive and
transgenically negative RNAs
The 32.8kb stretch of DNA from which the exons are derived was isolated 
on the basis that it was disrupted in the cleft palate transgenic mouse. Two novel 
transcripts were identified at 4.5kb and lOkb m transgenically positive tissues. One 
of these was too large to be transgene sequence alone and must therefore be a hybrid 
of transgene and cellular sequence. This suggested that a cellular locus near to the 
site of transgene insertion was affected in transgenically positive mice.
In order to address if these cellular sequences within the lOkb hybrid RNA 
were present or if the secondary PCR products were affected in the transgenic line, 
transgenically positive RNAs were tested by hybridisation with labelled exon- 
trapped products. Figure 24 shows total RNAs derived from the kidney and the 
spleen of transgenically positive and transgenically negative mice, hybridised with 
the total exon-trapped products derived from Phage 7. An 800 nucleotide product is 
seen in the spleen of both transgenically positive and negative mice. It does not 
appear as a doublet as the transcript identified is not discrete. No change in size of 
the transcript is detectable between the transgenically positive or transgenically 
negative spleen RNA samples. Neither of the transgenically negative or 
transgenically positive kidney samples appear to express the 800 nucleotide 
transcript. The smaller 500 nucleotide transcript is not detected in any of the samples. 
Several larger transcripts are observed in some of the samples, though their pattern of 
expression is not consistent in the different samples between transgenically positive 
and negative RNAs. This erratic pattern of expression means that nothing conclusive 
can be drawn from their presence on the blot. The hybrid transcripts were not 
detected, this may be a result of the low level of expression of the hybrid transcripts. 
It may also be a result of none of
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Figure 24: Analysis of expression of secondary PCR products 
between post-natal transgenically positive and transgenically 
negative tissues.Total RNA was prepared from the kidneys (K) and spleens 
(S) from transgenically positive(+) and transgenically negative (-) 
age matched mice. lOpg samples of total RNA were 
electrophoresed through denaturing formaldehyde gels. Northern blotted and probed with radio-labelled total secondary PCR products of exon-trapping from Phage 7. Two transgenically negative kidney 
RNA samples are shown above.Loading was controlled for by probing the Northern with 
GAPDH, Note: the O.Skb transcript detected in heart RNA in Figure 
18 is detected in both the transgenically positive and transgenically negative Spleen samples, but is not detected in any of the kidney 
samples.
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trapped exons being part of the hybrid transcripts, this may indicate that there are 
different transcripts derived from this locus.
The secondary PCR products from the exon-trapping, when hybridised to 
total RNAs from transgenically positive and transgenically negative tissue, revealed 
an upregulation in the level of the 800 nucleotide transcript in the transgenically 
positive spleen. Neither of the lOkb or 4.5kb hybrid transcripts was found in either 
transgenically positive RNA sample and no signal was observed in either the 
transgenically positive or transgenically negative kidney samples.
2.7 Characterisation of individual exons from total PCR products
Having shown that sequences contained in the secondary PCR products are 
part of a transcription unit expressed from mouse genomic DNA, individual exons 
from the pools were isolated. The secondary PCR products from the individual phage 
were cloned into pAMPlO (Materials and Methods). Ligated products were 
transformed into XLl-Blue, for each pool of ligated products about 100 transformed 
colonies were plated and 10-20% of these transformants were analysed. Thirteen 
white colonies (i.e. recombinants) from Phage 7, fourteen white colonies from Phage 
1 and nineteen white colonies from Phage 4 were selected at random initially for 
analysis by Colony PCR (Colony PCR was carried out as in Materials and Methods). 
By this method the presence of inserts and their size can be discerned. The products 
of Colony PCR were electrophoresed on 2% agarose gels, then blotted. To identify 
those products that contained sequence derived from the 30kb of mouse genomic 
DNA, these blots were then hybridised with entire radiolabelled recombinant phage 
DNA, Each set of subcloned PCR products was hybridised with the respective phage 
from which they were derived.
Figure 25 (a) shows the result of hybridisation of Phage 4 to Colony PCR 
products from Phage 4. Out of the nineteen colonies from Phage 4, fifteen hybridised 
with mouse genomic sequences. In this case fourteen of the PCR products were about 
250bp in size. 177bp of the 250bp is vector sequence due to the location of the
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Figure 25 (a): Isolation of individual exons trapped from Phage 4 
cloned genomic DNA.Total secondary PCR products trapped from Phage 4 were 
cloned and transformants analysed using colony PCR. A fifth of the 
PCR reaction was electrophoresed on 2% agarose gels, Southern 
blotted and hybridised with radio-labelled Phage 4 total cloned genomic DNA.The contact print of the autoradiograph shown represents 
some of the cloned exon-trapping PCR products form Phage 4 EcoR 
I fragments probed with Phage 4 total genomic DNA. Each lane is an individual colony PCR product from the cloned products of exon 
-trapping. On the basis of this analysis individual colonies were chosen and their plasmids sequenced.
The fXTDduct from lane 8 was found to be a 206bp exon and designated exon p51.The PCR product in lane 1, 3, 4, 6, 9 ,10,11, 12,13,14,16,17,18 and 19 were sequenced and found to be identical to each other, this was designated exon p52.
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primers used for the Colony PCR this would result from an exon of approximately 
80bp in size. The remaining PCR product hybridizing with mouse genomic 
sequences was just under 400bp. Again allowing for the 177bp of vector sequences 
this would result from an exon of 220bp in size. Out of the fourteen colonies from 
Phage 1 tested, only one appeared to be positive. The PCR fragment is 600bp in size, 
177bp of which is vector sequence, therefore, this PCR fragment contains a putative 
exon of approximately 450bp. Similarly for the thirteen colonies tested from Phage 7, 
only one hybridised with mouse genomic sequences. This PCR fragment was also 
600bp, similar to that isolated from Phage 1 which again would mean a putative exon 
of 450bp (data not shown).
It was possible that not all the trapped exons were being identified. A total 
of about 300 colony PCR products were screened using individual phage fragments. 
Those phage fragments which had been identified previously as containing exon 
sequences were used. Using this approach it was possible to identify another six 
clones. Figure 25 (b) shows the same Southern blot of PCR products probed with two 
different Phage derived fragments. Although they reveal PCR products of a similar 
size, the pattern of hybridisation is completely different. The pattern of 
hybridisations in Figure 25 (b) indicated that a single Colony PCR product was 
derived from the 1.9kb EcoR I fragment of Phage 7, while four of the Colony PCR 
products are derived from the 1.25kb EcoR I + Not I fragment from Phage 4.
Since different exons may be the same size, several of the clones of each 
size were sequenced. Twenty-five subcloned secondary PCR products were 
sequenced in total. Out of these twenty-five sequences five novel exons were 
identified. For each exon the location on the 32,8kb of DNA was ascertained, 
patterns of expression characterised, and conservation across species investigated. 
The novel exons were assigned the names of p50, p51, p52, p56 and p57 for the 
purposes of reference only.
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Figure 25 (b);(i) Isolation of exon p56, (ii) Isolation of exon p57.
Colony PCR was performed on cells transformed with 
ligations of total seconda^ PCR product from Phage 1. One fifth of each PCR reaction was electrophoresed on a 2% agarose gel, blotted 
and hylxidised with (i) the 1.2kb EcoR I and 1.25kb EcoR I+Not I fragments from Phage 4 and (ii) the 1.9kb EcoR I fragment that is found in all Phage clones. The autoradiographs of these 
hybridisations are shown above.
Several PCR products were found to hybridise to these probes, isolation and sequencing of all the identified PCR products 
in (i) revealed that they were the same sequence and this sequence was designated exon p56. One PCR product was found to hylwidise 
to the 1.9kb EcoR I fragment from Phage 7 (ii), it was isolated, 
sequenced and designated exon p57.
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2,8 Characterisation of trapped exons
The following results have been sub-divided into several sections. Each 
section deals with an individual exon and the results contained within each section 
follow the same layout. Firstly, the sequence analysis for each exon and any database 
information. The sequence analysis for each exon includes motif searches on the 
GCG package. This was carried out for both nucleic acid sequence and predicted 
amino acid sequence of ORFs. Motif searches are, of course, limited by the motifs 
present in the database and the only matches acknowledged are those which exhibit 
100% homology. The sequence analysis will be followed by the mapping of the exon 
onto the phage map. There then follows Southern analysis of conservation of the 
exon across species and expression analysis. All the techniques used are detailed in 
the Materials and Methods.
2.8.1 Characterisation and expressional analysis of exon p50
Exon p50, isolated from the Phage 4 exon pool, was sequenced using 
double stranded dideoxy sequencing (Sanger et aL, 1977) with primers to the T7 and 
SP6 promoters present in the vector flanking the multiple cloning site. Exon p50 is 
composed of 446bps (see Figure 26). When analysed using MacVectorTm or the 
GCG package several Open Reading Frames (ORF) were found. None, however, was 
complete across the exon. This analysis did not reveal any nucleic acid motifs. 
Translation of the ORFs did not reveal any protein motifs in the deduced amino acid 
sequence when compared to the GCG package Motifs program. A search of the 
BLASTN database revealed that the sequence of exon p50 contained two major 
LINE-1 sequence repeats that constitute over 95% of the exons sequence. LINE-1 
repeat sequences are widespread in the mouse genome (Charlesworth et aL, 1994). 
They are found in the sequence of some retrotransposable elements. The database
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Figure 26: Sequence analysis of Exon p50
Nucleotide Sequence of Exon p50: oligos used to prime PCR are indicated by bold type and underlining.
20
AGTACAGAGA
TCATGTCTCT70
TGCCACACCC
ACGGTGTGGG
30
CAAAGTTTGG
GTTTCAAACC80
GGGGATCCAT
CCCCTAGGTA
40
AGCTGAGATG
TCGACTCTAC90
CCCATAATCA
GGGTATTAGT
50
AAAGATGACC
TTTCTACTGG
100
GCCTCCAAAC
CGGAGGTTTG
10
TCATGGAAGA 
AGTACCTTCT 60
ATCTAGAGAC 
TAGATCTCTG110 120 130 140 150
GCTGACACCA TTGCATACGC CAGCAAGATT TTGCTGAAAG GACCCTGATA
CGACTGTGGT AACGTATGCG GTCGTTCTAA AACGACTTTC CTGGGÀCTAT160 170 180 190 200
TAGCTGTCTC TTGTGAGGCT ATCTGGTGCC TGGCAAACAC AAGTGGATGC
ATCGACAGAG AACACTCCGA TAGACCACGG ACCGTTTGTG TTCACCTACG210 220 230 240 250
TCACAGTCAT CTATAAGATG GAACACAGGG CCCCCAGTGG AGGAGCTAGA
AGTGTCAGTA GATATTCTAC CTTGTGTCCC GGGGGTCACC TCCTCGATCT260 270 280 290 300
GAAAGTACCA AAGGAGCTAA AGGGATCTGC AACCCTATAG ATGAACAACA
CTTTCATGGT TTCCTCGATT TCCCTAGAGG TTGGGATATC TACTTGTTGT310 320 330 340 350
ATATGAACTA ATCAGTACCC CCGAGATCGT GTCTCTAGCT GCATATGTAT
TATACTTGAT TAGTCATGGG GGCTCGAGCA CAGAGATCGA CGTATACATA360 370 380 390 400
CAGAAGATGG CCTAGTCTGC CATCACTGGG AAGAGAGGCC CTTTGGTCTT
GTCTTCTACC GGATCAGACG GTAGTGACCC TTCTCTCCGG GAAACCAGAA410 420 430 440 450
GCAAACTTTA
CGTTTGAAAT
TATGCCTCAG
ATACGGAGTC
TACAGGGGAA
ATGTCCCCTT
TGCCAGGGCC
ACGGTCCCGG
AAGAAGTTCTTC
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search revealed that these LINE-1 sequences are also present in the 5’ and 3' 
untranslated regions of several genes, e.g. Mus muscaris bradykinin B2 Receptor 
gene sequence (Ma et al 1994) and the mouse interleukin 6 (IL-6) gene (Tanabe et 
aL 1988).
Exon p50 was mapped onto the restriction map of the 32.8kb of isolated 
mouse genomic DNA (Figure 27). This was achieved by probing a Southern blot of 
phage DNA digested with EcoR I with an exon p50 probe. The exon p50 probe 
hybridised to the 6kb and the repetitive 3kb EcoR I fragments found in Phage 1 and 
Phage 7, it also hybridised to the 4.1kb EcoR I fragment found in Phage 4. The same 
fragments were identified by Reverse Southern analysis and by Reverse Northern 
analysis. The fragments identified appeared to be the most highly repetitive and also 
the most highly expressed. The fact that these fragments probably contain LINE-1 
repetitive sequence helps to explain previous observations.
Mapping is, however, complicated by this result and by this approach alone 
it is not possible to ascertain which of these two fragments the exons are derived 
from. Exons derived from Phage 4 did not exhibit the pattern of hybridisation seen 
with exon p50, when used as a probe on a Southern blot of phage DNA digested with 
EcoR I (Figure 21), suggesting that although LINE-1 sequences are present in the 
Phage 4 they are not contained in an exon trapped in this analysis. Exons derived 
from Phage 1 and Phage 7 did exhibit this pattern of hybridisation. It appears then, 
that exon p50 resides in either the 6kb EcoR I fragment or the 3kb EcoR I  fragment 
of Phage 1 and Phage 7.
If the sequence of exon p50 is part of an 'important' transcript, then it may 
show conservation across species. The conservation of the sequence of exon p50 was 
analysed by hybridisation to a Zoo blot (Figure 28). Figure 28 shows that this 
sequence is highly repetitive in mouse and no discrete band is observable. It is also 
highly repetitive across species as rat, hamster and human all exhibit a repetitive 
pattern at low temperature and low stringency. At a higher temperature of 65«C, the 
repetitive signal is still apparent in the mouse and human DNA, though the rat and
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Figure 27: Location of exon p50 in cloned genomic DNA.Contact print of the autoradiograph of a Southern blot of 
cloned genomic DNA probed with radio-labelled exon p50. Each 
lane represents Ipg of each genomic clone digested witii EcoR I + 
Not r, lane 1, Phage 1; lane 2, Phage 4; lane 3, Phage 7. Samples were electrophoresed through an 0.8% agarose gel, Southern blotted 
and probed.
Note: exon p50 identifies the 3kb and 6kb EcoR I fragments 
from Phage 1 and Phage 7 and die 4.1kb EcoR I fragment from Phage 4.
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Figure 28: Zoo blot analysis of DNA isolated from several species 
hybridised with exon p50.5pg of DNA from each species was digested with EcoR /, 
electrophcaesed through a 0.7% agarose gel, Southern blotted and 
probed with exon p50. The samples used are Mm, mouse male; Mf, mouse female; R, rat; H, hamster and Hu, human. Hybridisations 
were carried out at 55°C and Ix Church Buffer overnight. Blots 
shown were washed to a final stringency of (a) 55°C and IxSSC, 
and (b) 65°C and IxSSC.Note: that exon p50 hybridises to the mouse and human DNA samples at the higher stringency, exon p50 does still hyWdise 
to the rat and hamster DNA samples but the signal is greatly 
reduced at this higher stringency.
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hamster samples show a much reduced signal. In the hamster lane there appears to be 
a band at about 6kb . When the stringency was increased, although the high level of 
repetitive signal in mouse and human DNA decreased, no obvious bands are 
observable. This result is consistent with the sequence data.
Expressional analysis was carried out. The exon p50 sequences were 
hybridised to Northern blots of mouse embryonic day 15.5 total RNA. As Figure 29 
(a) shows, the sequences contained within exon p50 are highly expressed at day 15.5 
of mouse embryonic development. However, no single transcript is detectable. This 
is not surprising considering the number of LINE-1-like repetitive elements dispersed 
throughout the mouse genome. The association of these LINE-1 sequences with 
many genes explains the high level of expression detected by Northern analysis. 
When a similar Northern blot of mouse embryonic RNAs was probed using the total 
exon-trapped secondary PCR products derived from the original phage, several 
signals were detected at >10kb (see section). These large signals were only observed 
on the Northern blots probed with the exon-trapped products of Phage 1 and Phage 7. 
The pattern of expression exhibited by exon p50 at day 15.5 of mouse embryonic 
development identifies these larger transcripts, although the intensity is much 
stronger. This difference is probably due to the reduced representation of exon p50 in 
the total secondary PCR product. This would reduce the specific activity of the 
labelled fragment and consequently produce a much reduced signal on a Northern 
blot
2.9.1 Characterisation of exon p51 sequences
That exon p51 from Phage 4 was confirmed by hybridisation of Phage 4 
sequences to exon-trapped sequences that had been subcloned and analysed by 
colony PCR. Both strands were sequenced by dideoxy sequencing (Sanger et al., 
1977), using primers to the flanking T7 and SP6 promoters present in the cloning 
vector. Sequencing of exon p51 showed that it is 205bp (Figure 30). When this 
205bp sequence was analysed using MacVector™ and the GCG package no nucleic
"9
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Figure 29: Analysis of exon p50, exon p51 and exon p52 expression 
during mouse embryonic development
Total RNA isolated from the head (H) and body (B) of embryonic day 15.5 mice was electrophoresed and hybridised at 
65°C in Ix Church Buffer overnight with radio-labelled (a) exon 
p50, (b) exon p51 and (c) exon p52. Blots were washed at 65°C and 
0. IxSSC and 0.1% SDS.Note: exon p50 hybridises strongly with many RNA species, while exon p51 and p52 hybridise to an RNA species that 
runs at the 28S ribosomal RNA band.The lower panel shows the same blot jxobed with glyceraldehyde 3-phosphate dehydrogenase (Gapdh) as a loading 
control.
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Figure 30: Sequence analysis of Exon p51
(a) Nucleotide Sequence; oligos used to prime PCR are indicated by bold type and underlining.
10 20 30 40 50GAGAATACGA ACACGAACTA TAACTTTCTC GTCAAAAAAT AGAGAGGAAACTCTTATGCT TGTGCTTGAT ATTGAAAGAG CAGTTTTTTA TCTCTCCTTT60 70 80 90 100GAGTAATAGT AAGAGGCGAT GATGATAACC ATAATCATAG TAAGAAGTTTCTCATTATCA TTCTCCGCTA CTACTATTGG TATTAGTATC ATTCTTCAAA110 120 130 140 150AGTCACGTGA AATTTGAATT GAAATCAAAA GAGGAACGTA ACTTAAAGAGTCAGTGCACT TTAAACTTAA CTTTAGTTTT CTCCTTGCAT TGAATTTCTC160 170 180 190 200TCAACAAGAT GACAAAGACC TTCTACCTAA AACATCCGTA TTGCTAGGCGAGTTGTTCTA CTGTTTCTGG AAGATGGATT TTGTAGGCAT AACGATCCGC
210AGACG
ICTGC
(b) Open Reading Frames of Exon p51
20 40 60 80 100 120 140 160 180 200
1
2
3
4
5
6
160 180 20080 14040 10060 12020
(c) Amino Acid Sequence Of Translated ORF From Exon p51
10 20 30 40 50RIRTRTITFS SKNREERVIV RGDDDNHNHS KKFSHVKFEL KSKEERNLKS
60 70QQDDKDLLPK TSVLLGET
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acid sequence motifs were identified. A search of the BLASTN database with the 
nucleic acid sequence revealed several similarities to the sequence of exon p51. No 
other matches produced 100% identity, at the nucleotide level, though a number of 
sequences exhibited a level of 70-80% homology across short stretches of nucleic 
acid sequence. Of these sequences, a T.brucei variable surface glycoprotein gene 
with 80% identity across 60 bases (Young et al, 1987), a rice partial cDNA with 
71% identity across a stretch of 48 bases (Sasaki and Minobe, unpublished) and the 
rat Map2 gene for microtubule associated protein with 76% identity across 41 bases 
(Kindler et a l, 1990) were the best matches found in the databases.
Using MacVector™ a single ORF that spanned the sequence was identified 
(Figure 30 (b)). The ORF was translated using the GCG package (see Figure 30 (c)). 
The predicted amino acid sequence of the ORF is 68 amino acids in length. A search 
of the BLAST? databases using this peptide sequence did not reveal any high level 
of similarity to other peptide sequences across its entire length. Short stretches of 
<10amino acids did show very high levels of identity. These matches were too 
numerous and the types of genes too diverse for anything to be concluded. Several 
larger peptide sequences however did exhibit a low level of similarity. Macrogolgin, 
a human structural protein, exhibited a 25% identity across 51 amino acids of the 
translated exon (Seelig et a l, 1994). When similar amino acid substitutions are 
included in the analysis, the level of similarity increased slightly to 28%. Another 
amino acid sequence which exhibited a low level of similarity was neurofilament 
triplet M protein from the Pacific electric ray (Linial and Scheller, 1990). Over a 50 
amino acid sequence it showed a 29% identity and a similarity of 43% when similar 
amino acid substitions are included.
2.9.2 Mapping of exon p51 onto mouse genomic DNA
To identify where on the mouse genomic DNA exon p51 is located, it was 
hybridised to a Southern blot of phage DNA digested with EcoR I ( Figure 31). Exon 
p51 was found to reside on the 3.9kb fragment of Phage 4, though it was quite
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Figure 31: Location of exon p51 in cloned genomic DNA
Contact print of the autoradiograph of a Southern blot of cloned genomic DNA probed with radio-labeUed exon p51. Each 
lane represents Ipg of each genomic clone digested witii EcoR I + 
Not /; lane 1, Phage 1; lane 2, Phage 4; lane 3, Phage 7. Samples 
were electrophoresed through an 0.8% agarose gel. Southern blotted 
and probedExon p51 hybridises to the 3.9kb EcoR I fragment from Phage 4.
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difficult to be sure that it only hybridised to the 3,9kb fragment due to the strength of 
the signal. The 3.9kb EcoR I and the 4.1kb EcoR I subclones were digested with 
several restriction enzymes, electrophesed on an agarose gel, blotted and probed with 
exon p51. Exon p51 was found to hybridise to the 3.9kb EcoR I fragments 
subfragment and not to the 4.1kb EcoR I fragment digested with several restriction 
enzymes. Exon p51 is trapped from the 3.9kb and not the 4.1kb EcoR I fragment.
2.9.3 Analysis of conservation of the exon p51 sequence across species
Exon p51 was hybridised to a Zoo blot (data not shown). The Zoo blot 
contained DNA digested with EcoR I from mouse, rat, hamster and human. Although 
random labelling of the exon produced probes of high specific activity, when these 
probes were hybridised to the Zoo blots they produced no clear signal upon washing. 
In view of the ability of the exon p51 successfully to hybridise to Southern blots of 
the phage fragments that it was derived from, it was unclear as to why this should be. 
177bp of the exon-trapped products is derived from the vector. This possibly results 
in a probe too small for genomic blots (though fine for blots of cloned DNA). This 
added to the number of sequences available for hybridisation present in the genomic 
DNA samples may explain the lack of hybridisation.
2.9.4 Expressional analysis of exon p51
Exon p51 was hybridised to a Northern blot of mouse embryonic day 15.5 
total RNA (Figure 29(b)). Exon p51 did not hybridise to the 500 and 800 nucleotide 
transcripts detected when the total secondary PCR product was hybridised to 
Northern blots of embryonic RNA, even after the blot had been exposed for over 
seven days. The nonspecific signal is seen at about the 28S Ribosomal RNA band, A 
fainter signal is observed at >10kb, in both head and body RNA. This is also 
observed in other Northern blots probed with total PCR products. It may be that this 
is a real transcript and that it contains exon p51. Exon p51 is either not part of the 
500 or the 800 nucleotide transcripts observed with the total secondary PCR product
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or the fragment is too small to make a good probe by random priming. This would 
seem to be true as it did not hybridise to the 3.9kb EcoR /  on a Southern blot. The 
Northern blots that exhibited the 500 and 800 nucleotide transcripts had been probed 
with total secondary PCR products. Exon p51 may belong to the primary transcript 
that produces the 500 or 800 nucleotide mature mRNA and splicing removes it from 
the final transcript. Or exon p51 may belong to a completely separate transcript that 
has not been observed at this stage of development.
In view of the inability to detect any hybridisation of exon p51 to the Zoo 
blot there was the possibility that the probes were too small to detect the sequence on 
the blot. Each exon fragment used as a probe contains 177bp of vector sequence. Due 
to the nature of exon-trapping this 177bp of vector sequence cannot be easily 
removed by restriction digestion. To overcome this problem two other strategies 
were attempted to produce high specific activity probes. Primers were designed to the 
5' and 3' ends of the exon sequence, PCR was then carried out (Materials and 
Methods). This PCR product should consist solely of exon p51 sequence with the 
vector sequences removed. Several templates known to contain the exon p51 were 
used in PCR reactions. No matter the reaction conditions used no PCR product could 
be identified, either by ethidium bromide staining of agarose gels or by hybridisation 
of exon p51 to blots of exon p51 PCR reactions. The reason why the PCR analysis 
failed is unknown. It is possible that there were tertiary structures in the DNA 
molecules that prevented Taq polymerase from progressing through the molecule, 
this could also be the reason for the poor probes generated. However exon p51 was 
sequenced using T7 polymerase with no difficulties and therefore it is unlikely that 
tertiary DNA structure is the reason why PCR analysis failed.
The oligonucleotides designed to the 3' and 5' ends of exon p51 for PCR 
(Figure 30) were end labelled and hybridised to Northern blots of embryonic RNAs 
and Zoo blots, in an attempt to overcome the problems caused by the small size of 
the probes used previously. No matter the hybridisation conditions nor the washing 
conditions used with the oligonucleotide probes, no signal could be detected on any
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of the blots. Due to pressures of time all the conditions used for this analysis could 
not be investigated.
2.10.1 Characterisation of exon p52
Exon p52, isolated from Phage 4, was identified by hybridisation of Phage 4 
sequences to the exon-trapped products derived from Phage 4. Exon p52 was 
sequenced using the dideoxy sequencing method (Sanger et a l , 1977). Both strands 
were sequenced (Materials and Methods). The sequence information obtained 
showed that it is composed of 81 nucleotides, see Figure 32. Subjecting this 81 
nucleotides of sequence to sequence analysis using MacVector^^  ^ and the GCG 
package revealed no nucleic acid sequence motifs. Comparison of this sequence to 
those present in the BLASTN database revealed a small number of sequences with a 
high degree of similarity at the nucleotide level. Most of these sequences were 
derived from the Calcium/calmodulin-dependent protein kinase H gene (CaM kinase 
II), from three different species. They were, Xenopus laevis (Taylor, unpublished). 
Mus musculus (Karls et a l, 1992) dinà Rattus rattus (Bennett et a l,  1987). A 
comparison of the sequence of CaM kinase II gene from Mus musculus to that of 
Rattus rattus revealed that they were 97% identical at the nucleotide level across the 
entire length of the gene including the 3' untranslated region (Karls et a l , 1992).
The sequences of CaM kinase II from the three species had exactly the same 
percentage similarity to the sequence of exon p52. Over a stretch of 70 bases, 47 
were identical (68%) between the exon sequence and the database sequence. 
Although the size of exon p52 is very smaU, the level of identity is reasonably high. 
This might suggest that exon p52 sequence is part of a protein kinase gene sequence. 
Another match in the database search was to a human cDNA clone, from an 
unknown gene located as an expressed sequence tag (EST) from human brain 
(Adams et al, 1993). The region of similarity was smaller, 60 bases, but the level of 
similarity was higher, 40 identical bases or 75%.
I l l
Figure 32: Sequence analysis of Exon p52
(a) Nucleotide Sequence: oligos used to prime PCR are indicated by bold type and underlining.
10 ■ 20 30 40 50
GGGGATGGTT ATGCCTACAA AATCCATCTT CCAGAAACAG TAGAACAACTCCCCTACCAA TACGGATGTT TTAGGTAGAA GGTCTTTGTC ATCTTGTTGA60 70 80GAGGAAATTC AATGCAAGGA GAAAACTAAA G
CTCCTTTAAG TTACGTTCCT CTTTTGATTT C
(b) Open Reading Frames of Exon p52
70 80
1
2
3
4
5
6
70 8030 6020 40 5010
(C) Amino Acid Sequence of Exon p52 ORFs 
0RF2
10 20 SGSLCLQNPS SRNSRTTEEI QCKAKTK
0RF3
10 20 GDGYAYKIHL PETVEQLRKF NARRKLK
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Using M a c V e c t o f T M  two ORFs were found that spanned the entire exon 
see Figure 32(b), both of these ORFs shared the same orientation. Translation of 
these two ORFs produced two very different peptide sequences see Figure 32(c). The 
peptide sequences were named after the ORF they were derived from see Figure 
32(b)&(c). Neither of these two peptide sequences contain structural protein motifs 
as shown by a peptide sequence motif search on the GCG package. A comparison of 
each peptide sequence to peptide sequences in the BLAST? database was performed.
ORF 2 was found to have a high degree of similarity at the amino acid level 
to the peptide sequence of calcium/calmodulin-dependent protein kinase II. Out of 
the twenty-seven amino acids present in the peptide ORF 2, sixteen of these were 
identical to part of the sequence of calcium/calmodulin-dependent protein kinase II 
(59% identity). This level of identity was found with CaM kinase II peptide 
sequences from Drosophilia, Human, rat, mouse and Xenopus (Hanson and 
Schulman, 1992) over the same region. This region of CaM kinase from each of the 
different species showed 90% identity to each other. The level of similarity increased 
to 97% when similar amino acid substitions are included.
A search of the BLASTP database with the deduced amino acid sequence of 
ORF 3 revealed that the deduced amino acid sequence of ORF 3 was similar to the 
Sex Determining Region Y protein. ORF 3 showed a lower level of identity, 43% 
identity across 23 amino acids to SRY amino acid sequence, than that exhibited by 
ORF 2 to calcium/calmodulin-dependent protein kinase II, The level of similarity of 
the deduced amino acid sequence for ORF 3 to SRY sequence, increased to 73% 
when similar amino acid substitutions are included. Again this level of similarity was 
consistent when ORF 3 was compared to the SRY peptide sequence from different 
species (Bianchi et al, 1993 and Pailhouse et al, unpublished). The region of the 
SRY protein that was found to be similar to the deduced amino acid of ORF 3 by the 
database searches, appears to be the HMG box of the protein. The deduced amino 
acid sequence of ORF 3 was found to be 36% identical and 63% similar across 25
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amino acids of the 55 amino acids of the HMG box of the SRY protein from Sus 
scrofa (domestic pig) (Pailhouse et a l, unpublished).
The database searches using the nucleotide sequence and the deduced amino 
acid sequences from ORF 2 and ORF 3 are both informative and interesting in 
regards to the nature of exon p52 and the gene that exon p52 belongs to. Though the 
nucleic acid sequence is highly conserved in other species the presence of two 
complete ORFs gives us several possibilities regarding the nature of the gene(s) 
present at this locus. The results of the database search imply that either ORF may be 
part of a single gene or that each belongs to two separate transcripts, both sharing the 
same sequence at the nucleic acid level but different ORFs.
2.10.2 Mapping of exon p52 onto mouse genomic DNA
Exon p52 was labelled by the random priming method (Materials and 
Methods), then hybridised to a Southern blot of phage DNA digested with EcoR I 
see Figure 33. Exon p52 was found to be located on the 3.9kb EcoR I fragment of 
Phage 4, As with exon p51. The 3.9kb EcoR I fragment was digested with several 
restriction enzymes, run on an agarose gel and blotted, then probed with exon p52. 
Exon p52 resides on the 3.9kb EcoR I (data not shown). Exon p52 appeared to reside 
on the same restriction fragment as exon p51 on the 3.9kb EcoR I  fragment. A 
comparison of the sequences of exon p51 and that of exon p52 reveals no similarity. 
These results suggest that exon p51 and exon p52 are within the same EcoR I DNA 
fragment in mouse.
2.10.3 Conservation of exon p52 sequence across species
The conservation of exon p52 sequence was examined via hybridisation to a 
Southern blot of DNAs from several species. As was observed with exon p51, no 
signal was apparent on the blot after washing, no matter the washing conditions used. 
It was considered that the size of the exon p52 sequence was too small to be a good 
probe under the conditions used, hence the lack of signal even with long exposure
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Figure 33: Location of exon p52 in cloned genomic DNA.Contact print of the autoradiograph of a Southern blot of 
cloned genomic DNA probed with radio-labelled exon p52. Each 
lane represents Ipg of each genomic clone digested with EcoR I  + 
Not /; lane 1, Phage 1; lane 2, Phage 4; and lane 3, Phage 7. Samples were electrophoresed through an 0.8% agarose gel. 
Southern blotted and probed.Exon p52 hybridises to the 3.9kb EcoR I fragment from 
Phage 4.
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times of this blot. Due to a lack of time not all the conditions of hybridisation could 
be tested and so nothing can be said about the conservation of exon p52 across 
species.
Primers were designed to the 5' and 3' ends of the exon p52 sequence for 
PCR (Materials and Methods). These oligos were end-labelled using polynucleotide 
kinase, and hybridised to the Zoo blots. This analysis failed to produce any signal on 
the Zoo blot under the conditions used for hybridisation and subsequent washes. 
Again due to lack of time not all of the conditions used could be tested and so this 
analysis does not tell us any thing about the conservation of exon p52 across species.
Using the same oligonucleotide primers described in Figure 32(a) PCR was 
attempted to show that the exon p52 sequences were present in the mouse genome. 
The conditions for PCR were tested and when the optimum PCR conditions were 
established for the primers, the exon p52 sequences were amplified from mouse 
DNA. Male and female samples of mouse genomic DNA were analysed by PCR. 
Figure 34 shows the Southern blot of these samples probed with exon p52 sequences. 
From this blot Exon p52 appears to be present in the mouse genome, the other 
samples are from human DNA and it appears that the exon p52 primers can amplify 
sequences from the human DNA. Quite what the sequence of this PCR product from 
human DNA is, is unknown. It will require the cloning and sequencing of this 
product.
PCR was used to investigate the conservation of exon p52 sequences across 
species. If the oligonucleotides designed to exon p52 were sufficiently conserved 
then it should be possible to use PCR to detect the presence of exon p52 related 
sequences in the DNA of other species. It was possible that in other species the 
primer sequences had themselves diverged from the mouse sequence and that the 
PCR would be unable to amplify any sequence from these DNAs. DNA from mouse, 
rat, hamster, cow and human were analysed. Samples of the PCR reactions were 
analysed by electrophoresis, blotted and probed with exon p52. Figure 35 shows that 
the PCR reaction amplified a product from each species tested that was the same size
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Figure 34: PCR analysis of DNA from mouse and humanPCR was carried out using DNAs as template from; Mf, 
Mouse female; Mm, Mouse male; H-, unaffected human; H+, 
human exhibiting sex-linked cleft palate; c,no template control. 
Reactions were primed using exon p52 forward and reverse primers. 
300ng of genomic DNA was used as template and the PCR carried 
out as described in Materials and Methods.A fifth of the PCR products were electrophoresed through a 
2% agarose gel and blotted onto a Nylon membrane. This was 
probed with radio-labelled exon p52 sequences.Note: the presence of product in all the DNA samples indicates the presence of primer sequences in the DNA of mouse 
and human. The presence of the PCR product in both human 
samples suggests that exon p52 sequences are present in both 
affected and unaffected human DNA samples.
Mf R Ha Co Ma Hu cFigure 35: 
Size kb
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Figure 35: PCR analysis of DNA isolated from several species for exon p52 related sequences.PCR was carried out using DNAs as template from; Mf, 
mouse female; R, rat; Ha, hamster; Co, cow; Ma, marmoset; Hu, human and c,no template control;. Reactions were primed using exon p52 forward and reverse primers. 300ng of genomic DNA was used as template and the PCR carried out as described in Materials and Methods. A fifth of the PCR products were electrophoresed 
through a 2% agarose gel and blotted onto a Nylon membrane. This was probed with radio-labelled exon p52 sequences.Note: A product is observed in all samples including the no template control, indicating contamination of this sample.
117
as the product obtained from the mouse sample. At first it appeared that the sequence 
was present in the DNA of other species. Unfortunately it also amplified a product 
from the water only control. This contamination should have rendered this analysis 
meaningless. However, the products amplified, when blotted and probed, exhibit a 
great difference in their strength of hybridisation to exon p52 sequences. This could 
mean that the sequences amplified in this PCR analysis are real. However, this PCR 
analysis will have to be repeated to remove the contaminant from the control.
2.10.4 Expressionai analysis of exon p52
To analyse whether exon p52 sequence is expressed at the RNA level 
during mouse embryonic development, exon p52 was hybridised to a Northern blot 
of embryonic total RNAs, Figure 29(c) shows that exon p52 hybridises to a sequence 
around the 28S Ribosomal RNA on this blot. The vector control secondary PCR 
products produce this signal when hybridised to day 15.5 embryonic total RNA. The 
fainter signal seen at >10kb found on the Northern blots hybridised with exon p50 
and exon p51 is also present. This Northern analysis does not confirm whether exon 
p52 is part of a transcript or not. The fact that exon p52 does not hybridise to a 
Southern blot of mouse genomic DNA means that nothing conclusive can be drawn 
from this Northern analysis. The 500bp and the 800bp transcripts detected by the 
total exon-trapped products are not observed. It is possible that several exons are 
present on a single fragment of cloned DNA used in the exon-trapping. These may be 
spliced together during the processing of the RNA transcript, from the vector and 
trapped sequences, to form larger products that for whatever reason are resistant to 
cloning. These larger exon products would be a better template for generating probes 
and it may be the hybridisation of these larger products that produces the signal seen 
on the blots probed with total secondary PCR product.
Again lack of signal on the Northerns may have been due to the size of the 
exon sequences. The oligonucleotide primers designed for PCR were end labelled 
and used to probe Northern blots of embryonic RNA. This analysis failed to produce
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Figure 36: RT-PCR detection of exon p52 expression during embryonic development.Ipg of total RNA from embryonic day 13.5 mice was DNase 
treated, then reverse transcribed to cDNA primed with oligo [dT]. 
PCR was then carried out using forward (F) and reverse (R) primers 
designed to exon p51, p52, p56 and p57. The basic PCR protocol 
outlined in Materials and Methods was followed.The combination of primers used were:
Lane 1; Exon p51 (F) + (R)
Lane 2; Exon p52 (F) + (R)Lane 3; Exon p56 (F) + (R)
Lane 4; Exon p57 (F) + (R)Lane 5; Exon p52 (R) + Exon p57 (R)
Lane 6; Exon p52 (F) + Exon p57 (R)Lane 7; Exon p52 (R) + Exon p57 (F)
Lane 8; Exon p52 (F) + Exon p57 (F)The template used for lane 1-8 was cDNA reverse 
transcribed from day 13.5 mouse embryonic RNALane 9-lane 16, is a repeat of the PCR reactions described for lane 1-8, except that the template used was DNase treated RNA 
that had not been reverse transcribed to cDNA^is controls fcx* DNA 
contamination.A fifth of the PCR reaction was electrophwesed through a 2% agarose gel, blotted onto Nylon membranes and probed with 
exon p52.Note: detection of product in lane 2 demonstrates that exon 
p52 is expressed at the RNA level at day 13.5 of embryonic development The detection of product in lane 6 demonstrates the axrect (xientation of the oligos to give the linked product between exon p52 and exon p57.
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any signal on a Northern blot (data not shown). As before a complete analysis could 
not be attempted and not all of the conditions were tested due to lack of time.
The primers designed to the 5' and the 3’ ends of exon p52 were used to 
analyse expression during embryonic development. Reverse transcribed-PCR (RT- 
PCR) was used to detect expression of exon p52 during mouse embryonic 
development (Materials and Methods). RT-PCR is a highly sensitive method of 
detecting expressed sequences. It is particularly useful for detecting transcripts 
present at very low levels. The first stage of RT-PCR is cDNA synthesis from the 
RNA under analysis. The day 13.5 mouse embryonic total RNA sample was treated 
with DNase to ensure that no DNA sequences would contaminate the PCR reaction, 
then cDNA was synthesized from this RNA sample. PCR was then carried out on 
this cDNA template using the primers designed to the 5’ and 3' ends of exon p52. The 
PCR products were then electrophoresed on a 2% agarose gel, blotted and probed 
with exon p52 sequences. As can be seen from Figure 36, exon p52 sequences were 
detected in day 13.5 mouse embryonic RNA. The water only control and the RNA 
only control confirm that the product observed with RT-PCR is a product of 
expressed sequences.
The detection of exon p52 sequences by RT-PCR demonstrates that exon 
p52 is expressed and part of a transcript(s) during embryonic development. However, 
it does not indicate what size the transcript is nor in what tissues it is expressed. In 
the light of this RT-PCR analysis the lack of detection by Northern analysis of 
transcripts using exon p52 as a probe is probably due to experimental conditions, 
which need to be optimised using hybridisation to, and detection on, a Southern blot 
as a control.
2.11.1 Characterisatioii of exon p56
Hybridisation of the Phage 4 ,1.2kb EcoR /  fragment to the secondary PCR 
products of exon-trapping from Phage 4 identified exon p56. Sequencing of this PCR 
product showed that it was composed of 99 nucleotides (see Figure 37), Using the
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Figure 37 Sequence analysis of Exon p56
( a ) Nucleotide Sequence: oligos used to prime PCR are indicated by bold type and underlining.
10 20 30 40 50
TACTCCTAAG ATGGCAGCAA CTCTGGATGG ATGACAAAGC TTCTCTCCTAATGAGGATTC TACCGTCGTT GAGACCTACC TACTGTTTCG AAGAGAGGAT60 70 80 90 100TGGTTCAGTG GGTCTTCTCT GTGGCTTCTA GAACCCATCT GTAACCAGACCAAGTCAC CCAGAAGAGA CACCGAAGAT CTTGGGTAGA CATTGGTC
( b ) Open Reading Frames of Exon p56
10 20 30 40 50 60 70 80 90
10 20 30 40 50 60 70 80 90
(c) Amino Acid Sequence of Exon p56 ORF
10 20 30LLRWQQLWMD DKASLLWFSG SSLWLLEPIC NQ
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GCG package and the MacVector^M program to analyse the nucleotide sequence no 
nucleic acid motifs were found. This exon’s nucleic acid sequence was compared to 
the sequences present in the BLASTN database. The search revealed that there were 
no similar sequences present in the database. This confirms that the sequence of this 
trapped exon is not derived from the exon-trapping vector and that this exon 
sequence is unique. The GCG package and the MacVector™ identified a single ORF 
spanning the complete exon.
The deduced amino acid sequence of the exon p56 ORF was then compared 
to the sequences present in the BLASTP database. No matches of high identity were 
found. The matches that were found between the predicted amino acid sequence and 
the sequences present in the database were either high identity over a very short 
region, or a low level of identity across the entire sequence. A low level of identity to 
the G alpha-7 and G alpha-8 subunit genes of Dictyostelium discoideum (Wu et al, 
1994) was found. Over 28 amino acids 7 were identical (28%) increasing to 42% 
when similar amino acid substitutions were taken into account. Another protein 
sequence that exhibited a low level of identity was GATA binding factor-3 of 
chicken, a general switch factor for cell specific development (Yamamoto et a/., 1990 
and Ko et al., 1991). It exhibited a 32% level of identity over 28 amino acid residues. 
The level of similarity increased to 42% when similar amino acids substitutions are 
included. A tyrosine 10 receptor kinase from mouse was found to have a 35% level 
of identity, increasing to 50% similarity across 18 amino acid residues (accession 
number S42796 EMBL databank). Another match from this search was PHSE 
protein from E.coli, which is a penicillin binding protein. Although it exhibited a low 
level of identity at 28% across 24 amino acid residues, the level of similarity was 
54% (Accession number P33013 EMBL databank).
These matches from the database reveal that the deduced amino acid 
sequence of exon p56 does not share a high level of identity to any amino acid 
sequences present in the databases. This suggests that the sequence of exon p56 is 
unique and does not reveal a high level of relatedness to other proteins in the
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database. This protein database search supports the results of the nucleotide sequence 
database search.
2.11.2 Mapping of exon p56 onto mouse genomic DNA
To ensure that exon p56 had been exon-trapped from Phage 4, exon p56 
was hybridised back to the phage clone it was derived from. Figure 38 shows a 
Southern blot of Phage 4 DNA digested with EcoR I probed with exon p56. It can be 
clearly seen that exon p56 is indeed derived from the Phage 4 1.2kb EcoR /  fragment. 
This confirms the isolation of exon p56 by hybridisation of the Phage 4 1.2kb EcoR I 
fragment to subcloned secondary PCR products.
2.11.3 Conservation of exon p56 across species
Exon p56 was hybridised to a Zoo blot of DNAs from various species. The 
blot included DNA taken from mouse, rat, hamster, cow and human. The exon p56 
sequences were labelled using the random priming method. As with the other exon 
sequences no signal was observed when the blot was washed. This was true no 
matter the washing stringency. The probes used had been of high specific activity 
and had already been shown to hybridise to mouse DNA sequences present in 
recombinant phage. As with the previous exon probes derived from the exon- 
trapping vector it was believed the probe was too small to detect sequences in 
genomic DNA under the conditions used.
Oligonucleotide primers were designed to the 5' and 3' ends of exon p56. 
These primers were used for two experiments. Firstly they were end labelled and 
used to try and produce probes of high specific activity. They were also used for PCR 
reactions to detect the presence of exon p56 sequences in DNA samples and also 
RNA samples. Zoo blots hybridised with oligonucleotides from exon p56 exhibited 
no signal on short exposures. On longer exposures (in excess of 7 days), all that 
could be observed was a high level of background. There are many reasons as to why 
the end labelled oligonucleotides failed to hybridise. The lack of specific signal is
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Figure 38: Location of exon p56 in cloned genomic DNAContact print of the autoradiograph of a Southern blot of cloned genomic 
DNA probed widi radio-labelled exon p56. Each lane rejxesents Ipg of Phage 4 
DNA digested with the enzymes shown, electrophcxesed through an 0.7% agarose gel, blotted and probed. Enzymes used are El, EcoR I  + Not /; KI, Kpn /; 
SI, Sal I\S\ ,SstI  and XI, Xba I.Note:exon p56 hybridises to the 1.25kb EcoR I + Not I  fragment.
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probably a result of the optimal hybridisation conditions not being used. Due to the 
lack of time the optimal conditions were not defined.
PCR was attempted to confirm that exon p56 was present in mouse genomic 
DNA samples. Using the oligonucleotide primers designed to the 5' and 3' ends of 
exon p56. Conditions for PCR were tested varying magnesium concentration and 
primer concentration, (see Figure 39(a)), when these PCR conditions had been 
optimised using plasmid DNA as template, PCR was conducted using mouse 
genomic DNA. From Figure 39(a) exon p56 is present in mouse genomic DNA, this 
confirms that the analysis of Zoo blots using end labelled oligonucleotides requires 
different conditions to those used. Due to the results of expression analysis (see 
below), the conservation of exon p56 across species was not addressed using PCR.
2.11.4 Expressional analysis of exon p56
To analyse whether exon p56 was expressed during mouse embryonic 
development, exon p56 was hybridised to a Northern blot of embryonic mouse total 
RNAs. No transcript of any nature was revealed by this analysis. It was also possible 
that the failure of hybridisation resulted from the small size of the exon used to probe 
the filter and the hybridisation conditions used, as experienced with other exon 
hybridisations. The oligonucleotide primers, used to show the presence of exon p56 
in mouse genomic DNA above, were used for oligonucleotide hybridisation to the 
Northerns. The hybridisation of end labelled oligonucleotide primers to Northern 
blots of embryonic RNA also proved negative.
RT-PCR was then attempted to address expression of exon p56 sequence in 
day 13.5 embryonic total RNA. The RT-PCR reaction samples were electrophoresed 
on agarose gels. No product could be detected by ethidium bromide, therefore the 
gels were electroblotted and probed with exon p56 sequence, which also was 
negative (data not shown). The 500bp control product was clearly visible, this means 
that the cDNA synthesis step of the reaction was successful. It is possible that the
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Figure 39: PCR detection of (a) exon p56 and (b) exon p57 in 
mouse genomic DNA, varying the Mg^ + concentration.
PCR was carried out using primers to exon p56, lane 1-6 
and 13, exon p56 forward and reverse primers;and exon p57, lane 7- 12 and 14, exon p57 forward and reverse primers. Lane 13 and 14 
are no template controls.MgCl2  concentration was varied between reactions, lane 1 
and 7, OmM; lane 2 and 8, 0.5mM; lane 3 and 9, l.OmM; lane 4 and10,1.5 mM; lane 5 and 11,2.0mM; lane 6 and 12,2.5mM. The no 
template control reactions were carried out at 1.5mM MgCl2 .
A fifth of each PCR reaction was electrophoresed through a 
2% agarose gel. Southern blotted and probed with (a) exon p56 and(b) exon p57.Note: the primers to exon p56 are capable of priming PCR 
at all of the Mg^ "^  concentrations used, except in the absence of 
Mg2+. The primers to exon p57 are optimal at 15mM Mg^ +, lane 
10 .
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secondary structure of RNA containing exon p56 sequence restricts the synthesis of 
cDNA or alternatively that it is simply not expressed at this stage of development. 
Exon p56 may still be expressed at another stage of embiyonic development or even 
postnataly. Thus it can not be deduced from these results that exon p56 is not part of 
an authentic transcript.
The results of analysis of exon p56 only reveal that it is present in mouse 
DNA. Due to time limitations the question of exon p56 expression and the temporal 
and spatial aspects of that expression will have to be addressed at a later date.
2.12.1 Characterisatioii of exon p5 7
The hybridisation of Phage 1 and Phage 7 sequences to the secondary PCR 
products produced by exon-trapping, resulted in the identification of exon p57 from 
the exons-trapped from Phage 7. Both strands were sequenced and exon p57 was 
found to be 101 base pairs long (Figure 40). Nucleic acid sequence analysis using 
M a c V e c to r 'T M  and the GCG package revealed no sequence motifs. A search of the 
sequence to identify ORF revealed several, one of which spanned the entire 
sequence. The putative amino acid sequence of the ORF was determined using the 
GCG package. Analysis of this amino acid sequence using the motif option of the 
GCG package failed to reveal any motifs.
The amino acid sequence was then compared to amino acid sequences 
present in the BLASTP database. No high levels of similarity at the amino acid level 
were found for long stretches of the sequence of exon p57s' translated ORF. Small 
regions of the amino acid sequence revealed high levels of similarity. One peptide 
sequence showed a high degree of similarity to amino acid sequence from a diverse 
range of genes. The identical peptide sequence, FSEDPTS, occurred in a range of 
sequences from the mouse homeobox protein H0X-D4 {Hox-4,2), to the yeast AFGl 
protein, which belongs to the CDC48/PAS1/SEC18 family. Several other ammo acid 
sequences in the database exhibited a lower level of similarity to the entire exon p57 
amino acid sequence. The E.coli nucleoside specific channel-forming protein TSX
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Figure 40: Sequence analysis of Exon p57
( a ) Nucleotide Sequence of Exon p57: oligos used to prime PCR are indicated by bold type and underlining.
10 20 30 40 50GGTGCAGTAC TAGCTGCTGT GTCAAGTCAC AAATTCAATT CCTTCTATGGCCACGTCATG ATCGACGACA CAGTTCAGTG TTTAAGTTAA GGAAGATACC60 70 80 90 100GGACCCTCCT GÀAGAGTTGC CAGATTTCTC CGAAGACCCT ACCTCCTCAGCCTGGGAGGA CTTCTCAACG GTCTAAAGAG GCTTCTGGGA TGGAGGAGTC
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( b ) Open Reading Frames of Exon p57
10 20 30 40 50 60 70 80 90 100
1
2
3
4
5
6
10 20 30 40 80 90 10050 7060
(c) Amino Acid Sequence of Exon p57 ORF
10 20 30GAVLAAVSSH KFNSFYGDPP EELPDFSEDP TSS
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(Bremer et al, 1990) exhibited a 46% level of identity at the amino acid level (over 
the entire 33 amino acid residues of translated sequence). When similar amino acid 
substitutions were included the level of similarity increased to 57%. A human 
transcription factor GATA-2 (Dorfman et a l, 1992) showed a lower level of identity 
(28%) across the 33 amino acid residues. The degree of similarity increased to 53% 
when like amino acids substitions were included in the analysis. The final amino acid 
sequence from this comparison was the cucumber mosaic virus (CMV) lA  protein 
(Hayakawa et a l, 1989). It displayed a 36% identity to the deduced amino acid 
sequence of exon p57. It also displayed a 51% level of similarity when similar amino 
acid substitions were included.
The database searches carried out do not reveal much information about the 
nature of exon p57. The database searches reveal that the nucleotide sequence of 
exon p57 has no similar sequences present in the database. It also proves that the 
sequence of exon p57 is not derived from vector sequences. Although a search of the 
BLASTP database with the translated ORF revealed several sequences with a low 
level of identity, the levels of similarity are quite low.
2.12.2 Mapping of exon p57 onto mouse genomic DNA
Exon p57 was mapped onto mouse genomic DNA. Exon p57 sequences 
were random prime radio-labelled, then hybridised to a Southern blot of Phage DNA 
digested with EcoR I (Figure 41). Figure 41 confirms that exon p57 is derived from 
the 1.9kb EcoR I fragment that is common to all phage. Exon p57 clones were 
isolated from the pools of exon-trapped products from all three phage. The results of 
section 2.6.4, do indicate that some secondary PCR products are shared between the 
exon-trapped products from the different phage as seen in Figure 21. Exon p57 is one 
of these exon-trapped products. The subcloned 1.9kb EboR /  fragment was restriction 
digested, electrophoresed through an agarose gel, and electroblotted. Exon p57 was 
hybridised to this blot. Exon p57 is mapped to a 0.2kb EcoR V-BamH I  restriction 
fragment present in the 1.9kb EcoR I fragment (data not shown).
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Figure 41: Location of exon p57 in cloned genomic DNA.
Contact print of the autoradiograph of a Southern blot of 
cloned genomic DNA probed with radio-labelled exon p57. Each 
lane represents Ipg of each genomic clone digested widi EcoR I  + 
Not I; lane 1, Phage 1; lane 2, Phage 4; lane 3, Phage 7. Samples were electrophcwesed through an 0.8% agarose gel, Southern blotted 
and probed.Note: that exon p57 hybridises to the 1.9kb EcoR I fragment that is present in all the Phage clones.
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2.12.3 Conservation of exon p57 across species
To analyse the evolutionary conservation of exon p57 sequences, exon p57 
was hybridised to a Zoo blot of DNAs from a variety of species. As with the previous 
exon hybridizations to Zoo blots, no signal was observed with any of the washing 
conditions used. This lack of hybridisation detected with the random labelling of the 
exon sequences is probably due to the small size of the exon sequences. 
Oligonucleotide primers were designed to the 5' and the 3' ends of the exon p57 
sequence. These primers were used in end labelling reactions and for PCR reactions. 
The end labelling of the oligonucleotides was an attempt to produce probes of high 
specific activity. As described earlier, it was hoped that these labelled 
oligonucleotides would overcome the problems found with random labelling.
The oligonucleotide primers to exon p57 were used in PCR reactions to 
investigate the presence of exon p57 in DNA samples. The conditions for PCR were 
defined using mouse DNA as template, see Figure 39(b). These results demonstrate 
that exon p57 sequences are present in the mouse genome. They were also used to 
define the PCR conditions required for subsequent analysis.
PCR reactions were used to investigate the conservation of exon p57 
sequences in different species. If the sequence of the oligonucleotides is not 
sufficiently conserved then we might expect that the PCR will not work. The PCR 
products were electrophoresed, blotted and probed with exon p57. This revealed the 
presence of products from the different species the same size as exon p57 (Figure 
42). As with the PCR on the sequences from exon p52, there appears to be 
contamination that can be clearly seen in the water only (no template) control. This 
means that no meaningful analysis can be made of these results. The blot shows that 
the more divergent the species from mouse the greater the reduction in ability of the 
PCR product to hybridise with the exon p57 probe. This suggests that the sequences 
though conserved are sufficiently diverged to produce a difference in ability to 
hybridise to the original mouse sequence. The water control exhibits an intensity of
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Figure 42: PCR analysis of DNAs isolated from several species for 
exon p57 related sequences.PCR was carried out using DNAs as template from, lane 1, 
male mouse; lane 2, rat; lane 3, hamster; lane 4, cow; lane 5, human and lane 6, no template control. Reactions were primed using exon 
p57 fcfward and reverse primers. 300ng of genomic DNA was used 
as template and the PCR carried out as given in Materials and 
Methods.A fifth of the PCR products were electrophoresed through a 
2% agarose gel and blotted onto a Nylon membrane. This was 
probed with radio-labelled exon p57 sequences.
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hybridisation equivalent to that of the mouse DNA control. This suggests that the 
contamination observed is restricted to the water only control and that the PCRs in 
the other DNA samples are real and not artifacts. This can be only proven by 
repeating the PCR.
2.12.4 Expressional analysis of exon p57
To determine whether exon p57 is part of a transcript, exon p57 was 
hybridised to a Northern blot of mouse embryonic total RNA. Absolutely no signal 
was detected on any Northern blot of embryonic RNAs derived from different stages 
of devlopment. Reprobing of these blots with the total secondary PCR product 
revealed the 800 nucleotide and 500 nucleotide transcripts, which showed that the 
RNAs present on the blot were intact. As with the other exons used as probes the 
conditions of hybridisation were not optimised for exon p57. As the Southern blot 
analysis failed to show the presence of exon p57 in genomic DNA but showed that it 
was present in the cloned genomic DNA then the lack of hybridisation is probably a 
result of the conditions used.
The lack of hybridisation with exon p57 may also be a result of the 
transcript that exon p57 is part of being present in RNA at a very low level, or 
present in an RNA that was not tested. RT-PCR, as mentioned earlier, is a highly 
sensitive method for detecting the presence of low level transcripts. The primers that 
were used to detect the presence of exon p57 in DNA, were used in RT-PCR analysis 
of embryonic RNA. RNA from day 13.5 embryonic mice was reverse transcribed to 
cDNA. This cDNA was then used as a template for PCR. The products were 
electrophoresed through a 2% agarose gel, blotted and probed with exon p57. Figure 
43 shows that exon p57 is transcribed at day 13.5 of mouse embryonic development. 
RT-PCR analysis cannot reveal the size of the transcript that exon p57 belongs to. 
RT-PCR on total RNA from the body of embryonic mice also does not reveal 
whether the transcript is ubiquitous or confined to one cell type or organ.
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Figure 43: RT-PCR detection of exon p57 expression during 
embryonic development.
Ijj-g of total RNA from embryonic day 13.5 mice was DNase 
treated, then reverse transcribed to cDNA primed with oligo [dT]. PCR was then carried out using forward (F) and reverse (R) primers designed to exon p51, p52, p56 and p57. The basic PCR protocol 
outlined in Materials and Methods was followed.
The combination of primers used were:Lane 1; Exon p52 (F) + (R)Lane 2; Exon p57 (F) + (R)
Lane 3; Exon p52 (R) + Exon p57 (R)Lane 4; Exon p52 (F) + Exon p57 (R)Lane 5; Exon p52 (R) + Exon p57 (F)Lane 6 ; Exon p52 (F) + Exon p57 (F)
Lane 7-lane 12, RNA controls for the above.
The template used for lane 1-6 was cDNA reverse 
transcribed from day 13.5 mouse embryonic RNA.Lane 7-lane 12, is a repeat of the PCR reactions described for lane 1-6, except that the template used was DNase treated RNA 
that had not been reverse transcribed to cDNA,as controls for DNA 
contamination.A fifth of the PCR reaction was electrophoresed through a 2% agarose gel, blotted and probed with exon p57.Note: exon p57 hybridises to the RT-PCR product in lane 2 indicating that exon p57 is e^ qxessed at day 13.5 of embryonic 
development Exon p57 hybridises to the RT-PCR product in lane 4 confirming that exon p52 and exon p57 are linked together.
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Characterisation of the expression of exon p57 fully using RT-PCR was not 
attempted due to lack of time.
As two exons have been shown to be expressed using RT-PCR it is 
probable that the hybridisation conditions used for Northern blot analysis, using the 
exon sequences as probes, are not optimal and this results in the lack of hybridisation 
observed with the exon probes.
2.13.1 Orientation of the trapped exons to each other
The method used to subclone the secondary PCR products is non- 
directional. This results in being unable to either orientate the exons relative to each 
other or orientate them on the DNA from which they are derived. If the exons are 
part of the same transcript then the cloning of the cDNA of that transcript would 
reveal their relative orientation to each other. Another approach is to use PCR to 
amplify between the individual exons from the genomic DNA or the cloned 
recombinant phage DNA. As the exons identified could not be shown to be expressed 
by Northern analysis, no attempt was made to screen a cDNA library prepared from 
mouse embryonic RNA. Instead an attempt was made to use PCR to amplify between 
the individual exons. There were some problems with this approach. Firstly, one 
(p51) of the exons was resistant to PCR analysis. The reason for this remains unclear, 
so PCR analysis using exon p51 was not attempted. Secondly, exon p50 is composed 
of repetitive sequence, therefore PCR using exon p50 primers within the repeat 
would produce uninterpretable results. Thirdly, a potential problem with the PCR 
approach was the relatively large distances that separated the exons, exon p50 and 
exon p52 are separated by about lOkb DNA. Nevertheless, this approach was 
attempted for the exons which were deemed least problematic.
Exon p56 and exon p57 are separated by at least 8 kb of genomic DNA. 
Contained within this 8 kb of DNA is some very highly repetitive sequence, as shown 
previously by Southern analysis. Individual primers from one exon were coupled 
with a single primer from the other exon, in each PCR reaction. This resulted in four
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possible combinations of primers. The PCR products were electrophoresed through a 
2% agarose gel, blotted and probed with exon p56 and exon p57 sequences. The 
results of the PCR are inconclusive (data not shown). Although several products 
hybridise to the separate exon sequences, only a single band hybridises with 
sequences from both exons. This single band though is only Ikb in size and is not 
compatible with the restriction map produced for the SOkb of cloned DNA. There is 
the possibility that repeat sequences were deleted out early in the PCR resulting in 
the 8 kb reduced to Ikb PCR product, this may therefore suggest the orientation of 
exon p56 to exon p57.
2.13.2 Analysis of expression by RT-PCR across different exons
RT-PCR is a very sensitive method for detecting the presence of transcripts. 
In the case of the exons that have been studied here, RT-PCR has been used to 
determine whether those sequences are expressed individually. The analysis so far 
has shown that at least three of the exon sequences are expressed, exon p50, exon 
p52 and exon p57. Because the RT-PCR was carried out on individual exons it could 
not be determined whether the exons were part of one transcript or separate 
transcripts
RT-PCR was carried out between individual exons to determine whether the 
separate exons were part of a single transcript. If the exons did belong to a single 
transcript this RT-PCR would reveal if any other exons are intervening in the 
transcript. The same primers were used for this inter-exon RT-PCR as had been used 
to analyse the expression of the individual exons. The primers that were available for 
exon p50 were thought be unsuitable for RT-PCR analysis of exon p50, as the entire 
sequence of exon p50 is highly repetitive. There was a high probability that the 
primers to exon p50 would anneal to other LINE-1 sequences in the RNA. Attempted 
RT-PCR using primers to exon p50 confirmed the redundancy of the primers, so 
exon p50 primers were not used for inter-exon RT-PCR.
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RT-PCR was attempted between exon p52 and exon p57 (Figure 36 and 
Figure 43). The cDNA templates used were day 13.5, 15.5 and 16.5 mouse 
embryonic total RNA. Figure 44 shows the blot of the RT-PCR reactions probed with 
exon p57. A product of about 177bp was observed to hybridize with exon p57. The 
blot was reprobed with exon p52 and a similar pattern of hybridisation was observed. 
The 177bp product was amplified from all three RNA samples, for different 
embryonic time points, tested. The controls for cDNA synthesis appear to have 
worked, as visualised by ethidium bromide staining (data not shown). The product is 
also the same size as the sum of the two exons added together. To confirm that, the 
RT-PCR product was authentic, it was subcloned and sequenced (Figure 45).
Analysis of the sequence of the RT-PCR product revealed that the observed 
177bp product was indeed derived from the two exons (see Figures 32 & 40). A 
database search of BLASTN, unsurprisingly, identified the same sequences that the 
individual exon sequences identified. When this nucleic acid sequence was analysed 
to identify any ORFs it was found that several were present. Only one ORF was 
complete across the entire sequence of both exons. So the ORF of exon p57 was 
maintained. One of the two ORFs (0RF3) present in exon p52 reaches a stop codon 
in exon p57 and was not identified in this search, while the other (0RF2) is open 
with the exon p57 ORF. This is partly due to slightly different parameters in the 
search. The ORF analysis was weighted towards longer ORFs to identify one which 
covered the entire nucleic acid sequence. The sequence of the larger ORF that 
extends across both exons shows a level of similarity to the sequence of CaM kinase 
n at the nucleotide level observed with exon p52. The region of similarity extended 
into exon p57 from exon p52 giving new values for the extent of homology. The 
orientation of the ORF is 5' in exon p52 to 3' in exon p57.
Over a 30 amino acid sequence ( 6  of which are derived from exon p57 
sequence) 2 0  amino acid residues (6 6 %) were found to be identical to residues in the 
sequence of CaM kinase n. This was found to be true no matter the species the CaM 
kinase II was derived from. When similar amino acid substitutions were taken into
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Figure 44: Analysis of expression by RT-PCR of exon p52-exon 
p57 sequences during development
Ipg each of total RNA from embryonic day 13.5 ,15.5 and
16.5 mice were DNase treated, then reverse transcribed to cDNA primed with eith«* oligo [dT], lanes 1,3 and 5 or random primers, lanes 2,4 and 6 . PCR was then carried out using the combination of primers found to produce the exon p52-exon p57 RT-PCR product in 
Figure 33, lane 5. The basic PCR protocol outlined in Materials and 
Methods was followed.
RT-PCR controls are; Rl, day 13.5 RNA only; R2, day 15.5 RNA only and R3, day 16.5 RNA only. Cl, C2 and C3 are cDNA synthesis controls to ensure that cDNA was synthesised as template 
for the RT-PCR. RT-PCR products were electrophoresed through a 2% agarose gel, blotted onto Nylon membrane and hybridised with exon p57.
Note: exon p52-exon p57 RT-PCR jwoduct is detectable in day 13.5 cDNA, day 15.5 cDNA and on longer exposures in day16.5 cDNA. The variation in intensity of hybridisation reflects the efficiency of the PCR reaction.
Figure 45: Sequence Analysis of the Exon p52-p57 RT-PCR Product
(a) Nucleotide Sequence: oligos used to prime RT-PCR are indicated by bold type and underlining.
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10 20 30
GGGGATGGTT ATGCCTACAA AATCCATCTT 
CCCCTACCAA TACGGATGTT TTAGGTAGAA 60 70 80
GAGGAAATTC AATGCAAGGA GAAAACTAAA 
CTCCTTTAAG TTACGTTCCT CTTTTGATTT110 120 130
TGTCAAGTCA CAAATTCAAT TCCTTCTATG 
ACAGTTCAGT GTTTAAGTTA AGGAAGATAC160 170 180
CCAGATTTCT CCGAAGACCC TACCTCC 
GGTCTAAAGA GGCTTCTGGG ATGGAGG
40 50
CCAGAAACAG TAGAACAACT 
GGTCTTTGTC ATCTTGTTGA90 100
GGGTGCAGTA CTAGCTGCTG 
CCCACGTCAT GATCGACGAC140 150
GGGACCCTCC TGAAGAGTTG 
CCCTGGGAGG ACTTCTCAAC
(b) Open Reading Frames of the Exon p52-p57 RT-PCR product
1601 0 0 120 140 80
1
2
3
4
5
6
60 80 140 1801 0 0 1604020 1 2 0
(c) Amino Acid Sequence Of Exon p52-p57 ORE
10 20 30 40
GDGYAYKIHL PETVEQLRKF NARRKLKGA VliAAVSSHKF NSFYGDPPE 60
PDFSEDPT
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account the level of similarity rose to 76% (23 out of 30 residues). This analysis of 
ORFs and deduced amino acid sequence suggests that the transcript which contains 
exon p52 and exon p57 shares a protein motif when translated with CaM kinase H.
The result of the RT-PCR suggests that in this transcript exon p52 and exon 
p57 are spliced together and no other exons intervene between exons p52 and p57. 
Although other exons may lie between exon p52 and exon p57 at the genomic level, 
that were not detected by the exon-trapping analysis. These other exons may be 
expressed as part of other transcripts that do not include exon p52 and exon p57 at 
different stages of development, or they may include exon p52 and exon p57 but be 
differentially spliced. To understand the transcripts expressed at this locus will 
require further analysis.
2.14 Disruption of RT-PCR product in transgenically positive mice
From the restriction map of this cellular locus, exon p52 and exon p57 are 
found to reside on separate EcoR I fragments that flank the transgene site of 
insertion. Evidence suggested that a cellular locus was affected by transgene 
insertion in the mutant line that exhibited sex-linked cleft palate. The nature of the 
cellular disruption is unclear. It is not known whether there is a physical disruption of 
the cellular locus, or if the pattern of expression is perturbed by the presence of the 
transgene. The total secondary PCR products were hybridised to a Northern blot of 
RNAs derived from transgenically positive and transgenically negative mice (see 
Figure 24). In this analysis no physical disruption of the transcript was observed. RT- 
PCR was used to test whether the transcript(s) that exon p52 and exon p57 belong to 
was affected in this transgenic Une.
RT-PCR, using the primers that produced the 177bp fragment containing 
exon p52 and exon p57, was repeated on transgenically positive and transgenically 
negative RNA. Figure 46 shows the result of this RT-PCR. The transgenically 
negative spleen sample appears to contain the expected 177bp PCR product. It also 
contains a slightly larger PCR product at about 250bp in size. It is difficult to decide
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at this stage whether this latter PCR product is from an alternatively spliced 
transcript or an artifact. The RT-PCR products from the transgenically positive 
sample exhibit a clear difference from those of the negative sample (Figure 46(a)). 
The 177bp product is again the predominant product and the slightly larger product 
at 250bp is also detectable. However two other PCR products are also present. One 
of these is again slightly larger than the 250bp PCR product at about 350bp. The 
other product detectable is a band of about Ikb.
These two RT-PCR products are clearly not detectable in the transgenically 
negative sample. The transgenic construct contained the EBV LMP-1 gene, and it has 
been shown to be expressed in transgenically positive mice. It is a multiply spliced 
transcript. It is possible that part of the LMP-1 transcript has become integrated into 
that of the exon p52-exon p57 transcript. To test this the blot of transgenically 
positive and transgenically negative RT-PCR products was probed with LMP-1 
sequences.
Probing of the RT-PCR products from transgenically positive and 
transgenically negative RNA with LMP-1 (transgene) identified a 250bp product, a 
350bp product (shown to hybridise with exon p52 and exon p57) and a product that 
is about 1.5kb in size (Figure 47(b)). No products were found to hybridise to 
transgenic sequences in the transgenically negative sample. The l.Skb product that 
hybridises to the LMP-1 sequences fails to hybridise to either exon p52 or exon p57, 
whereas the l.Okb fragment that hybridises to exon sequences fails to hybridise with 
the LMP-1 probe. This result indicates that exon p52 and exon p57 splice to LMP-1 
sequences in the transgenically positive sample. The exact sequence of the hybrid 
RT-PCR products is unknown at this stage. This will require the cloning and 
sequencing of these RT-PCR products to determine which LMP-1 sequences are 
present m the hybrid RT-PCR products.
What is clear from this result, is that the splicing of the exon p52-exon p57 
product is affected in transgenically positive spleen RNA, compared to the 
transgenically negative sample. This disruption is probably as a result of the presence
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Figure 46 (a): Disruption of the exon p52-exon p57 RT-PCR 
product in transgenically positive spleen; (b): Identification of 
cellular-transgene hybrid transcripts in transgenically positive spleen.
Ipg of total RNA prepared from the spleens of 
transgenically positive (+) and negative (-) mice were separately 
DNase treated, then reverse transcribed to cDNA primed with oligo 
[dT]. PCR was then carried out using the primers that produced the 
177 bp RT-PCR product spanning exon p52 and exon p57 in embryonic RNA. The basic PCR protocol outlined in Materials and 
Methods was followed.'C denotes cDNA and 'R' denotes RNA control. PCR products were electrophoresed on a 2 % agarose gel, blotted and hybridised with (a) exon p57 and (b) the LMP-1 transgene 
constructNote: that four products are identiAed by hybridisation with 
exon p57 in the transgenically positive sample at 177bp, just under 250bp, about 350bp and just under Ikb. Compared to &e 177bp and 
about 250bp in the transgenically negative sample.Probing the same blot with the LMP-1 transgene construct identified three RT-PCR products only in the transgenically positive cDNA sample the 250bp product, the 350bp product and a product 
>lkb.
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of the transgene and transgene sequences are spliced to the exons present at the wild 
type locus.
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2.14.1. Critique II
As the analysis of genomic DNA described in sections 2.1 to 2.5 revealed a 
high degree of repetitive sequence the approach of exon-trapping was used to isolate 
gene sequences at the locus. All genomic DNAs and total RNAs used in Southern and 
Northern analyses were confirmed as being intact by ethidium bromide staining and 
UV visualisation. Probe fragments used were also believed to be intact, as argued in 
critique 1 (section 2.5.1) .
In the case of Northern blots presented in the analysis of exon-trapping 
products not every blot was controlled for sample loading. Where blots did not have 
loading controls no quantitative statements can be made and as such, estimations of 
relative quantities have been presented only for those that were normalised. The 
patterns of hybridisation observed with the pooled exon-trapped products (Figures 22 
and 23(a) & (b) were compared to the pattern of hybridisation observed when the 
same or similar Northern blots were probed with exon-trapped products from the 
COS-7 cells transfected with only the vector DNA. This control was performed to 
differentiate between any signal observed as being the result of hybridisation of 
incorporated exon sequences or vector derived sequences. The intact exon-trapping 
vector itself was not used as a probe control on a Northern blot but the protocols 
followed in the exon-trapping would not incorporate vector specific products that 
were not included in the control mentioned above.
All of the exons identified were used as probes on Southern blots of cloned 
genomic DNA to demonstrate that they were indeed derived from the cloned cellular 
DNA derived from the locus (Figure 21). However, although these probes hybridised 
to blots of cloned DNAs the specific activity of these exons as probes was not enough 
to reveal hybridisation signals to genomic DNA on Southern blots and total RNA on 
Northern blots. For this reason the pattern of expression at the level of RNA could not 
be addressed for the individual exons by Northern analysis.
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In view of the technical problem of low specific activity of these very small 
radio-labelled exons, the alternative approach of Reverse Transcribed-PCR (RT-PCR) 
was performed to investigate whether or not the exons were expressed. RT-PCR is 
not quantitative and therefore in the text no reference is made from these experiments 
to the levels of expression. However, what is important is that RT-PCR was used to 
demonstrate that several exons are expressed at the level of RNA during embryonic 
development at the time points investigated. Not only were two exons (exons p52 and 
p57) shown to be expressed but they were also shown to be spliced together (Figure 
44). Furthermore, this splicing is disrupted in the transgenically positive females 
(Figure 46). Figure 46 suffers from inadequate controlling as no hybridisation signal 
should have been observed in the 'R' tracks as these are RNA only controls. The 
presence of hybridisation suggests either (i), track overspill or (ii), exon 
contamination of samples. However, it cannot be genomic DNA contamination of 
RNA since in the genome the products (p52 & p57) are separated by several kilobases 
of DNA. Therefore, although the signal is low in the 'R' tracks, this experiment would 
need to be repeated to confirm the tentative conclusions regarding exon p52-exon p57 
expression.
Exon-trapping was used to isolate several very small exons from the cloned 
DNA. The trapped exons were derived from those fragments that were shown to 
contain highly repetitive sequences. One of the exons identified was found to consist 
of purely repetitive sequence of the LINE-1 class (see section 2.8.1). It is not 
surprising, in view of the repetitive nature of the DNA present at this locus and the 
small size of the identified exons, that the Zoo blot (section 2.4) analysis did not 
reveal any conserved transcribed sequences.
Unfortunately, a full length cDNA was not cloned in the course of this work. 
However, several different approaches to clone a cDNA molecule were attempted. 
These attempts were hampered by the inability to use the exons as probes due to their 
small size and consequent low specific activity as probes. For this reason exon 
sequences were not useful for screening cDNA libraries.
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RT-PCR had been used to demonstrate that several exons are expressed at 
the level of RNA during mouse embryonic development (Figure 44). Therefore RT- 
PCR afforded an alternative approach to the screening of cDNA libraries, namely 
Rapid Amplification of cDNA Ends (RACE). This was attempted to clone the 5' end 
of the transcript but proved unsuccessful. Unfortunately, RT-PCR only reveals 
whether or not a sequence is expressed and does not permit determination of the size 
of the transcript. Therefore it is quite possible that the 5' end of the transcript was at 
such a distance as to prevent efficient copying into DNA (reverse transcription) or 
subsequent amplification (PCR).
Subsequent to the analysis presented here, 3' RACE has been used to 
identify 1.5kb and a 0.8kb 3' products from mouse embryonic day 13.5 total RNA. 
These products, when used as probes on Northern blots of embryonic RNA, hybridise 
to transcripts at approximate sizes of lOkb and 5kb. These transcripts exhibit a pattern 
of expression completely different from each other within mouse embryonic 
development. These 3' RACE results indicate that the PCR extension times used for 
the 5' RACE in this study were probably insufficient to allow for the distance between 
the priming site and the 5' end of the transcripts.
Although the work presented in this thesis did not produce a complete 
cDNA (which subsequently has been isolated and is being characterised) the original 
aims of the Ph.D. project were achieved:
(i) Initial characterisation of a locus disrupted in a transgenic mouse mutant 
displaying sex-linked cleft palate.
(ii) The identification and isolation of transcribed sequences from the wild 
type locus.
(iii) Evidence of mutational disruption of the gene at the locus in the 
transgenic mutant (splicing of the transcript identified at this locus is altered in the 
transgenic mouse mutant).
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The work presented in this thesis has revealed highly repetitive sequence at 
this locus containing gene sequences, with a complex splicing pattern, linking several 
very smaU exons.
2.15 SUMMARY
32.8kb of the wild type mouse locus whose disruption in a transgenic mouse 
line resulted in sex-linked cleft palate has been isolated. This locus has been 
characterised at the level of expression and conservation of sequence across species. 
This characterisation revealed that the DNA sequences at this locus are replete with 
repeated sequences. The method that proved successful in isolating potential 
transcripts was that of exon-trapping. To date five individual exons have been 
isolated from DNA at this locus (Table 1) and mapped onto the isolated DNA from 
the wild type locus (Figure 47). The exons range in size from 81 base pairs (p52) to 
446 base pairs (p50) and four exons were found to contain ORFs that span the exon 
(p51, p52, p56 and p57). Searches of sequence databases have revealed that two of 
the four exons found to contain complete ORFs (p51 and p56) do not share any 
sequence similarity at all with any sequence present in the database. One exon (p52) 
shares a high level of similarity with Ca^+Zcalmodulin-dependent protein kinase II 
(CaM kinase II), while the largest exon (p50, which doesn’t contain a spanning ORF) 
is composed solely of repetitive sequence belonging to the LINE-1 class of repetitive 
elements.
Using RT-PCR two of these exons (p52 and p57) have been shown to be 
expressed at the level of RNA during development and to be spliced together. The 
predicted amino acid sequence of this RT-PCR product is very similar to that of CaM 
kinase II. RT-PCR analysis between these two exons in the transgenically positive 
line that exhibited sex-linked cleft palate resulted in several larger RT-PCR products 
that hybridise to LMP-1 sequences. This suggests that in the mutant the splicing of 
the RT-PCR product is defective. Visualisation of secondary PCR products from 
exon-trapping of cloned DNA suggests that other exons remain to be identified from 
this locus. The cloning of these exons and the RT-PCR products, along with the 
continued characterisation of this locus will facilitate the isolation of genes present.
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Table 1: Summary of exon characterisation
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Exon Size(bp) ORF Homology Expression(by RT-PCR: Exon Linkage
p 50
p 5 1
p52
p 5 6
P57
446
2 05
81
99
101
LINE-1
+ none
+ CaM Kinase
+ none
+ CaM Kinase(partial)
to p57 
to p52
£ 1 . . .  E l  , ,  El
Trniispcn: Inscinfni Sue
E1 ..1 El4
Exon pô 1 D.Exon p56 I Exon p 5 0
Figure 47: Schematic representation of exons trapped from isolated DNA.
Exons are represented by the rectangles. The solid line between 
exon p52 and exon p57 indicates that these two exons are spliced together 
as shown by RT-PCR.
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3 DISCUSSION
3.1 Repetitive DNA sequence at the locus
Using fragments of the isolated DNA as probes on Southern blots from this 
locus revealed that the DNA contained extensive repetitive sequence. When the 
isolated DNA was used as probes on Northern blots of embryonic and post-natal 
RNAs these repetitive sequences were found to hybridise to transcripts. The unique 
sequences that were found during the Southern analysis did not hybridise to 
transcripts. These results suggested that only the repetitive sequences hybridised to 
transcripts. The lack of hybridisation observed with the unique sequences could 
result from one of several possibilities, the most obvious being that there were no 
expressed sequences present in the unique fragments. The results of the exon- 
trapping identified that exons were only trapped from repeat containing fragments, 
supporting the idea that the unique fragments do not contain expressed sequence. 
However, exon-trapping can only be used to identify internal exons, that is exons that 
have both splice donor and acceptor sites. Moreover, there is the possibility that 
several exons contain EcoR I sites, which will have been missed in the protocol used. 
Therefore, not aU of the internal exons as well as the missing 5' and 3' exons could be 
isolated, as a result it remains feasible that unique stretches do harbour exons that are 
too small to have been detected by the Northern approach.
The analysis of conservation of sequence from this locus revealed several 
fragments were conserved between different mouse species e.g., the 1.3kb EcoR I- 
Not I from Phage 7, while others were conserved into human e.g., the 4.Ikb EcoR I 
fragment from Phage 4. The presence of repetitive sequences complicated this 
analysis of conservation of sequence and so, quashing was used to overcome this 
problem. The quashing of repetitive sequence revealed that the Phage 4 4.Ikb EcoR I
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fragment contained sequence that was conserved into rat, hamster, marmoset and 
human DNA samples at medium stringency of washing. Other fragments exhibited 
no unique sequence conservation across species whenever the repetitive sequences 
were quashed, e.g. the 6 kb and 3kb EcoR /, however no unique signal was observed 
in the mouse DNA samples, an indication that the entire fragments are composed of 
highly repetitive elements. The results of the analysis of conservation of sequence 
revealed that there were several regions that were conserved at a low stringency, 
however the majority of the sequences from this locus did not contain unique 
sequence that was conserved in humans.
The patterns of expression observed with repetitive fragments may not 
reflect the actual expression of the sequences contained within the fragment. Rather 
these sequences could hybridise to expressed sequences also containing the repeats 
that are not derived from this locus. Employing the exon-trapping methodology an 
exon (exon p50) was isolated that was composed solely of repetitive sequence, 
related to LINE-1 elements. It was trapped from the 6 kb EcoR I fragment of Phage 1 
and Phage 7, so it is probable that the pattern of expression seen by Northern analysis 
with this fragment reflected the expression of related sequences in many other 
transcripts. Sequencing of this fragment and subsequent database searches revealed 
that the sequences found in exon p50 were widespread in the mouse genome, so the 
sequences of the 6 kb EcoR I fragment probably hybridise to other expressed 
sequences not from this locus. Exon p50 also hybridised to the 4. Ikb EcoR I 
fragment from Phage 4, though no exons were trapped from this fragment suggesting 
that the expression pattern observed with this fragment is a result of hybridisation to 
repeats expressed from other loci.
Sequence analyses of some of the isolated genomic DNA fragments and of 
the trapped exons revealed the presence of highly repetitive DNA, the database 
analyses showed that a large proportion of this sequence belonged to a group of 
elements known as SINE (composed of short, interspersed Alu and Alu-like repeats) 
and LINE (long interspersed repeated elements ). These two families of repeated
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sequences constitute the majority of middle-repetitive DNA (Charlesworth et a l , 
1994). The SINE and LINE sequences along with processed pseudogenes coding 
mRNAs and small nuclear RNA pseudogenes share common properties suggesting 
that all three are generated from RNA intermediates. Therefore, they have been 
classified as retrotransposons if they possess the ability to code for functions to 
facilitate the retrotransposition process or, retroposons when they do not encode 
reverse transcriptase. The main features of the LINE-1 retrotransposons are detailed 
in the introduction.
LINE-1 sequences are 6-7kb in size and are present in some mammalian 
genomes at copies. They comprise 1-8% of the genome. In primates there is
a single major LINE family called LIH and in mice another called LIM. LIH and 
LIM are 60-70% homologous, except at the 3' end (Holmes et a l y 1994), These 
retrotransposable sequences have variable (A)-rich tails at their 3' end and are 
flanked by short repeats. Their potential ability to multiply and re-insert into the 
genome means that LINE sequences may be a powerful form of mutation in the 
genome. The exact process by which LINE sequences have replicated is not fully 
understood. But the retrotransposons appear to have a preference for (A)-rich 
sequences to integrate into. The extent of these repetitive sequences at this locus may 
have been factorial in the problems encountered in cloning this locus. It was far 
beyond the scope of this project to investigate the nature or reason for unstable 
recombinant phage X clones, (it was difficult enough to isolate stable clones). But, 
the presence of highly repetitive sequences would allow the bacteria that the phage 
were propagated in to homologously recombine the sequences and loop out 
sequences, complicating the cloning process.
It is interesting to speculate about the presence of the LINE-1 elements at 
the DXRib 1 locus, whose disruption resulted in the mutant phenotype. There have 
been several documented cases of gene mutation as a result of LINE-1 insertion 
(reviewed in Amariglio and Rechavi, 1993). To date there have been three recorded 
LINE-1 insertions into the dystrophin gene of humans (Holmes et a l , 1994). One of
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these insertion events results in muscular dystrophy with a phenotype intermediate 
between that of Duchenne and Becker muscular dystrophies. Analysis of the affected 
kindred revealed that a truncated LRE (LINE Retrotransposable Element), 2kb in 
size, had inserted into exon 48 of the dystrophin gene and resulted in the mutant 
phenotype (Holmes et a l, 1994). The definitive precursor of the LRE has been 
isolated and is one of a growing number of active LRE  ^that have been isolated and 
analysed. The study of these isolated LRE  ^will help increase the understanding of 
the mechanisms used by this family of retrotransposable elements to transpose.
LINE-1 insertional mutants have been recorded in the mouse. One example 
is the well characterised disorder,the spontaneous mouse mutation, spastic i^pd). At 
about two weeks of age, spa homozygotes develop a severe neuromuscular disease 
characterised by an exaggerated startle response, rapid tremor, myoclonus, rigidity, 
abnormal gait and impaired righting reflex. Kingsmore and his colleagues have 
shown that defects in the gene encoding the p-subunit of the glycine receptor {Glrb) 
underline spa. Glrb maps to the same region of mouse chromosome 3 as spa, and 
Glrb mRNA is markedly reduced throughout brains of spa mice, most likely as a 
result of an insertional mutation of a 7. Ikb LINE-1 element within intron 6  of Glrb 
(Kingsmore et a l , 1994).
Several questions arise from the presence of these LINE-1 sequences at this 
locus. Do the LINE-1 sequences form a complete element and if so, is it capable of 
transposition? To answer these questions is beyond the scope of this project. 
However, we know that the LINE-1 sequences are not involved in the mutant 
phenotype observed at this locus, as these LINE-1 sequences are present at this locus 
in the wild type mouse. The search of the BLAST database revealed the wide 
dispersal of the LINE-1 sequences throughout the genomes of mammals. Not only 
was the LINE-1 sequence associated with the pseudogenes and small ribosomal 
RNAs mentioned earlier, they were also associated with the 5' and 3' of many genes 
(see sequence analysis in section 2.5 and section 2.8.1)
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It is difficult at this stage, without a complete cDNA of the gene found at 
this locus, to know whether exon p50, the 450 base pair exon is part of a gene 
transcript from this locus or if the LINE-1 sequences harbour a common exon that is 
trappable but forms no part of the gene at this locus. The 450 base pairs of the exon 
p50 have been shown to contain several ORFs, though a nucleic acid motif search of 
the sequence showed the presence of stop codons in all reading frames and no splice 
sites, suggesting that it cannot be functionally translated. However, a recent letter to 
the editor of Cell (Margalit et a l, 1994) remarked on the presence of two Alu 
elements in the coding region of RMSA-1 (regulator of mitotic spindle assembly 1) 
indicating that it is possible for transposon derived sequences to be part of protein 
encoding regions of genes.
The first of these two Alu sequences, including its poly [A]+ tail, resides 
completely within the RMSA-1 gene. While the second Alu is flanked by direct 
repeats of exactly 9 base pairs, a hallmark of transposition, there is no reminiscence 
of such direct repeats associated with the first Alu element This would indicate that 
the first Alu element had lost its direct repeats as a result of sequence divergence, or 
that the first Alu element is not a transposition product. This observation has 
important implications for the evolution of genes and transposable elements alike and 
throws up an intriguing paradox. 40% of the RMSA-1 gene is composed of Alu 
elements, yet this essential gene is conserved into mouse and chicken (Yeo et a l , 
1994). The mouse genome is known to lack a dimeric Alu element and chicken does 
not have any Alu-related sequences at all. So the gene product seems old but the Alu 
elements are new. Only sequence analysis of the mouse and chicken homologs of 
RMSA-1 will reveal the answers, or provide a few suprises.
Although LINE-1 sequences were found in the sequence information 
obtained from several fragments of cloned DNA from the DXRIB 1 locus they alone 
do not account for all the repetitive sequences, other repetitive elements are present. 
One of these sequences is a mini-satellite repeat (GA)n that occurs in the 1.3kb EcoR 
I + Not I  DNA fragment from this locus. The use of this fragment as a probe on a
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Zoo blot showed that the repetitive sequences are present at low copy numbers in the 
mouse genome. However this repetitive element appears to be present at a much 
higher copy number in primate genomes. When this sequence was compared to 
sequences present in the BLAST database, the only matches were found in primate 
sequences.
3.2 Characterisation of exons trapped from this locus
When the total secondary PCR products from the exon-trapping procedure 
were used as probes on Northern blots of embryonic and post-natal RNAs an 
interesting pattern of expression was found. Three transcripts were detected, one at 
about 5kb, one at 0.8kb and one at 0,5kb. The 0,8kb and 0,5kb transcripts were 
detected in the body sample of embryonic day 12.5 total RNA and increased in the 
level of expression during development. These transcripts were also detected in 
embryonic head RNA samples from embryonic day 13.5 onwards. Post natally the 
0.8kb transcript was detected in bone, spleen and stomach total RNA samples from 
day 13,5 post natal mice, indicating that this transcript is also expressed post natally 
in these tissues. The expression of the 0.5kb transcript post natally was not 
addressed.
Probing of a Northern blot of embryonic RNA with total secondary PCR 
products trapped from Phage 4 detected another transcript at day 13.5 in total body 
RNA that did not appear to be expressed in any of the other RNA samples tested. 
The transcript was about 5kb m size and was not detected in a total head sample at 
day 13.5 of embryonic development. This suggests that exons present at this locus 
either belong to alternatively spliced transcripts or to separate transcripts. This 5kb 
transcript was not detected with exons derived from Phage 1 and Phage 7 suggesting 
that the exons that hybridise to the 5kb transcript are located only in Phage 4 DNA, 
although the absence of the 5kb transcript on blots probed with total secondary 
products from Phage 1 and Phage 7 may reflect the quality of the RNA samples on 
the Northern blots probed or the conditions of hybridisation used.
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To date, five individual exons have been isolated from the total PCR 
products of exon-trapping. Southern analysis revealed the presence of the exons in 
the cloned DNA they were trapped from. Using the exons as probes on genomic 
Southerns and Northerns awaits optimisation of conditions. RT-PCR analysis 
demonstrated that exon p52 and exon p57 are expressed during mouse 
embryogenesis.
3.2.1 Putative gene(s) present at this locus
Sequence analysis and database searches have been carried out in order to 
identify a potential gene that the isolated exons belong to. These database searches 
with the nucleic acid sequence of the exons and putative amino acid sequence have 
revealed that some of the exon sequences are novel and that the other exons show 
interesting similarities to sequences already present in the database.
The sequence of exon p50 is composed of repetitive sequence as shown by 
Southern analysis and matches found with the database search. The repetitve 
sequence has been identified as belonging to the LINE family of repetitive 
sequences, detailed above. No ORF was found to span the exon suggesting that it 
may belong to the 5' or 3' untranslated sequences of a gene or alternatively be 
unrelated to the gene(s) at this locus as discussed above.
Another possibility is that exon p50 is a pseudoexon. Pseudoexons belong 
to a rare form of pseudogene (Thompson et ah, 1995). Most pseudogenes were 
processed mRNAs that have been reverse transcribed and inserted back into the 
genome. Pseudoexons belong to a class of pseudogene that contain functional exons 
and introns, i.e. exons that are capable of being functionally spliced. Thompson and 
his colleagues report that these pseudoexons are capable of being trapped using the 
exon-trapping protocol. For people investigating large regions of DNA the presence 
of pseudoexons in genomic DNA is another complication in the isolation and 
characterisation of genes. Several groups have cloned pseudoexons using various 
methods from a region on chromosome 5 that spans the Spinal Muscular Atrophy
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(SMA) critical region. Exons have been identified that are 90% identical at the 
nucleotide level to exons of p-glucuronidase, the functional gene for which is on 
chromosome 7. Two variant forms of the gene encoding promelanin-concentrating 
hormone (the functional gene being located on chromosome 1 2 ) have also been 
isolated and a pseudogene of a novel member of the cadherin gene family 
(Thompson et a l, 1995). However, the pseudoexons found to date contain stop 
codons and so cannot be translated allowing them to be identified as 'pseudo'.
Exon p51 shows only a low degree of similarity with a limited number of 
sequences in the database in the BLAST database, while exon p56 shows no 
similarity to any sequences in the database. The database searches using these exons 
putative amino acid sequence revealed that although many amino acid sequences 
shared short regions of homology there were no sequences present that had a high 
level of similarity over the majority of the sequence of the exons. The results of these 
database searches would indicate that these exons belong to a gene that has not been 
identified before and is unique. However these exons are very small and therefore 
represent only a small part of a gene's sequence. This may mean that the sequence of 
these exons represents a region of a gene that is not very highly conserved and would 
therefore not be identified by a database search.
Sequence comparisons carried out using exon p52 and the RT-PCR product 
of exon p52-p57 have been most informative regarding the possible nature of the 
gene(s) at this locus. Exon p52 was found to contain two ORFs that span the entire 
exon in different plus reading frames. Database searches using the nucleotide 
sequence and deduced amino acid sequence of the putative ORFl of exon p52 
revealed similarities to the nucleotide sequence and amino acid sequence of 
Ca^+Zcalmodulin-dependent protein kinase II isoforms (CaM kinase II). A database 
search using the sequence of exon p57 alone produced no matches at the nucleotide 
level and the deduced amino acid sequence of putative ORFs revealed only short 
regions of homology with other proteins. RT-PCR analysis of embryonic RNA has 
shown that not only are exon p52 and exon p57 expressed, they are spliced together
157
in the same transcript. When this RT-PCR product was sequenced an ORF was found 
that spans both of these exons. Translation of this ORF, using the M a c V e c to r ^ M  
program, resulted in an amino acid sequence that is the same as the deduced amino 
acid sequences of the ORF of exon p52 and the ORF of exon p57, joined together. 
This suggests that in this transcript at least, 0RF3 of exon p52 and the ORF of exon 
p57 form the bona fide polypeptide.
The amino acid sequence of the other complete ORF (ORF2) of exon p52 
was found to have a low level of similarity to the HMG-box sequence of Sry from 
mouse. The 28 amino acids of 0RF2 exhibited a low level of identity 34% to a 
region of the SRY protein of mouse (Gubbay et a l , 1990), When similar amino acid 
residues are included the level of similarity increases to 69%. A comparison to the 
HMG-box sequences from several HMG-box containing proteins did not identify any 
higher level of sequence similarity. The HMG-box motif is a 79 amino acid sequence 
that contains many basic residues and is a DNA binding motif. It has been found in 
many different proteins with known or suspected DNA-binding properties, including 
several transcription factors (Ner, 1992). The importance of the HMG-box has been 
emphasized by the finding that the HMG-box alone confers DNA-binding activity. In 
the case of Sty, the binding of DNA induces a substantial bend in the DNA which 
may be necessary for the formation of transcriptional complexes (Goodfellow and 
LoveU-Badge, 1993). However, with the splicing of exon p52 to exon p57, the ORF 
reaches a stop codon in exon p57 and is not identified by an ORF search of the joined 
sequences. It is not possible to state whether the 0RF2 is part of an authentic 
polypeptide expressed from a different transcript or merely a coincidence of the 
sequence contained within exon p52.
When the extended sequence of the RT-PCR product spanning both exons 
p52 and exon p57 was used for database analysis, CaM kinase II isoforms were 
identified as being highly similar at both the nucleotide level and amino acid level. 
The region of similarity spans the splice site between the two exons. This is 
interesting as a search of the BLAST? database with the putative amino acid
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sequence of exon p57 failed to find any similaritites with Ca^+Zcalmodulin-dependent 
protein kinase sequences present in the database. The lack of matches between the 
sequence of exon p57 and those in the database is probably a result of the parameters 
of the database search. The CaM kinase II sequence exhibiting the highest level of 
identity (47%) was that of the mouse y subunit of brain-specific Ca^ +Zcalmodulin- 
dependent protein kinase II. Analysis of the amino acid sequence of the rat y subunit 
of brain-specific Ca^+Zcalmodulin-dependent protein kinase II, revealed that the 
region of highest similarity with exon p52-exon p57 is the region constituting the 
calmodulin binding domain. This region is the most highly conserved in the family of 
multifunctional Ca^ +Zcalmodulm-dependent protein kinases, CaM kinase, (Tobimatsu 
et aL, 1988). This analysis suggests that the potential polypeptide of exon p52-exon 
p57 is a member of this family of proteins.
3.3 MULTIFUNCTIONAL CaM KINASE FAMILY
3.3.1 Isoforms of Ca^+Zcalmodulin-dependent protein kinase
CaM kinase II is a ubiquitous enzyme mediating the diverse effects of 
hormones and neurotransmitters that utilize Ca^ + as a second messenger. CaM kinase 
II is present in most tissues as an oligomer, composed 6-12 subunits, depending on 
the isoform and tissue. Differences between the cloned mammalian isoforms mostly 
lie in a variable region which lies between the calmodulin binding domain and the 
association domain and consist mostly of 11-3 9-amino acid insertions and deletions. 
Thus far, five isoforms (a, p, P', y, and Ô) have been cloned from rat brain. a-CaM 
kinase cDNA encodes a protein of 478 amino acids (54kDa) from a S.Okb message. 
The p-CaM kinase cDNA is translated to a 542-amino-acid protein (60kDa) encoded 
by a 4.8kb message. The a  and p sequences are closely related, with 91% identity in 
the amino terminal half of the protein, and 76% identity in the carboxy-terminal half. 
Alternative splicing generates both the p mRNA and a distinct P' isoform (Hanson 
and Schulman, 1992). Two other isoforms designated y and 6 , have been cloned from
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rat brain cDNA libraries (Tobimatsu and Fujisawa, 1989; Tobimatsu et a l, 1988). 
Northern blots demonstrate a broad tissue distribution for both the Ô and 7  subunits, 
with 7  detectable in all tissues examined and ô detectable in all except liver. Each of 
these is a distinct gene product with approximately 85% homology in amino acids 
and 75% homology in nucleotides to the a  subunit. The 7  cDNA encodes a protein of 
527 amino acids (59kDa), and the ô one of 533 amino acids (60kDa). It should be 
noted that antibodies to CaM kinase II have detected subunits, that do not correspond 
in size to any of the cloned isoforms, in both neuronal and non-neuronal tissues. 
Therefore, it is likely that additional isoforms that are either distinct gene products or 
alternatively spliced variants of the known isoforms exist.
Expression of the a  and p isoforms of CaM kinase appears to be mostly 
confined to the brain. The p isozyme of type II CaM kinase is expressed specifically 
in the brain of the rat, it appears to be concentrated in the forebrain postsynaptic 
densities. It acquires a Ca^+-independent activity when it phosphorylates itself, 
suggesting that it may be involved in producing long lasting changes in response to 
transient calcium signals (Miller and Kennedy, 1986). The rat 7  and Ô isoforms 
appear to be more widespread as RNA blot analysis shows transcription in many rat 
tissues (Tobimatsu and Fujisawa, 1989). All isoforms share a highly conserved 
catalytic domain at the amino-terminal portion of the molecule, an autoînhibîtory 
sequence overlapping with a calmodulin binding region, followed by an association 
domain which is important in holoenzyme formation (Figure 48).
Nghiem and colleagues have reported the cloning of two new isoforms of 
CaM kinase, 7 b and 7 c» from non-neuronal human tissue, the sequence of their 
calmodulin binding domains is shown in Table 2 (Nghiem et a l, 1993). Outside of 
the variable region all three variants of the 7  CaM kinase II are nearly 100% 
identical. Human 7 3  CaM kinase II differs from the rat brain 7 a by the insertion of a 
novel 23-amino acid segment in the variable region of 7 b, and the deletion of two 
segments of 21 and 11 amino acids. The human 7 c clone differs from human 7 g in 
that it does not include the 23-amino acid insert (Nghiem et al, 1993). The
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comparison of amino acid sequences from CaM kinase yb and 7 c with that of exon 
p5 2-exon p57 reveal that they share a 47% level of identity across the 44 amino acid 
residues shown in Table 2. Comparison of the exon p52-exon p57 sequence to that 
of CaM kinase II-p reveals a 46% level of identity. However, the sequences of CaM 
kinase II-7b/7c and CaM kinase II-p are more similar at 75% identity, to each other 
than either are to the sequence of exon p52-exon p57. These sequence comparisons 
demonstrate that the amino acid sequence of exon p52-exon p57 is related to the 
amino acid sequences of the members of the CaM kinase family and may be a unique 
new isoform or a related homologue.
Other members of the CaM kinase family have been described. CaM kinase 
I has been isolated from bovine brain and found to be a 42 kDa monomeric enzyme 
with a kinase activity similar to that of CaM kinase II (Naim and Greengard, 1987). 
It differs from CaM kinase II m the site of phosphorylation on its substrate. CaM 
kinase IV is a 474 amino acid protein and its kinase domains maintain the conserved 
features of protein kinase catalytic domains, but is only 32% identical overall to CaM 
kinase II (Hanson and Schulman, 1992). One gene was found to encode both 
calspermin and CaM kinase IV utilising two transcriptional start sites to generate the 
different messages (Ohmstede et al., 1991). Calspermin message is only detected in 
the testis, while CaM kinase IV has been detected in brain, testis, spleen and thymus. 
The kinase activity of CaM kinase IV differs from that of CaM kinase II in that it 
phosphorylates substrates not phosphorylated by CaM kinase II, e.g. Rap-lb ( a Ras 
related GTP-binding protein) (Sahyoun et a l , 1991). It may be that CaM kinase IV is 
another multifunctional CaM kinase given the different substrates to those of CaM 
kinase n. To address this requires the identification of other substrates and functions 
of CaM kinase IV in vivo .
3.3.2 Gene structure and domain structure of CaM kinase
The p subunit of brain-specific Ca^+Zcalmodulin-dependent kinase II was 
the first member of the CaM kinase II family to be cloned from m o u s e , ( K a r l s
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et a l, 1992). Sequence analysis of the coding region showed 97% homology at the 
nucleotide and close to 100% homology at the amino acid level with the published 
sequence of the rat (3 CaM kinase n gene. This high level of homology extended into 
the 3’ untranslated region of the gene (Karls et aL, 1992). The genetic structure of 
Camk2 appears rather complex with the 16 exons, ranging in size from 38bp to 
233bp, that comprise the 3' untranslated region and four-fifths of the coding region 
spread over 28kb of cellular DNA, The (3' isoform appears to be generated by 
alternative splicing of the transcript of the |3 gene, resulting in the deletion of exon 
VI. The 5' end had not been isolated for presentation in this paper (Karls et a l , 
1992).
The majority of the isoforms identified to date have been isolated from 
various cDNA libraries, resulting in a lack of information of the gene structure for 
each isoform. Thus, it is not clear as to whether the exon/intron structure is 
maintained or not between isoforms. However what is clear is that the domain 
structure of the proteins encoded by these isoforms is similar.
The deduced amino acid of the exon p52-exon p57 ORF shows homology to 
the regulatory domain of type II CaM kinases. This is composed of the primary 
phosphorylation sites, the inhibitory subdomain which maintains the kinase in an 
inactive conformation and a calmodulin-binding subdomain that is unique to the 
Ca2+/calmodulin-dependent protein kinases. The core of the calmodulin-binding 
subdomain is the amino acid sequence RRKLKGAILTTMLA. Synthetic peptides 
corresponding to this region of the kinase bind calmodulin in a Ca^+-dependent 
manner thereby blocking activation of calmodulin-dependent kinases. In the (3 CaM 
kinase II, as in many other CaM-binding proteins, this domain consists of a basic a  
helix which, in a helical wheel projection, forms a basic and a non-polar surface 
(reviewed in O’Neill and DeGrado, 1990),
The bipartite character of this core binding domain is emphasised by the 
fact that it is split between two exons in such a way that the basic part (amino acid 
residues R-297RKLK-301) is in one exon and the non-polar part (amino acid
163
residues G-302AILTTMLA-310) is in another exon, a splicing event brings these 
two sub-domains together. As described earlier the sequence of the binding domain 
is found in the deduced amino acid sequence of the RT-PCR product and 
demonstrates an identical split of residues between exon p52 and exon p57. There are 
differences though, while the basic part of the domain is present fully (RRKLK) in 
exon p52, the non-polar part of the domain does not appear to be as well conserved 
(GAVLAAVSS) in exon p57 (substituted residues are underlined). However the 
amino acid substitutions that have occurred retain the non-polar character of the 
amino acid sequence (non-polar residues are shown in bold type). A deduced 
secondary structure for the amino acid sequence of these two exons reveals that a 
putative a  helix would be formed, corresponding to that formed by the bipartite 
binding domain of type II CaM kinases (Schulman and Lou, 1989).
An inhibitory subdomain may extend the N-terminal portion of the 
calmodulin-binding domain to include a threonine residue (Thr286) which is 
autophosphorylated upon calmodulin binding to CaM kinase. Synthetic peptides 
corresponding to this region inhibit activity of the autonomous kinase in vitro. It is 
also interesting that the two threonine/serine residues which match the substrate 
consensus sequences for the kinase that are found in both the a-, (3- and y- subunits, 
Arg-X-Y-Thr286 and Arg-X-Y-Ser314, flank the inhibitory and calmodulin-binding 
subdomains. These two threonine/serine residues also occur in the deduced amino 
acid sequence of the exon p52-exon p57 ORF and are located in a similar position 
relative to the calmodulin-binding domain. However in the amino acid sequence of 
exon p52-exon p57 the substrate consensus sequence is not present. Part of the 
deduced amino acid sequence of exon p52-exon p57 ORF is given below, the 
calmodulin binding domain is shown in bold type, while the threonine/serine residues 
are shown in bold type and underlined.
(LPET-286VEOLRKFNARRKLKGAVLAAVSSHKFNS^314FYD>
For a comparison of amino acid sequences of the calmodulin-binding 
domains of CaM kinase II and those of several known protein kinases, with the
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Table 2
Calmodulin-binding domains of several enzymes
IV TGK AANFVHMDTAOKKLOEFNARRKLKAAVKAWASSRLGS A.S S .SHTS
I I  -  a  SHR- -  STVASCMHROETVDCLKKFNARRKLKGAILTTMLATRNFSGGRSGGN
I I - P  C Q R --S TVASMMHROETVECLKKFNARRKLKGAILTTMLATRNFSVGROTTA
-M QKD TKNME AKKL S KDRMKKYMARRKWOKTGHAVRAIGRLS SMAMISGM
-K  NNLAEKAKRCNRRLKSOILLKKYLMKRRWKKNFI-AVSAANRFKKSSSGALM
PHK-y QEY-------------------------- WEEVRHFSPRGKFKVICLTWASVKIYYOYRRVKP
Y B /C  --------------------VASMMHROETVECLRKFNARRKLKGAILTTMLv s RNFSAAKSL - -
p52-p57-------------YAYKIHL PETVEOLRKFNARRKLKGAVL AAVS S  HKFNS F YGD P P -
Comparison of the amino acid sequence of the putative calmodulin-binding 
domain of exon p52-exon-p57 with those of several known CaM kinases and protein 
kinases. Single-letter amino acid code is used and the amino acids that aie found in 
exon p52-exon p57 are in bold type. Predicted calmodulin-binding domains ai’e 
underlined. Alignment is by visual inspection and effort was made to minimize gaps. 
Enzymes listed: IV, CaM kinase IV (mouse); Il-a  and II-p, -a  and -P subunits of CaM 
kinase II (rat), -M, myosin light-chain kinase from smooth muscle (chicken); ~K, 
myosin light-chain kinase fi'om skeletal muscle (rat); PHK-y, phosphorylase kinase y 
subunit (mouse) i (Sikela , 1989)); Yb/c , Yb and Yc isoforms of CaM kinase II 
(human) (Nghiem et ai, 1993).
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deduced amino acid sequence of exon p52-exon p57 see Table 2. The comparison 
reveals that the sequence of exon p52-exon p57 shows a high level of similarity with 
mouse CaM kinase II-(3 and -y. However, the complete amino acid sequence of exon 
p52-exon p57 shows only a 46% level of identity to the CaM kinase II-|3 partial 
sequence. As the (3 subunit of CaM kinase II is brain specific in mouse and rat we 
can suggest that exon p52-exon p57 is part of a gene that may be a new CaM kinase 
isoform. The exon p52-exon p57 sequence was a product RT-PCR analysis of total 
RNA derived from the body of day 15.5 embryonic mice, this shows that the isoform 
found by this analysis is not brain specific.
3.3.3 Functions of CaM kinase
CaM kinase II was first specifically described in synaptosomal (nerve 
terminal) membranes (Schulman and Greengard, 1978), and was subsequently 
shown to be present in membranes from a variety of tissues (Kennedy and 
Greengard, 1991). This kinase phosphorylated the vesicle-associated protein 
synapsin I as well as several other proteins, two or three of which were later found to 
be autophosphorylated subunits of the enzyme itself. CaM kinase II was purified 
from rat forebrain cytosol using a number of substrates, including myosin light 
chains, synapsin, tryptophan hydroxylase, tubulin, microtubule-associated protein-2 
(MAP-2) and casein. All of the isolated kinases share the broad substrate specificity 
characteristic of CaM kinase II and are now recognised as being the same enzyme 
(Schulman and Greengard, 1978).
CaM kinase II prepared from rat forebrain typically contains subunits of 50- 
55kDa (a- subunits) and 58-60kDa (|3- subunits) in a ratio of 3-4:1, Four Ca^ + ions 
bind to a molecule of calmodulin and this then binds to CaM kinase, this in turn 
stimulates autophosphorylation of both subunits of the CaM kinase. The CaM kinase 
II holoenzyme isolated from rat forebrain has an apparent molecular weight of 
between 460,000 and 650,000 and is therefore likely to be a decamer or dodecamer. 
As detailed above, seven isoforms of CaM kinase II have been isolated to date. Thus
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far all mammalian isoforms identified utilise the same protein domain structure and 
differ from each other primarily in the size and nature of the inserts at the end of the 
calmodulin binding domain.
Mechanistic studies of multifunctional CaM kinase and its activation by 
Ca2+/calmodulin have provided evidence for a model in which CaM kinase is kept 
relatively inactive by the presence of an autoinhibitory domain (Figure 48), Binding 
of Ca2+/calmodulin eliminates this inhibitory constraint and allows the kinase to 
phosphorylate its substrates and also itself. This autophosphorylation significantly 
slows dissociation of calmodulin thereby trapping calmodulin even when Ca^ + levels 
are below those initially needed for activation. Once calmodulin dissociates, CaM 
kinase remains Ca^+-independent until the kinase is dephosphorylated. These effects 
of autophosphorylation enable the potentiation of brief transient Ca^ + fluxes.
The primary role of CaM kinase is as a kinase that regulates cellular 
processes by phosphorylating critical proteins in the cell. A growing list of putative 
substrates is being formed on the basis of in vitro assays in which proteins are found 
to be phosphorylated by the kinase. This list can be used to identify the consensus 
amino acid sequence around the phosphorylation sites recognised by CaM which 
permit identification of other possible substrates. Table 3 provides a list of the 
proteins that have been found to be good substrates of CaM kinase in vitro and in 
vivo. Consistent with being a multifunctional kinase, the enzyme phosphorylates a 
diverse group of proteins that includes enzymes, cytoskeletal proteins, ion channels 
and transcriptional factors. Other proteins have been identified as substrates of CaM 
kinase II in vitro but remain to be shown as being substrates in vivo and are not 
described here (Hanson and Schulman, 1992).
Distinct functions have not been demonstrated for all the isoforms identified 
to date, but their variety and differential expression suggest that they have become 
specialised for roles they play in multiple tissues. A role for CaM kinase, which has 
been identified in some nonneuronal tissues, includes regulation of a chloride- 
specific ion channel in human tissues. Cystic fibrosis (CF), a common lethal genetic
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Table 3: CaM kinase substrates* 
Protein (size kPa) Function
Acetyl-CoA carboxylase (260)
Alzheimers's disease amyloid precursor peptide(228) 
Calcineurin (58-61)
Caldesmon (87)
Glycogen synthase (85-90)
Myosin tight chain, smooth muscle (20)
Myosin tight chain kinase, smooth muscle (130) 
Phenylalanine hydroxylase (51)
Phospholamban (11)
Pyruvate kinase (61)
Ryanodine receptor (565)
Synapsin (80-86)
Tyrosine hydroxylase (59)
Fatty acid synthesis 
Phosphatase
Regulates actin-myosin binding 
Carbohydrate metabolism 
Myosin subunit 
Initiates muscle contraction 
Tyrosine synthesis 
Ca2+ uptake in SR 
Carbohydrate metabolism 
Ca^ -^  release
Neurotransmitter release 
Catecholamine synthesis
*Proteins listed have been shown to be substrates of CaM kinase II in vivo. The pathway in 
which they are involved is indicated in the right hand column. For a complete list of potential 
substrates in vitro and in vivo, see Hanson and Schulman, 1991.
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disease in Caucasians, leads to defective regulation of chloride ion transport which 
compromises the function of secretory epithelia of the lung and gut resulting in 
death. A major pathway for activation of chloride conductances, via cAMP- 
dependent protein kinase, is blocked by mutations in the CF gene, the cystic fibrosis 
transmembrane conductance regulator. A parallel pathway utilizing Ca^ + as a second 
messenger remains functional in CF and has recently been shown to be mediated by 
CaM kinase (Wagner et a l, 1991). CF airway epithelial cell lines which were 
deficient in chloride channel activation by the cAMP pathway were activated by Ca^ + 
ionophore or by injection of activated CaM kinase. Because this pathway to 
activation of chloride channels bypasses the defective signalling in cystic fibrosis, 
activation of human epithelial cell CaM kinase by increasing intracellular Ca^ + may 
provide an alternative approach of therapy for this disease.
The mouse CaM kinase II-p gene, Camk-2, was isolated from a mutant 
mouse, CAT40, which harboured a recessive lethal mutation caused by a transgene 
insertion event on chromosome 11 (Karls et a l, 1992). Embryos homozygous for the 
transgene insertion died shortly after implantation. However, it is highly unlikely that 
a lack of Camk-2 expression is responsible for the death of homozygous embryos. 
Camk-2 codes for a protein kinase that is found only in the brain. During normal 
development, transcripts are found for the first time in the head of day 12.5-embryos, 
much later than the time of death of homozygous embryos. A large deletion was 
found to accompany the insertion event, with SOkb of cellular DNA 3* to Camk-2 
deleted. To date no gene(s) have been located in this deleted region as attempts to 
clone the region have proved unsuccessful, due to the DNA inserts being extremely 
unstable in cosmid and phage vectors. It seems probable that gene(s) vital for 
embryonic development are located on this region and it is their loss, not Camk-2, 
that results in the death of embryos shortly after implantation. Thus far, there have 
been no reports of transgenic knockout mice of any CaM kinase isoforms and what 
phenotype such knockout mice would exhibit.
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3.4 Possible causes of phenotype observed in the transgenic mutant
Exons that contain an ORF which encodes an amino acid sequence very 
similar to the calmodulin-binding domain found in proteins belonging to the 
multifunctional CaM kinase family, have been located at the locus whose disruption 
resulted in sex-linked cleft palate. This family of genes encodes at least seven 
different isoforms that have a widespread pattern of expression and a role in many 
different signalling pathways in the cell. Using RT-PCR to analyse the expression of 
exon p52 and exon p57, which span the insertion site in the mutant, revealed that 
these two exons are expressed and spliced together in the same transcript. When the 
expression of these exons was analysed in transgenically positive RNA it was found 
that the RT-PCR product was altered. The 177 base pair RT-PCR product of exon 
p5 2-exon p57 was still present as expected in hemizygous individuals, but a Ikb, a 
350bp and a 250bp product were also detected using probes to exon p57 in the 
transgenically positive spleen RNA sample. Probing of the same blot of RT-PCR 
products from transgenically positive and negative spleen RNA with the LMP-1 
transgene has revealed that the 350bp and the 250bp products hybridise to LMP-1 
sequences and these are only found in the transgenically positive samples. These 
findings suggest that the splicing of exon p52-exon p57 is effected in the transgenic 
mutant. The sequence of these novel RT-PCR products has yet to be determined, 
sequencing of this RT-PCR product should demonstrate what other sequences are 
present in this product. The presence of the 177 base pair exon p52-exon p57 RT- 
PCR product in the transgenically positive sample reflects the fact that there is still a 
normal X chromosome present in the transgenically positive spleen. As X 
chromosome inactivation is random then transcripts can be derived from both the 
transgenic and the normal chromosome.
The transgene has three LMP-1 encoding exons. It is present in the 
transgenic mutant as two copies in a head to tail tandem array. Only the central exon
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contains both a splice acceptor and a splice donor and it is 80bp in size. The 
difference in sizes between the wildtype RT-PCR product (177bp) and the novel 
products is about 80bp (for the 250bp product) and about 160bp (for the 350bp 
product). Therefore it is possible that the single 80bp internal LMP-1 exon is present 
in the 250bp product and two 80bp LMP-1 exons, one from each transgene copy, are 
present in the 350bp product. The hybridisation of the RX-PCR products to LMP-1 
sequences supports this idea and the cloning and sequencing of these RT-PCR 
products will reveal the character of these products.
The Ikb RT-PCR product that hybridised with exon p57 sequences found in 
the transgenically positive sample failed to hybridise to the LMP-1 sequences. But 
the LMP-1 probe hybridised to a novel RT-PCR product >2kb in size that was not 
detectable using the exon p57 probe. As the oligonucleotide primers used for the RT- 
PCR are designed to exon p52 and exon p57 then all RT-PCR products should 
contain at least the oligo sequences. The reason why this >2kb product fails to 
hybridise to the entire exon p57 sequences is unclear, but may suggest that these 
larger products are artifacts. However, the fact that they are not amplified from the 
wild type RNAs would suggest that they could be genuine products.
Since the Ikb RT-PCR product failed to hybridise with LMP-1 sequences, it 
is possible that the transgene has affected the splicing of other exons at this locus 
without being incorporated in this product. If other exons are present in the genomic 
DNA lying between exon p52 and exon p57, these may be spliced to exon p52 and 
exon p57 and be amplified by the RT-PCR. The >2kb RT-PCR product that 
hybridises to the LMP-1 sequences, but fails to hybridise with entire exon p57 
sequences may also result from altered RNA processing at this locus as a result of the 
transgene. It is possible that this is a product of splicing from the transgene into a 
cryptic acceptor site within exon p57, allowing its amplification through the oligo but 
with the loss of most of p57 preventing the hybridisation to these sequences. Again, 
the cloning and sequencing of these RT-PCR products should clarify which of these 
theories is true.
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If the hybrid transcripts that hybridise to LMP-1, exon p52 and exon p57 
sequences are translated into protein would this be a functional protein? The fact that 
exon p52 and exon p57 encode the calmodulin-binding domain, any sequence 
splicing between these two exons would result in the disruption of this domain. The 
translation of the hybrid transcript would result in an altered amino acid sequence as 
the introduction of the exon from LMP-1 which is 80 base pairs in size introduces a 
frameshift and a stop codon. There is the possibility that the altered splicing 
suggested from the hybrid RT-PCR products introduced other sequences not yet 
isolated, which would keep the sequence in frame. It is feasible that the amino acid 
sequence of the calmodulin-binding domain would be maintained but separated by an 
intervening stretch of amino acids. In either situation the calmodulin-binding domain 
is affected resulting in an altered protein.
What effect these hybrid transcripts have in the mutant mouse is unknown. 
The probing of the RT-PCR products with exon p52 and exon p57 revealed that the 
177 base pair product observed in the wild type mouse is also present in the mutant 
female mouse (mutant male mice have not been analysed). This would indicate that 
in the transgenically positive female mouse there is a population of transcripts 
producing wild type and mutant proteins.
The developing palate is a complicated developmental system that is 
extremely sensitive to changes at the molecular level, disruption of any one 
molecular process may result in cleft palate (for review see introduction). The 
cloning of several exons belonging to a putative member of the CaM kinase family 
may mean that the disruption of a novel CaM kinase results in the phenotype 
observed. The CaM kinases identified to date exhibit a wide range of substrates, so 
the phenotype observed in the transgenic mutant may be a consequence from the 
perturbation of any one of many molecular pathways.
If the gene that exon p52-exon p57 belongs to is a member of the CaM 
kinase family, then the gene structure of Camk2 with its 16 small exons, down to as 
small as 38bp, would help in explaining some of the problems associated with
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cloning gene (s) from the DXRiB 1 locus. It is highly unlikely that using the strategy 
of conservation of sequence and expressional analysis that a 38bp exon would be 
readily detected. The gene structure of CaM kinase IV and the presence of the 
calspermin gene within it also offers the possibility that the three transcripts detected 
by exons from the DXRib 1 locus may be derived from separate genes and are not 
simply alternatively spliced transcripts. This exciting possibility relies on the gene, 
that the exon p52-exon p57 sequence is derived from, belonging to the CaM kinase 
family.
However, there is the possibility that the exons identified and shown to 
encode sequence similar to that of CaM kinase II belong to a gene that is not a 
member of this kinase family but also exhibits binding of calmodulin. The lack of 
substrate consensus sequences at the Thr-286 and Ser-314 phosphorylation sites 
suggest that if these exons belong to a novel CaM kinase then it may not undergo 
autophosphorylation. Therefore this sequence may belong to a gene product which 
has a completely different function compared to that of identified CaM kinases. 
Several types of protein that bind calmodulin have been identified in the nucleus of 
cells, (i) proteins involved in actin-myosin contractile systems, e.g. myosin light 
chain kinase and caldesmon; (ii) proteins involved in the phosphorylation or 
dephosphorylation of proteins, e.g. CaM kinase II and calcineurin; (iii) transcription 
factors, e.g. several transcription factors belonging to the basic helix-loop-helix 
structural group; (iv) proteins which associate to hnRNA, e.g. hnRNP A2; and (v) 
proteins of unknown function (Bach et a l, 1994). Each of these proteins has very 
different functions within the nucleus but they all interact with calmodulin in the 
presence of Ca^ +. The cloning of the cDNA from this locus should help in 
understanding the function of the gene(s) product and its relevance to the mutant 
phenotype.
The phenotypes observed in the CAT40 mutant mouse probably do not 
reflect disruption of CaM kinase H-(3 expression (Karls et a l , 1992) and do not help 
in understanding the events that result from disruption of the gene at DXRtB 1. If the
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gene located at the DXRiB 1 locus is a member of the CaM kinase H family then it is 
quite possible that it has a specific function, not identified in any of the other 
isoforms, the disruption of which impinges on palate development. An understanding 
of the phenotypes that result from transgene integration at DXRiB 1 is complicated 
by the fact that the transgene itself encodes a protein, LMP-1, that has been shown to 
have pleiotropic effects. The evidence to date is that LMP-1 induces a range of 
changes in the cell that affects its state of differentiation, with one of the affected cell 
types being epithelial cells (Wilson et al, 1990).
In palate development the epithelium plays a crucial role in inducing and 
responding to changes in the mesenchymal cells it is in contact with. Due to the 
speed of palatal development the epithelium responds rapidly to the inducing signals. 
If anything changes the differentiation state of the cells in the developing palate then 
it may be expected that palatal development itself may be affected. It was argued that 
the fact that these LMP-1 expressing lines which did not exhibit sex-linked cleft 
palate indicated that it is the insertion event and not transgene expression which 
caused the mutant phenotype. However, the transgenic line that exhibited cleft palate 
expressed LMP-1 at the highest level of all the transgenic lines. So the phenotype 
observed in the mutant line may be a result of the level of transgene expression 
directed by the CaM locus. This problem can only be rigorously addressed by the 
regeneration of the transgenic mouse for the site of insertion with a different 
transgene. If these transgenic mice exhibit sex-linked cleft palate then it is the 
disruption of the cellular locus that resulted in the mutant phenotype and not induced 
LMP-1 expression by the cellular locus.
3.5 Further characterisation of the locus
As this may prove to be a unique gene with a potentially important role in 
palatogenesis then there are an abundance of avenues of research for continued study. 
The immediate goal of future work will be the isolation of the cDNA in order to 
obtain the complete sequence. This can be attempted in one of several ways. From
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the results of the exon-trapping protocol it is clear that there are several exons present 
at this locus. Some of these exons have already been characterised and cloned. The 
analysis of the total exons-trapped revealed that some of the exons are part of a 
transcription unit. Individual exons were shown to be expressed using the technique 
of RT-PCR indicating that the lack of signal on Northerns, probed with individual 
exons, is a result of the hybridisation conditions used. RT-PCR can only detect the 
presence of a sequence in a transcript, it cannot reveal the size of that transcript. 
Although the RT-PCR revealed that exon p52 and exon p57 were parts of the same 
transcription unit, it could not identify if that transcript was the same as the 
transcription units detected with the total exons trapped from the locus.
An immediate goal of future work will be the optimisation of the conditions 
used to identify the transcripts from which the isolated exons are derived. Once the 
conditions have been optimised it should be possible to use the individual exons to 
isolate the cDNA for this locus from the relevant cDNA libraries. The optimisation 
of hybridisation conditions will allow other analyses, e.g. an analysis of the 
expression patterns of the locus during development.
3.5.1 Cloning of the cDNA(s) for the gene(s) at this locus
The results of the exonrtrapping experiments suggest that there are other 
exons present at this locus that have been trapped during the exon-trapping but these 
have not been cloned in the subsequent steps and remain to be isolated. If these 
uncloned exons, that hybridise to transcripts during embryonic development, could 
be isolated then the process of isolating the entire cDNA would be aided. There are 
several ways of overcoming this problem, the first is to repeat the exon-trapping and 
the subcloning using the DNA from the entire locus restricted with an alternative 
enzyme. This may result in a similar situation where, for whatever reason, the 
trapped exons remain uncloned. An alternative approach would be, rather than use all 
the DNA fragments from this locus to use the individual EcoR I DNA fragments for 
the exon-trapping. By using only individual EcoR I DNA fragments for exon-
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trapping there should only be a few exons trapped per DNA fragment. These exons 
can then be used as probes on Northern blots of mouse embryonic RNA and 
characterised in a similar fashion as before.
Two of the transcripts identified as being expressed during mouse 
embryonic development, with the total exons from this locus are quite small at 800 
and 500 nucleotides. The isolation and cloning of exons that belong to these 
transcripts offer the opportunity to isolate the cDNA in one of several ways. The 
most obvious method of cloning a cDNA is the construction and screening of a 
cDNA library. The transcripts revealed by Northern analysis are expressed from day
10.5 of mouse embryonic development, and I have already constructed two cDNA 
libraries, one from day 12.5 embryonic RNA and the other from day 16.5 embryonic 
RNA. These libraries can be readily rescreened with any exon that is expressed 
during development.
There is another more direct approach to cloning the cDNA for the gene(s) 
at this locus. As the transcripts identified are quite small then it should be possible to 
use anchored PCR to amplify the cDNA and subclone it. There are two possible 
approaches using anchored PCR either 3' RACE or 5' RACE. These methods are now 
standard procedures and a wide range of anchored primers are available 
commercially. The basis of anchored PCR is that a transcript is converted to a cDNA 
molecule then either the 5' or 3' end of cDNA molecule is tailed using a single 
nucleotide during the cDNA synthesis. Then PCR is carried out on the tailed cDNA 
molecules using a primer to known internal sequence of the transcript and a primer to 
the sequence added in tailing.
Two of the exons p52 and p57 were shown to be expressed using RT-PCR 
with RNA extracted from day 13.5, 14.5, 15.5 day 16.5 mouse embryos. It was 
possible to use RT-PCR to amplify between the exons indicating that the exons were 
adjacent to each other in the RNA molecule. The cDNA used for this analysis was 
primed using oligo dT and this indicates that the exons belong to a transcript in the 
poly[A]+ fraction of the RNA. Therefore it should be possible to use 3' RACE with
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an anchored primer to the poly[A]+ region of the transcript to produce a cDNA 
molecule which will be 3’ to the exons. It will be interesting to compare the products 
of the 5' and 3' RACE experiments. It may reveal that the exons trapped from this 
locus belong to more than one gene or alternatively, the products of 5' and 3’ RACE 
may reveal that the exons belong to the same gene but are parts of a differentially 
processed transcript.
The cloning of the cDNA(s) isolated from this locus will allow a number of 
questions to be addressed. A simple comparison of the sequence of this gene(s) to 
sequences present in the databases will reveal a great deal of information about the 
gene product. Similarities between DNA sequences and between putative protein 
sequences may give clues about the protein domains and functions of the gene 
product. The cloning of the 5' end of the gene(s) and a sequence analysis of it may 
indicate the sequence domains that are important in gene regulation e.g. binding 
domains for regulatory proteins which can be tested further. Identification of the 
regulatory gene sequences will permit an in depth analysis of gene expression 
control, both spatial and temporal.
3.5.2 Characterisation of expression of the gene(s) identified
With the identification of cDNA molecules derived from this locus the 
patterns of expression of the gene at the RNA level can be addressed. Again there are 
several ways in which to approach this analysis. The preliminary results of Northern 
analysis in this thesis (see section 2.6) suggest that the gene is widely expressed in 
different tissues during development and post-natally. Although the analysis to date 
has been limited there appears to be some tissue specificity in the pattern of 
expression already described. The analysis of the expression between transgenically 
positive and negative post-natal tissues, namely kidney and spleen, revealed that 
there was no difference in size of transcripts detected in the spleen RNA samples. 
However there was no transcript detected in either transgenically negative or positive 
kidney RNA samples. This clearly shows that although the gene is expressed in many
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tissues, the expression is not ubiquitous and that there is a level of specificity. The 
Northern analysis will be extended to many other tissues at different time points 
during development and post-natally to give a fuller understanding of the pattern of 
expression at the tissue level.
The extended Northern analysis will reveal only in which tissues the gene is 
expressed, which will not ascribe a function to the gene product. However if the gene 
is expressed in one specific cell type then this may help reveal some information 
about gene function. One of the methods for addressing the pattern of expression 
within the tissues, which cell types and even the cellular location of the transcripts, is 
to use the method of in situ hybridisation. As the preliminary characterisation shows 
that the level of expression of the transcripts increases during embryonic 
development, then it is probable that this gene is important during embryonic 
development. So whole section mounts of mouse embryos taken at different points 
during development could be effectively used for in situ hybridisation analysis. The 
sequence analysis of the cDNA should reveal which part of the sequence would be 
best to use as probe (i.e. least related to known sequences). Either riboprobes or 
oligos from the isolated cDNA could be used as probes for the in situ analysis.
The use of in situ hybridisation can help in predicting the function of the 
gene product, as probing whole embryo sections at different time points of 
embryonic development will reveal the pattern of expression across the embryo and 
any changes in expression that are occurring with time. This may take the form of 
local accumulations or depletions of transcripts at certain times, or prior to certain 
developmental changes suggesting a particular gene function, A good example of this 
is the expression of the TGFp-3 gene expression during palatogenesis. TGF(3-3 is 
expressed just prior to palatal shelf fusion and only at the tips of the palatal shelves 
(Ferguson, personal communication). Mice homozygous for the knockout of this 
gene exhibited the phenotype of cleft palate. The knockout mice, and the temporal 
and the spatial expression patterns of this gene indicate that it has an important role 
in palate development.
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The expression of a gene at the RNA level while revealing one level of 
expression does not indicate where or to what degree the protein product of that gene 
is expressed. To address this requires the generation of an antibody to the gene 
product. Knowing the sequence of the gene permits prediction of the protein 
sequence, this in turn allows the design of peptide antigens and the generation of a 
specific antiserum. With the generation of an antiserum the pattern of expression 
within tissues and the location of the protein within the cell can be analysed. These 
studies will take the form of immunohistochemical analysis of the whole mouse 
embryonic sections as described above. This analysis should reveal the location of 
the gene's protein product within the cells, complementing the in situ analysis 
described earlier and the sequence analysis of the cDNA.
The antisera may also be used to investigate any modifications that occur to 
the protein during development or between tissues. This could be addressed using the 
antisera against Western blots of protein extracts from embryonic samples and post 
natal tissues, thereby revealing the size of the protein product and changes in gel 
migration due to post-translational modifications (e.g. phosphorylation) or protein 
complexing.
As this gene has been isolated as a result of a transgene insertion event 
resulting in sex-linked cleft palate, then it may be expected to be expressed at high 
levels during palatogenesis. Alternatively, since other phenotypes were observed in 
the transgenic mutant mouse, (e.g. the spinal deformities and general skeletal defects) 
it may suggest that this gene may be of more importance in bone or extracellular 
matrix formation. This hypothesis is supported by the observation that the gene(s) 
expression is readily detected in embryonic body RNA samples. There is no reason 
to suggest that this gene does not have a role in palatogenesis but clearly it could 
have a wider role in development and post-natal viability. These expression studies 
coupled with the sequence analysis will help aid our understanding of the structure 
and function of the gene.
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3.5.3 R^eneration of the transgenic mouse exhibiting sex-linked cleft palate
However, to fully understand the phenotype observed in the transgenic 
mutant will require the extension of the above analyses to the transgenic mutant. 
Unfortunately the transgenic line that exhibited the mutant phenotype became extinct 
and so this study cannot be carried out in the original line. However, as mentioned 
earlier the transgenic line is being recreated. This is being achieved using 
homologous recombination in embryonic stem cells. Several new lines are being 
generated. One of these will be the regeneration of the original transgenic line 
containing the LMP-1 transgene at the same site of transgene insertion. A second line 
will be generated without the LMP-1 but still disrupting the locus in order to address 
the contribution (if any) of the LMP to the final phenotype. The final transgenic 
mutant that is planned is the targeted disruption of one of the exons identified from 
this locus. This will specifically address the role of the suspected gene in the 
phenotype.
The regeneration of new transgenic mice should unravel the role of the 
transgene insertion in the mutant phenotype. By the time that the transgenic mouse is 
regenerated the wild type gene(s) will already be well characterised and there will be 
numerous probes and antisera available for a study of the gene’s expression in the 
mutant line. As a potential second messenger (CaM kinase), the chain of signals 
involved in the morphogenic processes affected by this gene can be begun to be 
elucidated. The isolation of the gene(s) from this locus and the information gained 
from analysis of the wild type and mutated locus will allow an insight into the action 
of a developmentally important gene(s).
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4 MATERIALS AND METHODS 
4.1.1 Bacterial and bacteriophage culture
All of the strains of Escherichia coli and bacteriophage K used were 
obtained from Stratagene. The genotytpes of the strains used are given in the 
Stratagene manual along with maps of the phage used. All of the basic techniques 
used for bacterial and bacteriophage growth, plating, purification and titration are 
given in Current Protocols Vols 1 & 2. E.coli XLl-Blue (Stratagene) was routinely 
used for the propogation of plasmids and grown in L-broth with out any antibiotic 
present. To ensure the maintenance of the F episome in XLl-Blue bacteria, they 
were plated on LB agar supplemented with 25pg/ml tetracycline. The plasmid 
pBluescript (Stratagene) was used for the subcloning of DNA fragments. E.coli 
transformed to ampicillin resistance were grown in L-broth supplemented with 
50pg/ml ampicillin or 50pg/ml carbenicillin ( a more stable form of ampicillin ).
E.coli strains SRB, SRB(P2), XLl-B MRA and XLl-B MRA(P2) (all 
obtained from Stratagene) used in bacteriophage X related procedures, were grown in 
L-broth supplemented with 0.2% maltose and lOmM MgCla (LBMM).
4.1.2 Plasmid transformation of E,coli XLl-Blue
E.coli XLl-Blue were made competent for DNA transformation, starting 
from 1ml of a saturated overnight culture used to innocculate 100ml of of prewarmed 
2YT broth. The bacteria were grown to an absorbance at 600nm of 0.4 
(approximately 2 hours). The culture was cooled on ice and pelleted at 4,00% /  5 
minutes /  4°C. The bacterial pellet was gently resuspended in 50ml of ice cold 
50mM CaCl2  and left on ice for 20-30 minutes. The cells were then repelleted at 
4,000^ /  4°C / 5 minutes and resuspended in 2.5ml of ice cold 50mM CaClg for at 
least 1 hour ( cells made competent in this way remained competent for up to 24 
hours as long as they were stored in an ice bath). For each transformation, 200p,l of
181
competent cells were transformed with no more than lOOng of plasmid DNA in a 
maximum volume of SOpL This was incubated on ice for a further 20 minutes, then 
heat shocked at 42°C for 90 seconds and returned to ice for a further 2 minutes. The 
transformed cells were added to 800p,l of pre-warmed L-broth and incubated at 37<^ C 
for 50 minutes prior to plating on L-broth, 1.1% agar, plates (containing the 
appropriate antibiotic).
These plates also contained the lacZ transcription inducer 
isopropylthiogalactoside (IPTG) and a chromogenic substrate of (3-galactosidase, 5- 
bromo-4-chloro- 3 -inodyl- (3-galactosidase (Xgal) which allowed for the identification 
of non-recombinant plasmids. The plasmid pBluescript contains the lacZ gene which 
allows for the colour selection of recombinant plasmids. The presence of a ligated 
DNA molecule in the plasmid disrupts the lacZ gene and hence recombinant 
plasmids produce colourless colonies. Non-recombinant plasmids produce a blue 
colour as the lacZ gene present in the pBluescript plasmid remains intact.
To produce competent cells for storage at -70®C (for up to 3 months) a few 
drops of saturated overnight culture were grown in 5ml of L-broth to an absorbance 
at 600nm of 0.3. The 5ml of culture was then added to 100ml of L-broth and grown 
to an absorbance at 600nm of 0.48. The culture was cooled on ice, pelleted at 4,00% 
/  5minutes /  4°C and gently resuspended in 40ml of ice cold Tfbl [ 30mM KOAc, 
lOOmM RbCl2 , lOmM CaCl2, 50mM MnCl2 , 15% (v/v) glycerol; pH / 0.2M acetic 
acid / 5.8 ], incubated on ice for 5 minutes, then repelleted. This pellet was 
resuspended in 4ml of Tfbll [ lOmM MOPS-acid, 75mM CaCl2 , lOmM RbCl2 , 15% 
(v/v) glycerol; pH / KOH / 6.5 ] and 200|il aliquots snap frozen on dry ice. Prior to 
transformation the aliquot is gently thawed and stored on ice for 10 minutes, then 
transformed as detailed above.
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4.2 MOLECULAR CLONING AND MANIPULATION OF DNA
For the precipitation of nucleic acid, in the absence of any salt in the
solution, NaOAc ( pH5.5) was added to a final concentration of 0.3M. The DNA or 
RNA was precipitated by the addition of an equal volume of isopropanol or 2X the 
volume of ethanol, at -20^0 or on dry ice for fast precipitation. All collected 
precipitates were washed with 70% ethanol to remove excess salts and DNA pellets 
dried under vacuum, before resuspending in the appropriate volume.
4.2.1 Small scale preparation of plasmid DNA
One method was generally used (modified from: Bimboim and Doly, 1979). 
From overnight, saturated bacterial cultures, 1.5ml of each was microfuged in 
Eppendorf tubes for 2 minutes. The pellets were resupended by vortexing in 100(il of 
solution I [ 25mM Tris-HCl pHS, lOmM EDTA-NaOH pH7,5, 50mM glucose, 
Img/ml lysozyme (freshly added)]. 200pl of solution II [ 200mM NaOH, 1% (w/v) 
SDS (freshly made)] was then added to each, mixed gently by inverting the tube 
several times and the samples immediately placed on ice for 5 minutes. Following 
lysis, the samples were neutralised by the addition of 150pl solution III [5M KOAc 
pH4.8] and incubated on ice for 5 minutes. The flocculated mixtures were 
microfuged for 5 minutes and the supernatants transferred to new Eppendorf tubes. 
Each sample then underwent a protein extraction, by the addition of an equal volume 
of 2FC, vortexing, microfuging for 10 minutes and transfer of the overlying aqueous 
phase to new tubes, followed by an extraction using chloroform as the organic phase 
solvent. The plasmids were precipitated at room temperature for 2 minutes with the 
addition of 700pl of ethanol. The precipitates were collected by microfuging for 15 
minutes. Each pellet was washed with 70% ethanol and microfuged for 10 minutes. 
The precipitates were air dried at room temperature and resuspended in 50ml of TE,
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sufficient for 5-6 enzyme digests, with the simultaneous addition of RNase A to 
50pg/ml.
4.2.2 Large scale preparation of plasmid DNA
Relatively large quantities of very pure plasmid DNA (lOOpg) were 
prepared using Qiagen Columns (following the Manufacturers instructions) as this 
did not necessitate ultracentrifuging and was less time consuming. When very large 
quantities of highly pure plasmid DNA were required then plasmid DNA was 
prepared by caesium chloride continuous gradient centrtifugation (described by 
Maniatis et a l , 1982 ). A 30ml culture of the E.coli carrying the plasmid of interest 
was grown to an OD at 600nm of 0.6 (late log phase). 25ml of this culture was then 
used to innocculate 500ml of L-broth in a 2L flask. The culture was incubated for 2.5 
hours at 37^0 to an OD at 600nm of 0.4. The bacteria were pelleted at 4,000^ /  15 
minutes /  4°C. The cells were lysed by a scaled up version of the alkaline lysis 
detailed above.
Briefly the bacterial pellet was resuspended in 18ml of solution I, and 40ml 
of freshly prepared solution II added to this. After mixing the contents by gently 
inverting the tube several times the solution was stored at room temperature for 10 
minutes. 20ml of ice cold solution BI was added, the contents mixed by shaking and 
the tube stored on ice for 10 minutes. The bacterial lysate was centrifuged at 5,00% /  
15 minutes /  4°C to pellet the debris. The supernatant was carefully transfered to a 
250ml bottle and the plasmid DNA precipitated with the addition of 0.6 volume of 
isopropanol and incubation for 10 minutes at room temperature. The plasmid DNA 
was collected by centrifugation at 5,000^ / ISminutes / 4°C, washed with 70% 
ethanol and air dried. The pellet was resuspended in 3ml of TE (pH8).
The plasmid DNA was purified by equilibrium centrifugation in a 
continuous caesium chloride (CsCl)-ethidium bromide gradient. For every millilitre 
of DNA solution Ig of solid CsCl was added and dissolved. 0.8ml of ethidium 
bromide (lOmg/ml in water) was added for every 10ml of the DNA / CsCl solution
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and immediately mixed. The density of the resulting solution should be 1.55g/ml and 
was checked by removing 1ml of solution and weighing it. The solution was 
transfered to a Beckman Quick-Seal tube suitable for centrifugation in a Beckman 
vertical Ti65 rotor. The remainder of the tube was filled with paraffin oil. The density 
gradients were then centrifuged at 45,000rpm for 16 hours.
Two bands were routinely observed in the tube after centrifugation. The 
upper band consisted of linear bacterial chromosomal DNA and nicked circular 
plasmid DNA, the lower band consisted of closed circular plasmid DNA. The lower
band was collected with a hypodermic needle and the ethidium bromide extracted
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with 1-butanol. The DNA was pelleted by adding 3 volumes of water to the DNA
solution followed by 2  volumes of ethanol (this prevents the co-precipitation of
CsCl), incubation at 4®C for 15 minutes and centrifugation at 10,00% / 10 minutes /
4®C. The pelleted DNA was washed with 70% ethanol, resuspended in 1ml of TE 
(pH8 ), absorbance measured at 260nm and stored in aliquots (in 2  volumes of ethanol 
at -2 0 OC).
4.2.3 Small scale preparation of bacteriophage X DNA
Phage plaques required for DNA isolation, were picked in agar plugs ( from 
overnight, bacterial lawn infections grown on BBL, 0.7% agarose) and placed 
(separately) into 1ml SM buffer in 1.5ml Eppendorf tubes. These were stored at 4°C 
overnight, with shaking to facilitate phage release. Three dilutions of each phage 
suspension, (1 ,10"l, 1 0 "^  in 1ml SM buffer) were incubated with 200pl of saturated 
E. coli XLl-Blue MR culture, for 30 minutes at 37^ C and then transfered to 50ml of 
LB medium (0.2% maltose, lOmM MgSO )^ for overnight growth at 37°C. The 
dilution from each phage which produced the best bacterial lysis was used for DNA 
preparation. Alternatively, a phage plate stock in SM buffer was used.
The cultures for DNA preparation were cleared of intact bacterial cells, by 
the addition of a few drops of chloroform and vigorous shaking for 15 minutes. 40ml 
of each lysate was placed in a corex tube and centrifuged at 10,000^ / 4<>C /  10
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minutes. The supernatant was transfered to a fresh 40ml tube and incubated with 
RNase A (Ipg/ml) and DNase 1 (20p.g/ml) at 37°C for 30 minutes. The phage 
particles were pelleted by centrifugation at 45,00%/ 4°C / 2 hours and resuspended in 
0.5ml of SM buffer. The phage were lysed by the addition of 5pl 10% SDS and 25\il 
0.5M EDTA-NaOH pHS, and incubation at 6 8 °C for 15 minutes. Phage proteins and 
any residual bacterial proteins were extracted by addition of an equal volume of 2FC 
and subsequently extracted with an equal volume of chloroform. The phage DNA 
was precipitated with 2X volumes of ethanol, washed with 70% ethanol several times 
and resuspended in 50pl TE.
Large scale preparations of bacteriophage X FIXII (Stratagene) were 
attempted using the protocols described by Maniatis et al, (1982) and those found in 
Current Protocols Vols 1 & 2 (1992).
4.2.4 Preparation of high molecular weight DNA
High molecular weight mouse DNA was prepared from adult mouse brains 
using a variation of the procedure described by Blattner et a l (1978). Mouse brains 
(either fresh or stored at -70°C) were placed in a 2ml Nunc screw cap tube, chopped 
into smaller pieces using a scalpel blade and 1ml of Tail solution added [50mM Tris 
(pH8.0), lOOmM EDTA (pH8.0), lOOmM NaCl, 1% SDS]. The brain tissue m tail 
solution was incubated at 55°C overnight with gentle shaking. The lysed tissue cells 
were protein extracted twice with 2FC and then with chloroform. The DNA was 
collected by precipitation with IX volume ethanol, washed several times with 70% 
ethanol and pelleted by centrifugation in a microfuge 5, 00% /  4°C /  2 minutes. The 
DNA pellet was air dried and resuspended in 315 |il of TE and stored at 4°C.
4.2.5 DNA quantition, restriction and electrophoresis
DNA was quantitated by determining the absorbance, of dilutions from 
stocks, at 260nm (1=> 50mg/ml DNA). Digestion buffers and temperatures for DNA 
restriction endonucleases were formulated as recommended by the manufacturers.
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When cleaving small quantities of cloned DNAs, the typical total used was 20\xl, 
using 3 units of enzyme/pg DNA. To avoid shearing of cellular DNAs, the buffers 
and enzymes were initially mixed in gently and the samples incubated at the required 
temperature (37<>C for most enzymes) for 3-16 hours. Following which, more enzyme 
was added, vigorously mixed and incubated for another 2 hours. 20-30pl of digested 
DNA samples were routinely used for agarose gel electrophoresis.
300ml (maxi) or 100ml (midi) agarose gels were made in the range of 0.3- 
2.5% agarose (depending on the size of the fragments under analysis). The gels were 
run in horizontal electrophoresis chambers in either IX TAE or IX TBE running 
buffer. The running buffer chosen depended on the size of the fragments to be 
electrophoresed, IX TAE was routinely used with lager fragments (> Ikb), while IX 
TBE was used with smaller fragments (< Ikb). DNA was visualised under long wave 
(280nm) ultraviolet light after staining the gels with ethidium bromide (0.5pg/ml). 
Samples were loaded following the addition of 0.1 X the volume of loading buffer [ 
50mM EDTA-NaOH pH7.6, 20% (w/v) ficoll, 0.05% (w/v) bromophenol blue, 
0.05% (w/v) xylene cyanoll ]. The gels were run between 20-150 Volts for 1-16 
hours.
4.2.6 Isolation of specific DNA fragments and ligation
Specific DNA fragments were isolated in one of two ways. [A] The 
restricted samples were run in agarose gels made with low melting point agarose in 
TBE. As this does not give very good DNA band resolution, it was only used for 
non-complex DNA digestion products. The DNA fragment is excised in as small a 
volume of agarose as is possible, melted at 70°C and the desired proportion used 
directly for ligation. Other DNAs for the ligation were added at 70°C and on cooling 
to 37°C (at which temperature the agarose has still not set), the ligation buffers and 
enzyme were added and mixed quickly. Contrary to interfering with the ligation 
reaction, the solidified agarose acts to reduce the effective reaction volume and 
enhances the speed and frequency of ligations.
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[B] An efficient method for purifying DNA fragments was achieved with 
the use of DNA binding DEAE paper ( NA45 ). A small piece of the paper was 
inserted into a cut in the gel, made in front of the desired DNA fragment. Another 
was inserted behind it, to prevent contamination with more slowly migrating DNA 
fragments. Continued running of the gel electrophoresed the DNA onto the paper 
(allowed binding, as monitorred under UV light). The paper was rinsed in TE and the 
DNA eluted with two 15 minute incubations in 250ml IM NaCl at 70°C. The eluates 
were pooled and extracted with 2FC and chloroform and the DNA, ethanol 
precipitated and dissolved in TE.
Ligations of more than one DNA species were performed in small volumes 
(10\xl for a usual total DNA content of Ipig), with larger volumes used for the simple 
circular closing of DNA linears. The DNA ratios generally used werel:10 for 
plasmid vector:insert and 2:1 for X DNA arms:genomic DNA inserts. Restricted 
vector DNAs were generally treated with alkaline phosphatase ( to prevent self 
ligation ) prior to the ligation reaction with insert DNA. The samples were incubated 
at 12«C in ligation buffer [ lOmM Tris-HCl pH7.5, lOmM MgClz, 6 mM KCl, ImM 
dithiothreitol (DIT) and ligation additions [ ImM spermidine (plus Tris-acid to pH7 
), ImM ATP ( plus NH4 OH to pH7 ), lOmM DTP O.lmg/ml BSA ], with the quantity 
of T4 ligase recommended by the manufacturer (Promega),
PCR products were cloned into the TA cloning vector (Invitrogen), this 
vector takes takes advantage of the non-template-dependent activity of the 
thermostable polymerases used in PCR that add a single deoxyadenosine to the 3' 
ends of duplex molecules. The 3' overhangs are used to insert the PCR product into 
the vector which contains single 3' T-overhangs at its insertion site. The protocols 
supplied by the manufaturer for the TA vector were followed for cloning PCR 
products.
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4.2.7 Southern blotting of DNA and specific fragment detection
DNA in agarose gels was denatured in 500ml of denaturing buffer [ 1.5M 
NaCl, 0.5M NaOH ] until the bromophenol blue marker band appeared green 
(approximately 45 minutes). The gels were then washed in 0.5X TAE for 
electroblotting for 45 minutes. The gels were electroblotted onto Nylon membranes 
in 0.5X TAE using a constant voltage electroblotter (Hoeffer) at 40 volts for 3-4 
hours. The nylon filters were then baked at 80«C for 2 hours and then UV crosslinked 
for 90 seconds.
The filters were prehybridised within pyrex hybridisation tubes in a Hybaid 
Hybridisation Oven in IX Church buffer [ 7% (w/v) SDS, 1% (w/v) BSA, ImM 
EDTA, 0.25M NazHPO  ^HgO (pH7.2)] at 6 8 «C for 3-16 hours. Hybridisations were 
performed in IX Church buffer (generally 8 -10ml per filter) at the required 
temperature (50°C-68°C) for 16-20 hours. Random primed probes were used at a 
final concentration of 10^  d.p.m./ml. The filters were washed twice for 20 minutes at 
room temperature in a low stringency wash [IX SSC, 0.1% (w/v) SDS] and then at 
6 8 °C for 1 hour in a high stringency wash [O.IX SSC, 0.1 (w/v) SDS]. Filters were 
exposed to Kodak XAR5 film at -70°C, using intensifying screens.
4.2.8 Preparation of 32p labelled DNA probes
Hybridisation probes for all the blot analyses (nylon and nitrocellulose) 
were labelled by the random oligonucleotide-primed method (detailed in Current 
Protocols Vol 1) using the Klenow fragment of Escherichia coli DNA Polymerase I. 
Either 50pCi of (a-32p)-dCTP or (oc-32p)-dATP (3000Ci/mmol) were routinely used 
to label 50ng of probe material. Specific activities of 5 X lO^d.p.m. (per pg DNA) 
were routinely obtained. Unincorporated nucleotides were removed over G75 
Sephadex, disposable plastic columns, using IX STE buffer [ lOmM Tris.HCL,
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pH7.5, lOmM NaCl, ImM EDTA]. The second column peak (representing the probe 
DNA) was collected and used directly after boding for 10 minutes, or stored at -20°C.
Probes made from DNA that contained repetitive sequences resulted in 
cross-hybridisation of signal on the blots. To overcome this cross-hybridisation the 
repetitive sequences were competed out using cold DNA. This method for 'quashing' 
repetitive sequence was obtained from George Starks lab ICRF, London. DNA 
probes were generated via the random oligonucleotide-primed method, the volume of 
the probe was adjusted to lOOpl TE, then 100-200pg of competitor DNA (same 
species as probe, sonicated to approximately 200-500bp, free of RNA) was added. 
The volume was adjusted to 176pl with TE pH8  and then boiled for 10 minutes. 
Immediately 24pl of IM sodium phosphate was added and the boiled probe placed in 
a pre-warmed container (lead pot) in a 65°C oven for 2 hours. After the 2 hours the 
probe was used directly for hybridisation, as before.
4.2.9 cDNA probes for Reverse Northern analysis
The generation of cDNA probes for use in Reverse Northern analysis is 
basically first strand cDNA synthesis. In this protocol the first strand cDNA synthesis 
reaction is catalysed by SUPERSCRIPT H RNase H" Reverse Transcriptase (RT)™ 
obtained from Gibco BRL. This enzyme has been engineered to eliminate the RNase 
H activity that degrades the mRNA during the first strand reaction. SUPERSCRIPT 
n RT^ M is not inhibited significantly by ribosomal and transfer RNA and can be used 
effectively to synthesize first strand cDNA from a total RNA preparation.
lOng of oligo dT was added to 5pg of total cellular RNA in a final volume 
of 5pl. This was heated at 70®C for 5 minutes and then chilled on ice. 4pl of 5X 
synthesis buffer [200mM Tris-HCl (pH8.4), 500mM KCl, 25mM MgClg, Ipg/pl 
BSA], 2|uil of O.IM DTT, Ipl of dNTPs [ lOmM dATP, lOmM dGTP, lOmM dlTP], 
7pl of a32p dCTP (800Ci/mMol) and Ipl (200 units ) SUPERSCRIPT II RT were 
then added and the reaction mix incubated at 42®C for 90 minutes. This reaction was 
chased by the addition of 4pl of the follollowing premix [ 2pl 5X synthesis buffer.
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2.5[xl lOmM dCTP cold nucleotide, 4.5p,l RNase free water, Ipl (200 units) 
SUPERSCRIPT II RT] and a further incubation at 45®C for 90 minutes. The reaction 
was terminated by incubation at 70°C for 15 minutes. To remove the RNA template 
Ipl (2 units) of RNase H was added and incubated at 37°C for 20 minutes. The 
probes were seperated over G75 Sephadex columns. As the probes are single 
stranded there is no need to boil the probes prior to hybridisation.
4.2.10 End labelling and hybridisation of oligonucleotide probes
Oligonucleotide primers, to the 5' and 3' ends of trapped-exons that had 
been designed for PCR, were radio-labelled and used as probes on Southern and 
Northern blots in an attempt to detect if their sequences were present in mouse 
genomic DNA and RNA transcripts from mouse embryos. A polynucleotide kinase 
(PNK) labelling reaction was set up using fresh [y^^pjATP to label the 
oligonucleotides. lOpmoles of oligonucleotide were incubated in IX T4 
polynucleotide kinase buffer [ 50mM Tris-HCl (pH7.5), ImM MgCla, lOOpM DTT ] 
for 30 minutes at 37°C. Labelling reactions were incubated at 65°C to inactivate the 
kinase and unincorporated counts removed by passing the labelling reactions over a 
G-50 column. Filters to be probed with radio-labelled oligonucleotides were 
prehybridised at 65°C [ prehybridisation buffer; 6 X SSC, 20mM NaH2 P0 4 , 0.4% 
SDS, 5X Denhardts and denatured, sonicated salmon sperm DNA (500pg/ml) ]. The 
labelled oligonucleotides were hybridised overnight at 5-10°C below the Tm of the 
oligos in hybridisation buffer [ 6 X SSC, 20mM NaH2P04, 0.4% SDS, denatured, 
sonicated salmon sperm DNA, boiled prior to addition to hybridisation buffer 
(500pg/ml) ]. The filters were washed in 6 X SSC, 0.1% SDS at Tm -lO^C until the 
background had diminished. Filters were then exposed to Kodak XAR film overnight 
at -70°C, with an intensifying screen.
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4.2.11 Screening of libraries, clone purification and subcloning
A X Fix II Library was purchased from Stratagene. It had been constructed 
from size selected cellular DNA from the spleen of an adult female C57Black/6 
mouse. The recombinant DNA library was titrated on Exoli XLl-Blue MRA (P2). 
Four bioassay plates were plated with 20,000 recombinants per plate (in E.coli XLl- 
Blue MRA (P2)). Duplicate phage DNA lifts with nitrocellulose were taken from 
each plate. The filters were soaked in denaturing solution [ 1.5M NaCl, 0.5M NaOH ] 
for 2 minutes and then in neutralising solution [ 1.5M NaCl, 0.5M Tris-HCl pH 8.0] 
for 5 minutes, then soaked in rinse [2X SSC, 0.2M Tris-HCl pH7.5] for 30 seconds 
and air dried. Following baking (80°C for 2 hours under vacuum), these filters were 
prehybridised, hybridised and washed as described for Southern blots. Positive 
plaques were picked, plated and rescreened at least twice before DNA was prepared 
from the phage for subcloning and subsequent analysis.
DNA was prepared from positive phage and used for restriction mapping of 
the isolated DNA. The DNA was then digested with EcoR I and the EcoR I fragments 
were ligated into the EcoR I site of pBluescript. These plasmids were then used to 
prepare large quantities of the isolated DNA for subsequent analysis as described in 
Results section 2.
This procedure of screening was repeated for the cDNA and SauSA I size 
selected genomic DNA libraries also used during the project. The construction of 
these libraries is detailed below.
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4.3 ISOLATION AND CHARACTERISATION OF CELLULAR RNA
To avoid the introduction of ribonucleases, during the isolation and 
manipulation of RNA, all solutions and equipment which came in direct contact with 
the RNA, was autoclaved prior to use. All reagents were kept RNase free during all 
of the procedures.
4.3.1 Large scale isolation of total cellular RNA
Tissue samples were obtained fresh or from -70°C and placed in solution D 
[ 0.36ml 2X p-Mercaptoethanol 50ml guanidinum thiocyanate stock], 1ml solution 
D/lOOmg of tissue, and homogenised using a polytron. A 0.1 volume of 2M NaOAc, 
pH4.0, was added to the homogenised tissue and mixed vigorously. An equal volume 
of water saturated pure phenol was then added and mixed. To this was then added a 
0.2 volume of chloroformrisoamyl alcohol (49:1), This was vortexed for 15 seconds 
and placed on ice for 15 minutes. RNA was seperated by centrifugation at 10,000^ /  
20 minutes / 4°C in a Beckman JA20 rotor. The aqueous phase was transfered to a 
fresh tube and the RNA was precipitated by the addition of an equal volume of 
isopropanol and incubation at -20'^ C for at least 1 hour. The RNA was collected by 
centrifugation in a Beckman JA20 rotor at 10,000^ / 20 minutes /  4°C. The peUet was 
aspirated, resuspended in 300p^ l of solution D and transfered to an Eppendorff tube. 
The RNA was precipitated with 2X volumes of ethanol at -20°C for at least 1 hour, 
spun at 14,000^ in a microfuge, washed twice with 75% ethanol, air dried and 
resuspended in an appropriate volume of TE buffer containing 0.1% SDS (w/v) 
before storage at -20^C. An absorbance of 1 at 260nm, for RNA in solution, is 
equivalent to 40jAg/ml RNA.
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4.3.2 Selection of polyadenylated RNA
Polyadenylated (poly[A]+) RNA was purified by chromotography on oligo 
dT cellulose, by the manufacturers recommended procedure. This involves the 
binding of the poly [A] + fraction of total RNA to a 0.5ml (dry volume) cellulose 
column, in a high salt (500mM NaCl) buffer (flow through being the poly [A]" 
fraction), washing at mid-salt concentrations (lOOmM NaCl) and poly [A] + RNA 
elution in a salt free buffer (all buffers containing 0,1% (w/v) SDS). The poly [A]+ 
and poly [A]' fractions were ethanol precipitated, quantitated and stored as given 
before. In general lOOpg of poly[A]+ RNA was obtained per mg of total cellular 
RNA.
4.3.3 Formaldehyde agarose gel electrophoresis of RNA, Northern blotting 
and detection of specific RNAs
The procedure was modified from that presented by Maniatis et al (1982). 
For this procedure 100ml or 300ml (final volume) gels were made, containing 1% 
(w/v) agarose in MOPS electrophoresis buffer (MOPS-E). The agarose was melted in 
the buffer and cooled to 60°C, before the addition of 17.8% (v/v) formaldehyde and 
the addition of water to the final volume for pouring. lOpg of RNA from each 
sample, was ethanol precipitated and washed with 75% ethanol. This was then dried 
under vacuum and the RNA dissolved in 4[il of water, to this was added 16pl of 
loading buffer [IX MOPS-E, 50% (v/v) formamide, 17,8% (v/v) stock formaldehyde 
solution] with an addition of 2pl per sample of ficoll loading buffer. Each gel also 
included an RNA size ladder (GibcoBRL). Gels were electrophoresed in IX MOPS- 
E at 50mA until the bromophenol-blue had run 2/3 of the way to the end. The gels 
were run in continuously circulated running buffer.
After electrophoresis the gels were rinsed three times in 500ml of 0.5X TAE 
(each wash lasting 15 minutes), the last wash contained 50pg of ethidium bromide 
(15mg/ml) to visualise the RNA size markers and the ribosomal RNA bands. The
194
RNA was electroblotted on to nylon membranes at 40 Volts for 3-4 hours, the filters 
were then baked at 80®C for 2 hours and then UV crosslinked. Prehybridisation, 
probe hybridisation and filter washing was performed in exactly the same way as for 
Southern blotting and to the same stringency.
4.4 EXON-TRAPPING PROTOCOLS
4.4.1 Subcloning of isolated DNA:
Isolated phage DNA was digested with EcoR L The pSPL3 vector was also 
digested with EcoR I and calf intestinal alkaline phosphatase added to the linearized 
vector after the enzyme restriction reaction. The digested phage DNA and vector 
DNA were purified by one phenol:chloroform:isoamyl alcohol (25:24:1) extraction. 
The aqueous phase was transferred to a separate microcentrifuge tube and 
precipitated with 0.5 volumes of 7.5 M ammonium acetate and 2 volumes of absolute 
ethanol. This was mixed and held at -70°C for at least 30 minutes. The DNA was 
pelleted by centrifugation at 14,000^ for 15 minutes at 4°C, washed with 70% 
ethanol and dried at 37°C for at least 10 minutes. The DNA was resuspended in TE 
buffer to a concentration of 0.25pg/pl.
O.Spg of EcoR I restriction digested phage DNA was ligated to the EcoR I 
site of the pSPL3 vector (0.25p.g) by incubation with 1 unit of T4 DNA ligase in IX 
ligase buffer at 14°C for at least 16 hours. This ligation mixture was used to 
transform XLl-Blue E.coli made competent by the calcium chloride method. 10% of 
the transformation was plated on medium containing lOOpg/pl of carbenicillin. The 
remainder of the transformation was used to inoculate a lOX volume of selective 
liquid medium.
The colonies from the platings were counted and if the non-recombinant 
frequency was less than 10% plasmid DNA was isolated from the liquid culture. 
Individual colonies were screened for inserts by inoculating 3ml of liquid medium 
with individual colonies and preparing plasmid DNA using the alkaline lysis mini-
195
prep procedure. The mini-prep DNA was analysed by restriction digestion with EcoR 
I and agarose gel electrophoresis of products. Plasmid DNA was prepared from the 
liquid culture using a Qiagen column.
4.4.2 Transfection of COS-7 cells
COS-7 cells are African-green-monkey kidney cells that have been 
transformed by a derivative of SV40 and were obtained from the European Cell 
Culture. These lines were maintained in D-MEM supplemented with 10% fetal 
bovine serum (FBS), glutamine, nonessential amino acids, penicillin, and 
streptomycin (for the recipe see Solutions). The recombinant plasmid DNA was used 
to transfect these COS-7 cells using the transfection reagent DOTAP (Boehringer 
Mannheim).
The COS-7 cells were passaged one day prior to transfection by placing 4 x 
1 0  ^cells into 2ml of supplemented D-MEM in 3.5-cm, 6 -well dishes. Transfections 
were performed the following day when the cells were 60-80% confluent. For each 
transfection 20pl of the transfection-reagent (Img/ml) was diluted to 70p,l with HBS 
[Hepes 20mmol/l, NaCl 150mmol/l (pH7.4)] in a polystyrene reaction vial. Ipig of 
plasmid DNA was diluted to 70p.l in HBS in a separate polystyrene vial. The two 
solutions were combined, mixed gently and held at room temperature for 1 0  minutes. 
While this incubation was proceeding the COS-7 cells were prepared for transfection. 
The supplemented D-MEM was removed from the cells and 2ml of serum-free D- 
MEM medium added to each well. After the 10 minute incubation 0.8ml of serum- 
free D-MEM medium was added to the DNA/transfection-reagent mixture. The 
serum-free D-MEM was removed from each well and the combined 
DNA/transfection-reagent added to each well. The cells were incubated with the 
lipid-DNA complexes at 37^C in a 5% CO2  incubator overnight (never for more than 
24 hours). The DNA/transfection-reagent/medium mixture was removed by 
aspiration the following morning and replaced with 2ml of supplemented D-MEM.
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The cells were incubated for a further 24 hours at 37<^ C/5% CO2  before proceeding 
with RNA isolation.
4.4.3 Isolation of Total RNA
The medium was aspirated from the wells and the cells were lysed in the 
wells by the addition of 1ml of RNAzol™ B (Biogenesis Ltd) to each well. The cell 
lysate was passed through a pipette several times before being transfered to a RNase 
free Eppendorf tube. RNA was extracted by the addition of 0.1ml of chloroform per 
1ml of cell lysate, vortexed vigorously and then placed on ice for 5 minutes. The 
suspension was centrifuged at 12,000[g/15 minutes/4°C, the upper aqueous phase 
containing the RNA was transferred to a fresh tube. An equal volume of isopropanol 
was added and the samples stored at 4°C for 15 minutes, the samples were then 
centrifuged at 12,000^/10 minutes/4^C. The RNA pellets were washed with 1ml of 
75% ethanol vortexed vigorously and centrifuged at 7,500^/5 minutes/4°C. The 
pellets were air dried and resuspended in 50p,l of RNase free water, ready for use in 
cDNA synthesis.
4.4.4 cDNA synthesis
The cDNA synthesis reaction is catalyzed by SUPERSCRIPT II RNase H" 
Reverse Transcriptase (Gibco BRL). 3[ig of RNA isolated from the transfected cells 
was resuspended in a total volume of 12pil of RNase free water, to this was added 
l(ag of SA2 oligonucleotide. This mixture was incubated at 70^C for 10 minutes, 
chilled on ice for 1  minute and collected at the bottom of the tube by a brief 
centrifugation. To this mixture 4pl of 5X first strand buffer (250mM Tris-HCl 
(pH8.3), 375mM KCl, 15mM MgCla) was added, 2^ 1 of O.IM DTT and 1^ 1 of 
lOmM dNTP mix (lOmM dATP, dCTP, dGTP and dTTP (pH 7.0)). This was mixed 
gently and collected by a brief centrifugation. After an incubation at 42®C for 2
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minutes, 200 units of Reverse Transcriptase was added and the solution incubated at 
42^C for 30 minutes. This reaction was then transferred to a water bath at 55°C and 
incubated for 5 minutes before adding 2 Units of RNase H, the RNase H digestion 
was allowed to continue at 55°C. After a 10 minute incubation the reverse 
transcription reaction was collected by a brief centrifugation and placed on ice.
4.4.5 Primary PCR
The single stranded cDNA product was converted to double stranded DNA.
To a thin walled PCR tube 8 pl of the reverse transcription reaction was added, to this 
was added 4pl of lOX PCR buffer ( KCL 500mM, Tris-base lOOmM, MgCLg'tiHgO
15mM (pH8.4) ). 0.8fil of lOmM dNTP was added to the reaction followed by 20p.M
"I
of each of the primary PCR primers SA2 and SD6 , the total volume was brought to ■:r
39.5[al by the addition of 22.7 \il of water. The reaction mixture was incubated at 
95°C for 5 minutes before the addition of 2.5 units of Taq DNA polymerase. 6  cycles 
of PCR amplification were then carried out, each PCR cycle consisted of 1 minute at 
94°C, 1 minute at 60°C and 5 minutes at 70°C. After completion of the PCR cycles 
the reaction was incubated at 70°C for an additional 10 minutes and then held at 
55°C. A 20(xl aliquot of the reaction mixture was removed for analysis by agarose gel 
electrophoresis. To the remaining primary PCR reaction mixture 10 units of Bst XI 
was added and the restriction digest incubated overnight at 55°C. To ensure that 
digestion had gone to completion 4 units of Bst XI were added the following morning 
and the reaction incubated at 55°C for a further 2 hours.
4.4.6 Secondary PCR
5p,l of the digested primary PCR reaction was used for the second PCR 
amplification. This PCR amplification used the secondary primers, forward primer 
dUSD2;
5’(CTA)4GTGAACTGCACTGTGACAAGCTGCACGTGCTCTAGAGTCGACCC 
AGCA-3' and reverse primer dUSA4;
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5’(CTA)4CACCTGAGGAGTGAATTGGTCGAAATGGATCTGTCTCTGTCTCTC
TCTCCACCTTCTTCrrCTATTCCTTCCTTCGGGCCTGTCGGGTCCCCTCGGG
AGATCTCCAGG-3'
The secondary PCR reaction consisted of 5|j,l of Bst XI digested primary 
PCR product, 4.5pi of lOX PCR buffer, Ipl of lOmM dNTPs, Ipl of secondary PCR 
primers dUSA4 and dUSD2 (20pM) and 38pl of water. The secondary PCR mixture 
was incubated at 95°C for 5 minutes, after this incubation 2.5 units of Taq 
polymerase were added to the PCR reaction. 25 amplification cycles were then 
performed, each cycle comprised 1 minute at 95°C, 1 minute at 60°C and 3 minutes 
at 72°C. After completion of the amplification cycles the reaction was held at 72°C 
for 10 minutes. Products were visualised by staining with ethidium bromide after 
electrophoresis in 2.0% agarose gels. The secondary PCR products were radio 
labelled by the random priming method and used to probe Southern blots of isolated 
phage DNA, Southern blots of mouse genomic DNA and Northern blots of mouse 
embiyonic total RNA
4.4.7 Cloning and identification of secondaiy PCR products
The primers used in the secondary PCR contain uracil residues. Treatment 
of the secondary PCR products with uracil DNA glycosylase (UDG) removes the 
uracil residues allowing the products to be subcloned into the UDG cloning vector 
(Gibco BRL) at high efficiency. The cloning reaction was carried out in a volume of 
10|xl at 37°C for 30 minutes. The reaction was composed of lOOng of secondary PCR 
product, 50ng of the UDG cloning vector (already linearised), l|4 l of lOX PCR 
buffer, 1 Unit of UDG and distilled water to lOpl, After incubation at 37°C for 30 
minutes, 5pl of the ligation mix was used to transform lOOpl of competent E. coli, 
XLl-Blue (prepared by the Calcium Chloride method). The transformed cells were 
plated on LB plates containing lOOpg/ml carbenicillin and incubated at 37°C 
overnight.
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Transformants were selected the following morning and evaluated using 
colony PCR. A portion of each colony was placed in a tube containing the following 
PCR mix, 20pM each of secondary amplification primers, Ipl of lOmM dNTP mix, 
5pl of lOX PCR mix, 2.5 Units of Taq DNA polymerase and the final volume made 
up to 50p,l with distilled water. The PCR reactions were placed in a thermocycler and 
held at 94°C for 5 minutes, then 30 cycles of PCR amplification were performed, 
each cycle comprised 45 seconds at 94°C, 30 seconds at 55°C and 1 minute at 72°C. 
The reactions were then incubated at 72°C for an additional 10 minutes and then held 
at 4°C. The products of this PCR were visualised by ethidium bromide staining after 
electrophoresis in 2 .0 % agarose gels.
4.5 Dideoxy sequencing
In the original dideoxy sequencing procedure, primer extension was 
catalyzed by the Klenow fragment of E, coli DNA polymerase I. T7 DNA 
polymerase has several advantages over Klenow fragment sequencing:
(i) with it’s processtivity and high rate of polymerisation, longer chain-terminated 
fragments can be generated very rapidily. This allows a greater length of sequence to 
be determined.
(ii) because of its tolerance for substrate analogues, the same set of sequencing 
mixes may be used with either 32p or 3%.
The major difference when using T7 DNA polymerase rather than Klenow 
fragment is that the primer-extension reactions are performed in two stages, a 
’labelling' reaction and a 'termination' reaction. The two stages are required because 
the enzyme uses dideoxy-nucleotides very readily. To permit synthesis of long chain- 
terminated fragments, dideoxynucleotides are therefore excluded during the first 
stage, then added for the second.
Dideoxy sequencing was carried out using double-stranded template, the 
concentration of template was adjusted so that 32pl contained 1.5-2pg of DNA. The 
double-stranded template was denatured by the addition of 8 ml of 2M NaOH,
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vortexed gently, centrifuged briefly and incubated at room temperature for 1 0  
minutes. The denatured DNA template was precipitated by the addition of 7pl of 3M 
sodium acetate (pH4.8), 4|il of distilled water and 120p,l of ethanol, mixed, and 
placed on dry ice for 15 minutes. The precipitated DNA was collected by the 
centrifuging for 15 minutes. The pellet was washed with ice-cold 75% ethanol, 
recentrifuged for 10 minutes, then dried briefly under vacuum. The DNA pellet was 
redissolved in 1 0 | ^ 1  of distilled water.
The concentration of the primers used for the primer extension reaction was 
adjusted to 2.5-5piM. The primer was annealed to the template DNA by the addition 
of 2pil of sequencing primer and 2pl of annealing buffer [ IM Tris-HCl (pH7.6), 
lOOmM MgCl2  and 160mM DTT ] to the resuspended denatured template. The 
template and primer mixture was mixed gently and incubated at 65°C for 5 
minutes.The annealing mixture was placed at 37°C for 10 minutes and then placed at 
room temperature for a further 10 minutes. To the tube containing the annealed 
template and primer, 3^ il of labelling mix [ 1.375mM each dCTP, dGTP and dTTP 
and 333.5mM NaCl ], Ijxl of [a-35S]dATPotS, l^il of T7 DNA polymerase, were 
added and incubated at room temperature for 5 minutes.
While the labelling reaction was in progress the four sequencing mixes were 
warmed at 37°C for at least 1 minute. After the labelling reaction had been incubated 
for 5 minutes, 4,5ml of this reaction was transfered into each of the four pre-warmed 
sequencing mixes. The components were gently mixed and incubated at 37°C for 5 
minutes. The sequencing reactions were stopped by the addition of 5ml of stop buffer 
[ 0.3% each Bromophenol Blue and Xylene Cyanol FF; lOmM EDTA (pH7.5) and 
97.5% (v/v) formamide ].
3^ 1 of each sample was run on a 6 % polyacrylamide, 7M urea gel that had 
been pre-run for 2 hours at 50mA in IX TBE. The samples were boiled, loaded 
quickly and electrophoresed for the required time (2-6 hours). More than one aliquot 
from each sample was run on a single gel for varying lengths of time maximising the 
amount of sequence information. After electrophoresis the gels were dried directly on
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to Whatmaim 3MM paper at 80°C under vacuum for 1 hour. The gels were exposed 
to Kodak XAR film at room temperature.
4.6 Polymerase Chain Reaction
Oligonucleotide primers were designed to the 5' and 3' ends of sequences 
that were to be amplified by PCR. They are listed below;
Exon p50; forward primer, 5’-GGAGCTAAAGGGATCTGC-3’ 
reverse primer, 5'-GAGACACGAGCTCGGGGG-3'
Exon p51; forward primer, 5 -CGAACACGAACTATAACTTTCTCG-3' 
reverse primer, 5'-CTCGCCTAGCAATACGGATG-3'
Exon p52; forward primer, 5'-GGGGATCGTTATGCCTAC-3’ 
reverse primer, 5 -CTCCTTGCATTGAATTTCCTC-3'
Exonp56; forward primer, 5 -CTCCTAAGATGGCAGCAACTC-3’ 
reverse primer, 5'-CAGATGGGTTCTAGAAGCC~3'
Exon p57; forward primer, 5'-GTGCAGTACTAGCTGCTG-3‘ 
reverse primer, 5 -GGAGGTAGGGTCTTCGGAG-3'
The conditions for the PCR were optimised by varying the Magnesium 
concentration in the reactions, the temperature of primer annealing, the quantity of 
primer required and the amount of template required. The Tm was calculated for 
each primer on the basis of the following equation;
7wi = 2°C(A + T)+4oC( G + C)
The basic PCR protocol involved incubation at 94°C for 5 minutes, followed 
by 30 cycles of a dénaturation step of 94°C for 1 minute, an annealling step of 40°C 
for 1 minute and an extension step of 60°C for 1 minute. This was followed by an 
incubation at 70°C for 10 minutes. Products of the PCR reaction were analysed by 
electrophoresis on agarose gels (as detailed earlier).
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4.7 RT-PCR
PCR was adapted to detect the presence of RNA transcripts expressed at 
very low levels and amplify them, allowing them to be subcloned and sequenced. The 
PCR was carried out on first strand cDNA synthesized from the RNA of choice. In 
this case day 13.5, day 15.5 and day 16.5 mouse embryonic total RNA was used as 
the template for reverse transcription.
The synthesis of cDNA was similar to the method given in the exon- 
trapping section. To ensure that there was no DNA contaminating the RNA, used as 
template for the cDNA synthesis, amplification grade DNase (RNase free) was used 
to digest any DNA present. 10 units of DNase were used for every p,g of RNA to be 
amplified and the reaction was carried out in IX cDNA synthesis buffer at room 
temperature for 15 minutes prior to cDNA synthesis. The DNase was inactivated by 
addition of EDTA (final cone 2mM) and incubation at 65°C. This mixture was used 
directly for cDNA synthesis. 0.5pg of oligo dTi2 -i8  was added to 5[ig of total RNA 
in a final volume of 13(0.1. This was heated at 70°C for 1 0  minutes and cooled on ice 
for 1 minute. To this was added 2|xl of lOX synthesis buffer [ 200mM Tris-HCl 
(pH8.4), 500mM KCl, 25mM MgCl2 , l|og/(ol BSA ], l^il of lOmM dNTPs, 2|ol of 
O.IM DTT and finally 200 units of SUPERSCRIPT II RT^ M. The reaction mixture 
was incubated at room temperature for 10 minutes, transfered to a 42°C water bath 
and incubated for a further 50 minutes. The reaction was terminated by incubating the 
reaction at 70°C for 10 minutes. The RNA template was removed by the addition of 2 
units of RNase H and an incubation of 20 minutes at 37°C. 2ml of this final reaction 
mix was used as cDNA template in a PCR reaction. The PCR comprised of the cycles 
already found to be optimal in the PCR from genomic DNA template (see PCR 
protocol above). For each RT-PCR a RNA only template control was included to 
ensure there was no contaminating DNA.
203
4.8 Size selection of SauSA I  restricted cellular DNAs and construction of 
partial libraries in bacteriophage X EMBL4
lOpg of cellular DNA was mixed with SauSA I restriction buffer in a final 
volume of 150pl, 30pil was dispensed into one tube and 15(il dispensed into tubes 2 - 8  
and the remainder into tube 9. All the tubes were placed on ice. 4 units of SauSA I 
was added to tube 1 and mixed. 15pl of the reaction was added to tube 2. The enzyme 
was mixed well, with the twofold dilution series continued through to tube 8  and 
nothing added to tube 9. Tubes 1-8 were then incubated at 37°C for 1 hour. The 
reactions were stopped by heating the restriction digests to 70°C for 10 minutes. The 
samples were then electrophoresed on a 0.7% agarose gel in IX TAE and DNA 
visualised by ethidium bromide staining and exposure to UV light. The amount of 
enzyme that results in the greatest intensity of fluoresence of DNA in the 9-20kb 
region was noted. To obtain the maximum number of molecules in this size range, 
half of the amount of enzyme that produces the maximum amount of fluoresence was 
used to produce partially digested DNA fragments for ligation into X EMBL4 arms.
Using the exact same enzyme concentration, time, temperature, and DNA 
concentration, found to be optimal in producing the greatest number of DNA 
fragments, ranging in size from 9-20kb, 500pg of high molecular weight cellular 
DNA from female mouse brain was digested with SauSA /. A small aliquot of this 
digest was analysed by electrophoresis to ensure that the size distribution of the 
digestion products was correct. The DNA was gently extracted twice with 2FC, then 
precipitated with ethanol and then washed with 70% ethanol. The DNA pellet was 
then resuspended in distilled water to a final concentration of 0.25pg/pl. 10(ig of size 
selected DNA was treated with calf intestinal alkaline phosphatase to prevent smaller 
DNA molecules forming mulitple inserts during the ligation reaction.
X EMBL4 arms, pre-digested with BamH /, were obtained from Stratagene 
and used to construct a library with the size selected SauSA I partially digested 
DNA. 0.3 pg of SauSA I digested cellular DNAwas ligated to Ipg of X EMBL4 /  
BamH I  arms in a final volume of 5pl. The ligation was incubated at 4°C overnight.
1
2 0 4
The ligation products were then packaged using Gigapack II XL Packaging Extract 
(Stratagene), which preferentially size selects for extra large inserts. For example, a 
20kb insert will be packaged with a 95% higher efficiency than a 14kb insert when 
using a Lambda replacement vector. The Ligated DNA was packaged following 
exactly the protocol supplied with the packaging extract and the resultant 
recombinant phage library were titred on XLl-Blue MRA (P2) as detailed earlier.
4.9 cDNA Library construction
Routinely cDNA synthesis was achieved using the SUPERSCRIPT II RT^ M 
(Gibco BRL), however, for the construction of a cDNA library first strand synthesis 
was catalyzed using the Moloney Murine Leukaemia Virus (MMLV) reverse 
transcriptase from Pharmacia. It was supplied with T im e S a v e r ^ M  cDNA Synthesis 
Kit. Briefly, Ipg of poly[A]+ RNA derived from the total RNA of a embryonic day 
16.5 mouse whole body was resuspended in a total volume of 20pi of RNase-free 
water. This RNA was then heated at 65°C for 10 minutes and then cooled on ice. Ipl 
of 200mM DTT and 0.5pg of oligo dTi2 _i8  were added to a first-strand reaction mix [ 
MMLV Reverse Transcriptase, RNAguard, RNase / DNase-free BSA, dATP, dCTP, 
dGTP, dTTP, in aqueous buffer, (the exact composition of the first-strand reaction 
mix was unknown) ], then the heat denatured RNA. After gentle mixing the reaction 
was incubated at 37°C for 1 hour. The first strand reaction was then added to a 
second strand reaction mix {E.coli RNase H andÆco/f DNA polymerase I in aqueous 
buffer, (again, the exact composition of the second strand reaction mix was 
unknown) ], this reaction was then incubated at 12°C for 30 minutes and followed by 
22° C for 1 hour. The reaction was heated at 65°C for 10 minutes and then extracted 
with lOOpl of 2FC. The upper aqueous layer was then passed over a Sepharose CL- 
4B column prepared in ligation buffer [ 6 6 mM Tris-HCl (pH7.6), O.lmM spermidine, 
6 .6 mM MgCl2 , lOmM DTT, 150mM NaCl ] (following the manufacturers 
instructions), and the column effluent used directly for the addition of EcoR I /  Not /  
adaptors.
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Ipl of EcoR I ! Not I adaptor solution, 30pl of PEG buffer, Ipl of 15mM 
ATP, and 2 units of T4 DNA ligase was added to the lOOpl of column effluent, 
mixed gently and then incubated at 16°C for 1 hour. The reaction was heated at 65°C 
for 10 minutes to inactivate the DNA ligase and then cooled on ice. 1.5pl of 75mM 
ATP and Ipl of T4 polynucleotide kinase was then added, mixed and incubated at 
37°C for 30 minutes. The reaction mixture was heated to 65°C for 10 minutes and 
then extracted with 140pl 2FC. The aqueous layer was applied to a Sepharose CL-4B 
column, spun at 400g for 2 minutes, the effluent was used for ligation into prepared À 
Excell EcoR I  /  CIP arms (Pharmacia). A range of different volumes of column 
efffluent were used for test ligations. To a total volume of 20pl (column effluent plus 
the required amount of ligation buffer plus 2pg of prepared X arms) Ipl of 3M 
sodium acetate and 50pl of cold (-20°C) ethanol was added, precipitated at -70°C for 
15 minutes. The cDNA and X arms were pelleted, washed in 70% ethanol and briefly 
air dried.
The pellet was resuspended in 8  pi of ligation buffer, to which was added 
Ipl of 1 mM ATP solution and Ipl of T4 DNA ligase, this ligation mix was then 
incubated at 16°C overnight. The ligated DNA was packaged using Gigapack II Gold 
Packaging extract (Stratagene), this packaging extract gives the highest efficieny of 
packaging when used to package cDNA molecules (selecting against large DNA 
molecules thus avoiding the packaging of multiple inserts). The manufacturers 
protocol was followed exactly and the resultant recombinant cDNA X library titred on 
NM522 Ecoli (Pharmacia) and screened as detailed before.
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SOLUTIONS
4.10 Formulation of frequently used solutions
PBS.A 1% (w/v) NaCl
0.025% (w/v) KCl 
0.14% (w/v) Na2 HP0 4  
0.025% (w/v) KH2 PO4
PBS lOmM CaCl2
6 mMMgCl2  
in PBS.A
TE lOmM Tris-Base
ImM EDTA 
pH/HCl/7.6
SM 50mM Tris-HCl pH7.5
1 0 mMMgSO4  
lOOmM NaCl 
0 .0 1 % gelatin
IX TAE 40mM Tris-acetate
2mM EDTA
TBE 89mM Tris-Base
89mM Boric acid 
2mM EDTA
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MOPS-E 20mM MOPS-acid
ImM EDTA 
5mM NaOAc 
pH/NaOH/7.0
20XSSC 3MNaCl
0.3M Na3citrate.2H20 
pH/HCl/7.0
2FC 49.5% (v/v) redistilled phenol
49.5% (v/v) chloroform 
1 % (v/v) isoamyl alcohol 
0 .1 % (w/v) 8  hydroxyquinoline 
saturated with TE:pH8
STE lOmM Tris.Cl, pH7.5
lOmM NaCl 
ImM EDTA
lOX PCR BUFFER
500mM KCL
lOOmMTris-base
15mMMgCl2.6H20
SAMPLE LOADING BUFFER 
20% (w/v) Ficoll 
0.25% Bromophenol Blue 
0.25% Xylene Cyanol FF
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Formulation of frequently used growth media
DMEM+ 10% (v/v) FBS
2mM L-Glutamine
in Dulbecco’s Modified Eagle Medium
L- BROTH 1% (w/v) Bacto-tryptone
0.5% (w/v) Bacto-yeast extract 
1% (w/v) NaCl
LBMM 0.2% (w/v) maltose
lOmM MgS04 
in L-broth
2X YT 1.6% (w/v) Bacto-tryptone
1% (w/v) Bacto-yeast extract 
0.5% (w/v) NaCl
For the bacterial and bacteriophage plating, Bacto-agar was added to the 
appropriate medium at 1.1% (w/v), or for soft, top agar at 0.6% (w/v). To prevent 
adhesion of the overlays to nitrocellulose, in plaque-lift assays, the agar was 
replaced with agarose.
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